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CHAPTER	I		INTRODUCTION		Overview		 All	cells	across	the	tree	of	life	carry	the	instructions	for	their	identity	and	function	within	their	DNA.		A	portion	of	this	DNA	consists	of	genes,	which	can	be	turned	into	a	functional	product	(RNA	or	protein)	via	the	processes	of	transcription	(DNA	→	RNA)	and	translation	(RNA	→	protein)	outlined	by	the	“central	dogma”	of	molecular	biology	(Crick,	1970).		Specifically,	protein-coding	genes,	whose	products	carry	out	many	diverse	cellular	functions,	make	up	an	estimated	88%	of	the	4.6Mb	genome	in	the	model	bacterium	
Escherichia	coli	(4,288	genes	(Blattner	et	al.,	1997)),	70%	of	the	12Mb	genome	in	the	baker’s	yeast	Saccharomyces	cerevisiae	(5,885	genes	(Goffeau	et	al.,	1996)),	and	1.2%	of	the	3Gb	human	genome	(20,000-25,000	genes	(Consortium	and	others,	2004)).		The	rest	of	each	genome	either	encodes	RNA	(including	ribosomal	RNA	(rRNA),	transfer	RNA	(tRNA),	small	non-coding	RNA	(ncRNA),	or	long	non-coding	RNA	(lncRNA)),	or	is	regulatory	DNA.			As	its	name	implies,	this	regulatory	DNA	plays	an	important	role	in	regulating	the	expression	of	RNAs	and	protein.		Such	regulation	of	expression,	which	can	occur	through	altering	RNA	synthesis/transcription,	RNA	degradation,	protein	synthesis/translation,	and	protein	degradation,	ultimately	determines	a	cell’s	responses	to	changes	in	environmental	signals.		The	importance	of	this	regulation	is	underscored	by	the	fact	that	an	“incorrect”	cellular	response	may	result	in	death	for	a	single-celled	organism	such	as	E.	coli	and	yeast,	
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or	disease	for	the	human,	where	the	problem	is	compounded	by	the	presence	of	multiple	cell	types	that	must	communicate	appropriately	to	ensure	the	health	of	the	organism.		 My	dissertation	research	is	broadly	aimed	at	understanding	how	the	cell	achieves	an	appropriate	response	to	environmental	stimuli	through	regulation	of	transcription,	the	first	step	in	gene	regulation.		Transcription	is	catalytically	accomplished	by	RNA	polymerases	that	generate	RNA	based	on	a	DNA	template.		While	prokaryotes	possess	only	one	RNA	polymerase	(Murakami,	2015),	yeast	and	higher	eukaryotes	from	the	animal	kingdom	possess	three	nuclear	RNA	polymerases	(Vannini	and	Cramer,	2012).		The	three	eukaryotic	nuclear	RNA	Polymerases	are:	(1)	RNA	polymerase	I	(Pol	I),	which	is	responsible	for	rRNA	gene	transcription,	(2)	RNA	polymerase	II	(Pol	II),	which	is	responsible	for	mRNA	(the	RNA	that	encodes	protein)	gene	transcription	as	well	as	most	lncRNA,	micro	RNA	(miRNA),	and	small	nuclear	RNA	(snRNA),	and	(3)	RNA	polymerase	III	(Pol	III),	which	transcribes	small	RNA	encoding	genes,	including	tRNAs	and	certain	ncRNAs	(Vannini	and	Cramer,	2012).		Importantly	for	my	work,	much	of	the	process	of	transcription	regulation	is	similar	across	all	domains	of	life.		Indeed,	the	transcription	process	is	highly	conserved	from	baker’s	yeast	to	higher	eukaryotes	(Hahn	and	Young,	2011).		This	fact	justifies	the	use	of	yeast,	which	provides	the	advantages	of	a	rapid	doubling	time	(90	min)	and	facile	genetics	and	biochemistry,	in	the	use	of	my	studies	that	were	aimed	at	uncovering	mechanisms	of	transcription	regulation.	 		 My	work	specifically	focuses	on	Pol	II	transcription	regulation.		Each	one	of	the	thousands	of	protein-coding	genes	in	eukaryotes	must	be	transcribed	at	the	right	time	and	in	the	right	amount	for	healthy	cellular	function	(Shandilya	and	Roberts,	2012;	Weake	and	Workman,	2010).		The	challenge	for	the	cell	is	that	many	of	these	genes	have	unique	
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expression	requirements,	with	transcript	levels	among	different	expressed	protein-coding	genes	varying	~8,000-10,000	fold	under	normal	growth	conditions	(Djebali	et	al.,	2012;	Nagalakshmi	et	al.,	2008).		How	does	Pol	II	achieve	this	variability	in	transcription	output?		Through	analysis	of	the	literature	and	the	studies	presented	herein	on	how	one	transcription	activator,	Repressor	Activator	Protein	1	(Rap1),	drives	transcription	of	the	robustly	transcribed	Ribosomal	Protein	(RP)	genes,	this	document	explores	the	answers	we	have	to	this	question	in	terms	of	the	contributions	made	by	DNA	elements,	transcription	factors,	and	the	interactions	among	them.			DNA	Elements	Guide	Pol	II	Transcription	Regulation		 As	mentioned	above	in	“Overview,”	the	genome	of	every	organism	consists	of	coding	and	regulatory	DNA,	both	of	which	form	critical	elements	in	the	structures	of	protein	encoding	genes	(Figure	1.1).		These	DNA	elements	help	direct	the	three	phases	of	Pol	II	transcription	cycle:	initiation,	elongation,	and	termination	(Shandilya	and	Roberts,	2012).		Some	of	these	elements	affect	transcription	output	through	their	presence,	position,	and	binding	affinity	for	a	DNA-binding	transcription	factor(s)	as	observed	in	prokaryotes	(Browning	and	Busby,	2004;	Mitchell	et	al.,	2003;	Pribnow,	1975;	Ross	et	al.,	1993;	Schaller	et	al.,	1975).		They	can	also	be	divided	into	two	categories:	(1)	the	enhancer/silencer-promoter	and	(2)	the	transcription	unit	(defined	below,	see	also	Figure	1.1).				 The	enhancer/silencer-promoter	is	a	set	of	regulatory	DNA	elements	that	are	of	particular	importance	to	Pol	II	transcription	because	they	regulate	when,	where,	and	to	what	level	each	gene	gets	transcribed	(Levo	and	Segal,	2014).		In	fact,	the	~60	years	of	research	on	these	DNA	sequences	that	has	followed	the	discovery	of	regulatory	DNA	in	
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bacterial	systems	(Jacob	and	Monod,	1961)	has	defined	their	function,	location	relative	to	the	transcription	unit,	and	consensus	sequences.				 Enhancers	and	silencers	influence	transcriptional	activity	largely	independent	of	position	and	orientation	relative	to	the	transcription	unit	(Li	et	al.,	2016).		Enhancers,	which	act	to	stimulate	transcription,	and	silencers,	which	act	to	repress	transcription,	consist	of	6-12	base	pair	recognition	sites	for	one	or	more	transcription	factors	(Levo	and	Segal,	2014).		In	metazoans,	these	DNA	elements	may	be	located	several	kb	upstream/downstream	of	the	transcription	unit	or	even	within	an	intron	(Li	et	al.,	2016).		However,	in	S.	cerevisiae,	possibly	due	to	its	more	compact	genome,	these	elements	are	
Figure	1.1.		Structure	of	a	protein	encoding	gene.		A	diagram	of	a	protein-encoding	gene	is	presented.		In	this	model,	the	DNA	elements	of	the	protein	encoding	gene	are	divided	into	enhancer/silencer,	core	promoter,	and	transcription	unit	regions.		The	enhancer/silencer-promoter	consists	of	enhancer	(E,	black)	elements		(functionally	equivalent	to	the	UAS	in	yeast)	and/or	silencer	(S,	red)	elements,	(functionally	equivalent	to	the	URS	in	yeast),	which	represent	DNA	recognition	elements	for	DNA-binding	transcription	factors,	which	can	be	located	anywhere	from	200bp	to	several	kb	away	from	the	transcription	unit.		The	enhancer/silencer-promoter	also	contains	a	core	promoter,	which	may	contain	BREu	(orange),	TATA	(blue),	
BREd	(orange),	INR	(purple),	MTE	(yellow),	and/or	DPE	(red),	elements,	is	located	immediately	5’	to	the	transcription	unit.		The	transcription	unit	extends	from	the	transcription	start	site	(TSS,	arrow,	+1)	to	the	transcription	termination	site	(TTS)	and	overlaps	slightly	with	the	enhancer/silencer-promoter.		It	contains	exons	(gray),	which	encode	protein.		It	may	also	contain	introns	(light	green),	which	are	non	protein-coding	sequenced	that	are	spliced	out	during	the	production	of	mature	mRNA.		The	start	codon	(ATG)	and	stop	codon	(UAA),	required	for	translation	of	the	mRNA	into	protein	are	marked	by	the	white	star	(*)	and	yellow	labels.		Although	not	labeled,	the	sequence	between	the	TSS	and	the	ATG	encodes	the	mRNA	5’	untranslated	region	(UTR)	while	the	sequence	between	the	stop	codon	and	the	TSS	encodes	the	3’	UTR.	
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located	1,000	base	pairs	or	less	upstream	of	the	transcription	unit	and	are	termed	Upstream	Activating	Sequences	(UAS)	and	Upstream	Repressing	Sequences	(URS)	(Hahn	and	Young,	2011).				 While	the	consensus	sequences	for	many	of	the	transcription	factors	that	bind	DNA	within	enhancers	and	silencers	have	been	defined	and	annotated	(Jolma	et	al.,	2013;	Sandelin,	2004),	the	rules	guiding	the	configuration	of	transcription	factor	binding	sites	within	an	enhancer/silencer	remain	poorly	understood.		Some	of	the	data	obtained	from	analyses	of	both	individual	chromosomal	enhancers	and	libraries	of	synthetic	enhancers	supports	a	“billboard	model”	of	enhancer	configuration.		In	this	model,	the	identity	and	number	of	transcription	factor	binding	sites	within	an	enhancer	influences	transcription	levels	largely	independent	of	binding	site	arrangement	(Liu	and	Posakony,	2012;	Rastegar	et	al.,	2008;	Smith	et	al.,	2013).		On	the	other	hand,	data	obtained	from	dissection	of	other	chromosomal	enhancers	supports	an	“enhanceosome	model,”	wherein	transcriptional	activity	depends	on	a	specific	order	and	spacing	among	transcription	factor	binding	sites	(Liu	and	Posakony,	2012;	Thanos	and	Maniatis,	1995).		Chromosomal	enhancers	may	follow	either	model	in	practice	depending	on	a	gene’s	regulatory	demand,	with	“billboard”	enhancers	operating	predominantly	on	genes	where	a	response	to	each	environmental	stimulus	independently	is	appropriate	and	“enhanceosome”	enhancers	operating	on	genes	that	require	carefully	orchestrated	integration	of	multiple	signals	(Levo	and	Segal,	2014;	Liu	and	Posakony,	2012).		 All	enhancers	regardless	of	configuration	must	operate	in	conjunction	with	a	core	promoter.		The	core	promoter,	which	is	generally	located	30-120	base	pairs	5’	of	the	transcription	unit	(Li	et	al.,	1994),	is	the	minimal	stretch	of	DNA	required	for	accurate	RNA	
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Pol	II	transcription	initiation	(Kadonaga,	2012).		A	core	promoter	may	be	sub-divided	into	several	separate	DNA	units	that,	like	the	enhancer/silencer	elements,	form	recognition	sites	for	transcription	factors	and	influence	transcription	activity.		The	core	promoter	elements	whose	position	and	consensus	sequences	have	been	defined	to	date	are:	(1)	the	TATA	box	(TATA)	(Nagawa	and	Fink,	1985),	(2)	the	Initiator	(INR)	(Smale	and	Baltimore,	1989),	(3)	the	downstream	promoter	elements	(DPE)	(Burke	and	Kadonaga,	1997),	(4)	the	Motif-Ten	Element	(MTE)	(Lim	et	al.,	2004),	and	(5)	the	TFIIB	recognition	element	(BRE)	motifs	BRE	upstream	(BREu)	and	BRE	downstream	(BREd)	(Kadonaga,	2012;	Lagrange	et	al.,	1998)	(Figure	1.1).			Gene	class-specific	promoter	elements,	such	as	the	polypyrimidine	initiator	motif	(TCT)	which	is	found	in	place	of	the	Inr	in	the	promoters	of	metazoan	RP	genes,	have	also	been	defined	(Parry	et	al.,	2010).		The	majority	of	these	elements	have	been	discovered	in	the	fruit	fly	Drosophila	melanogaster	and	human,	although	no	native	promoter	in	either	of	these	organisms	contains	every	element	(Kadonaga,	2012).		Meanwhile,	the	TATA	is	the	only	element	that	has	been	defined	in	yeast,	where	20%	of	promoters	are	designated	“TATA-containing”	due	to	the	presence	of	a	consensus	TATA	(Basehoar	et	al.,	2004)	and	80%	are	designated	“TATA-like”	due	to	one	or	two	base	pair	mismatches	from	the	consensus	(Rhee	and	Pugh,	2012).		 Pol	II	initiation	and	elongation	influenced	by	the	core	promoter	(Kadonaga,	2012)	enables	transcription	of	the	transcription	unit,	a	sequence	of	DNA	that	extends	from	the	promoter	through	the	transcription	start	site	(TSS)	to	the	transcription	termination	site	(TTS).		This	stretch	of	DNA	sequence,	which	ultimately	encodes	the	mRNA,	consists	of	at	least	one	exon,	which	encodes	protein.		It	may	also	contain	intron(s),	which	are	non-protein-coding	sequences	that	are	co-transcriptionally	spliced	out	to	allow	the	exons	to	be	
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joined	together	during	the	production	of	mature	mRNA	(Neugebauer	and	Roth,	1997).		Mature	mRNA	is	ultimately	exported	out	of	the	nucleus	to	be	used	as	a	template	to	direct	protein	synthesis.		The	sequence	that	becomes	the	part	of	the	mature	RNA	that	extends	from	the	start	codon	(AUG)	to	the	stop	codon	(UAA,	UGA,	or	UAG)	contains	the	open	reading	frame	(ORF)	to	be	translated	into	protein.		ORF	sequences	direct	translation	and	may	influence	both	mRNA	and	protein	stability.		Thus	the	sequences	of	the	enhancer/silencer-promoter	and	transcription	unit	ultimately	determine	regulation	of	gene	expression	at	the	levels	of	transcription,	mRNA	degradation,	translation,	and	protein	degradation.		 Pol	II	Function	and	Structure		 RNA	polymerases	synthesize	RNA	from	all	transcription	units	in	a	cell.		As	mentioned	in	“Overview”,	while	bacteria	possess	only	one	RNA	polymerase	(Murakami,	2015),	eukaryotes	(excluding	plants,	which	have	up	to	five	distinct	nuclear	DNA-dependent	RNA	polymerases	(Haag	and	Pikaard,	2011))	have	three	nuclear	RNA	polymerases:	Pol	I,	Pol	II,	and	Pol	III	(Roeder	and	Rutter,	1969),	each	of	which	synthesizes	a	different	class	of	RNA	(Weinmann	and	Roeder,	1974;	Zylber	and	Penman,	1971).		RNA	Pol	II	function	and	structure	are	detailed	here	due	to	the	emphasis	of	this	dissertation	on	mRNA	gene	transcription.		Areas	of	homology	between	Pol	II	and	the	other	Polymerases	(Vannini	and	Cramer,	2012)	are	also	noted.		 RNA	Polymerase	II	in	all	eukaryotes	accomplishes	its	mRNA	synthesis	function	through	the	initiation,	elongation,	and	termination	phases	of	the	transcription	cycle	(Figure	1.2)	(Shandilya	and	Roberts,	2012),	processes	directed	by	the	DNA	elements	
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described	above	and	the	general	transcription	factors	(GTFs)	required	for	accurate	transcription	initiation	described	in	the	“Basal	Transcription	Factors”	section.		The	initiation	phase	begins	when	RNA	Pol	II	binds	the	promoter	and	synthesizes	the	first	phosphodiester	bonds	of	RNA	(Hahn,	2004).		However,	initiation	does	not	guarantee	full-length	transcript	generation;	transcription	may	be	aborted	at	5	or	fewer	nucleotides	(Holstege	et	al.,	1997).		To	synthesize	a	full-length	transcript,	Pol	II	must	escape	the	promoter.		After	promoter	escape,	Pol	II	may	pause	transcription	(Gilmour	and	Lis,	1986;	Muse	et	al.,	2007),	providing	an	opportunity	to	regulate	transcription	elongation	that	is	particularly	important	in	metazoans	(Adelman	and	Lis,	2012).		Alternatively,	Pol	II	may	proceed	into	the	elongation	phase	of	transcription,	a	process	facilitated	by	Pol	II-associated	elongation	factors	such	as	TFIIS	(Rappaport	et	al.,	1987;	Reinberg	and	Roeder,	1987;	Sekimizu	et	al.,	
Figure	1.2.	The	RNA	Polymerase	II	Transcription	Cycle.		A	diagram	illustrating	the	phases	of	the	RNA	Polymerse	II	transcription	cycle	is	shown.		In	the	“Pre-initiation”	phase,	Pol	II	(blue,	only	one	of	the	multiple	CTD	heptad	repeats	(N’-YSPTSPS-C’)	is	shown)	is	bound	to	promoter	DNA.		The	TSS	and	TTS	sites	on	the	sample	protein-coding	gene	are	indicated	here	for	reference.		The	“Initiation”	phase	begins	when	Pol	II	proceeds	into	the	TSS	and	begins	its	entrance	into	the	gene	ORF,	synthesizing	the	first	few	mRNA	(red)	nucleotides.			At	this	phase,	Pol	II	is	located	where	levels	of	phosphorylated	Pol	II	CTD	heptad	repeat	Ser5	are	highest.		Following	promoter	clearance,	Pol	II	enters	the	“Elongation”	phase	of	transcription,	extending	the	synthesis	of	the	mRNA.		Once	it	reaches	the	TTS,	Pol	II	and	the	synthesized	full-length	mRNA	are	released	from	the	ORF	in	the	“Termination”	phase	of	transcription.		During	this	phase,	Pol	II	is	located	at	the	3’	end	of	the	gene,	where	Pol	II	CTD	heptad	repeat	amino	acid	Ser2	phosphorylation	levels	are	highest.		Once	it	is	released	from	the	template,	Pol	II	is	free	to	begin	the	cycle	of	transcription	anew.		
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1979),		and	transcribe	the	entire	transcription	unit.		Upon	completing	transcription	unit	mRNA	synthesis,	both	Pol	II	and	the	mRNA	it	has	recently	generated	are	released	from	the	template	in	the	termination	phase	of	transcription.		Pol	II	is	then	free	to	begin	another	round	of	transcription.		It	may	reinitiate	transcription	on	the	same	gene,	a	process	facilitated	by	transcription	factors	that	remain	at	the	promoter	during	the	transcription	cycle	(Yudkovsky	et	al.,	2000)	and/or	gene	looping	guided	by	transcription	termination	factors	(El	Kaderi	et	al.,	2009).	Alternatively,	Pol	II	may	initiate	transcription	of	a	different	gene.			 Like	all	enzymes,	Pol	II	achieves	its	transcription	activity	through	its	structure.		Yeast	Pol	II,	whose	structure	is	largely	conserved	in	higher	eukaryotes	and	is	the	focus	of	this	discussion,	consists	of	12	subunits,	designated	Rpb1-12	(Table	1.1)	(Edwards	et	al.,	1990;	Kolodziej	et	al.,	1990;	Treich	et	al.,	1992;	Vannini	and	Cramer,	2012).		All	subunits	except	Rpb4	and	Rpb9	are	essential,	although	cells	lacking	Rpb4	and	Rpb9	exhibit	a	slow-growth	phenotype	(Woychik	and	Young,	1989;	Woychik	et	al.,	1991,	1993).		10	Pol	II	subunits	(Rpb1,	Rpb2,	Rpb3,	Rpb5,	Rpb6,	Rbp8,	Rpb9,	Rpb10,	and	Rpb12)	form	the	enzyme’s	stable	catalytic	core,	while	Rbp4	and	Rpb7	dissociate	during	elongation	(Mosley	et	al.,	2013).		However,	Rbp4	and	Rpb7	are	required	for	initiation	(Edwards	et	al.,	1990).		Rbp9	provides	RNA	cleavage	activity	and	helps	relieve	Pol	II	stalling	(Awrey	et	al.,	1997).		Five	of	the	catalytic	core	subunits	(Rpb5,	Rpb6,	Rpb8,	Rpb10,	
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and	Rpb12)	are	shared	with	Pol	I	and	Pol	III	(Vannini	and	Cramer,	2012).				 Some	Pol	II	subunits	also	possess	sequence	and	structural	homology	to	the	bacterial	RNA	polymerase,	which	consists	of	two	α	subunits,	the	β	and	β’	subunits,	an	ω	subunit,	and	a	σ	subunit	(Murakami,	2015).		The	catalytic	core	subunits	Rpb3	and	Rpb11	resemble	the	two	bacterial	RNA	polymerase	α	subunits	(Zhang	and	Darst,	1998).		Rpb6	serves	structural	roles	and	is	most	similar	to	ω	(Minakhin	et	al.,	2001).		Meanwhile,	Rpb1	and	Rpb2	form	the	Pol	II	active	center	and	are	similar	to	the	β	and	β’	subunits,	respectively	(Allison	et	al.,	1985;	Cramer	et	al.,	2001;	Sweetser	et	al.,	1987).		These	subunits	contain	the	nucleotide	binding	pocket	and	catalyze	the	formation	of	phosphodiester	bonds	needed	to	build	the	mRNA	chain	(Riva	et	al.,	1987).		Rpb1	and	Rpb2	can	also	bind	the	death	cap	mushroom	toxin	α–amanitin.		This	binding	event	inhibits	the	translocation	of	DNA	and	RNA	needed	to	extend	the	mRNA	chain	(Bushnell	et	al.,	2002)	and	is	responsible	for	the	observed	sensitivity	of	Pol	II	to	α–amanitin	(Schultz	and	Hall,	1976).		 In	addition	to	its	role	in	catalysis,	Rpb1	contributes	to	transcription	via	its	essential	C-terminal	domain	(CTD)	(Allison	et	al.,	1988;	Zehring	et	al.,	1988).		The	Rpb1	CTD	consists	of	25	repeats	in	yeast	(up	to	52	in	higher	eukaryotes)	of	the	amino	acid	sequence	Y1S2P3T4S5P6S7	(Allison	et	al.,	1985;	Corden	et	al.,	1985).		These	repeats	are	the	target	for	post-translational	modification,	particularly	phosphorylation.		Indeed,	Rpb1	phosphorylation	was	noted	in	early	studies	that	defined	RNA	Pol	II	subunit	composition	(Kolodziej	et	al.,	1990).		The	two	most	well	studied	CTD	post-translational	modifications	are	Ser5	phosphorylation	(Ser5-P)	and	Ser2	phosphorylation	(Ser2-P)	(Hsin	and	Manley,	2012).		Chromatin	immunoprecipitation	(ChIP)	experiments	have	found	that	Ser5-P	levels	are	highest	at	the	5’	end	of	the	transcription	unit	while	Ser2-P	levels	are	highest	at	the	3’	
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end	of	the	transcription	unit	(Komarnitsky	et	al.,	2000)	(Figure	1.2).		Perhaps	consistent	with	this	localization,	Ser5-P	is	catalyzed	by	the	Kin28	subunit	of	the	GTF	TFIIH	(Lu	et	al.,	1992)	found	at	gene	promoters	(see	“Basal	Transcription	Factors)	and	removed	primarily	by	Ssu72	(Krishnamurthy	et	al.,	2004),	a	subunit	of	the	yeast	cleavage/polyadenylation	factor	(CPF)	complex.		Meanwhile,	Ser2-P	is	catalyzed	by	the	Bur1/Bur2	and	Ctk1	kinases	(Keogh	et	al.,	2003;	Lee	and	Greenleaf,	1991;	Qiu	et	al.,	2009)	involved	in	elongation	and	removed	by	Fcp1	(Cho	et	al.,	2001).		 The	Ser5-P	and	Ser2-P	RNA	Pol	II	CTD	modifications	create	binding	sites	for	factors	important	for	cotranscriptional	mRNA	processing	and	completion	of	the	transcription	cycle.		For	example,	Ser5-P	is	recognized	by	mRNA	capping	enzymes	(Cho	et	al.,	1997)	that	act	on	the	5’	end	of	transcription	unit	while	Ser2-P	is	associated	with	transcription	termination/mRNA	polyadenylation	factors	(Barillà	et	al.,	2001)	that	act	on	the	3’	end	of	the	transcription	unit.		In	support	of	this	simple	“CTD	code,”	a	recent	mass	spectrometry	analysis	showed	that	Ser5-P	and	Ser2-P	rarely	co-exist	on	the	same	repeat,	and	CTD-interacting	factors	associate	primarily	with	either	Ser5-P	or	Ser2-P	repeats	(Suh	et	al.,	2016).		Thus,	CTD	phosphorylation	appears	to	provide	a	means	to	permit	transcription	accessory	factors	to	specifically	associate	with	the	phase	of	the	transcription	cycle	that	is	most	appropriate	for	their	activity.	 	Basal	Transcription	Factors			 In	spite	of	its	complex	structure	and	function,	eukaryotic	Pol	II,	in	contrast	to	bacterial	RNA	polymerase,	cannot	accurately	initiate	transcription	on	its	own	(Weil	et	al.,	1979).	Instead,	eukaryotic	Pol	II	requires	factors,	termed	basal	transcription	factors	or	
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general	transcription	factors	(GTFs),	to	initiate	transcription.		Like	Pol	II,	each	of	the	six	GTFs	(transcription	factor	for	RNA	Polymerase	II	A	(TFIIA),	TFIIB,	TFIID,	TFIIE,	TFIIF,	and	TFIIH	(Table	1.2)	are	obligate	components	of	transcription	machinery	(Thomas	and	Chiang,	2006).		These	six	GTFs,	which	were	named	according	to	their	fractionation	from	crude	cell	extracts	(Matsui	et	al.,	1980;	Sayre	et	al.,	1992),	and	Pol	II	form	the	pre-initiation	complex	(PIC).		Each	of	the	GTFs	interacts	with	the	promoter	elements	described	in	“DNA	Elements	Guide	Pol	II	Transcription	Regulation,”	plays	a	critical	role	in	Pol	II	promoter	binding	and	PIC	formation	(Figure	1.3),	and	adds	ways	to	regulate	gene	expression	(Roeder,	2005).		Yeast	GTFs	will	be	the	focus	of	this	discussion.			As	was	the	case	for	Pol	II,	the	structure	and	function	of	these	transcription	factors	are	largely	conserved,	and	important	differences	are	noted.			 TFIIA:		The	45kDa	TFIIA	complex	is	composed	of	two	subunits:	Toa1	(32kDa)	and	Toa2	(13kDa)	(Ranish	and	Hahn,	1991),	each	encoded	by	a	single	copy	essential	gene	(Ranish	et	al.,	1992).		Although	it	does	not	bind	DNA	on	its	own,	TFIIA	aids	in	PIC	formation	by	enhancing	the	binding	of	the	TATA	Binding	Protein	(TBP)	to	promoter	DNA	via	direct	
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TFIIA-TBP	interaction	(Yokomori	et	al.,	1994).		This	TFIIA-TBP	interaction	can	competitively	displace	interactions	between	TBP	and	a	part	of	the	subunit	of	the	TBP-containing	complex	TFIID	(TBP-associated	factor	1	(Taf1)	N-terminal	domain	(TAND)	(Bai	et	al.,	1997;	Kotani	et	al.,	1998))	that	prevents	TBP	binding	to	DNA	(Kokubo	et	al.,	1998;	Ozer	et	al.,	1998),	explaining	the	requirement	of	TFIIA	for	TFIID	promoter	binding	under	certain	conditions	(Emami	et	al.,	1997;	Lieberman	and	Berk,	1994;	Sanders	et	al.,	2002a).		Additionally,	TFIIA	interacts	directly	with	transcription	activators	such	as	VP16	and	Zta	to	
Figure	1.3.	Model	for	PIC	Assembly.	A	model	for	PIC	complex	assembly.	PIC	nucleation	begins	with	the	promoter	binding	of	TBP	(green),	which	can	be	stabilized	by	TFIIA	(purple).		TBP	and	TFIIA	promoter	binding	is	stable,	while	TFIIB	(light	blue)	promoter	binding	is	dynamic.		TFIIB	direct	interaction	with	TBP	(green)	stabilizes	TBP-DNA	binding.	TFIIB	binding	to	the	core	promoter	enables	the	association	of	the	remaining	GTFs,	including	Pol	II	(medium	blue),	TFIIF	(yellow),	TFIIE	(red),	and	TFIIH	(pink).		This	fully	assembled	PIC	enables	Pol	II	initiation	of	transcription.		Importantly,	the	first	step	of	TBP-binding	can	be	stimulated	by	interaction	between	the	Taf	subunits	of	the	TBP-containing	complex	TFIID	(not	shown)	and	transcription	factors	called	transcription	activator	proteins	(not	shown)	described	in	“Transfactors	Confer	Gene-Specific	Transcription	Regulation.”		TFIID	Tafs	may	also	be	required	for	promoter-binding	in	the	absence	of	a	consensus	TATA.		
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coactivate	transcription,	usually	by	stimulating	TFIID	DNA-binding	(Kobayashi	et	al.,	1995;	Lieberman,	1994;	Lieberman	et	al.,	1997;	Ozer	et	al.,	1996).			 TFIIB:	The	38kDa	GTF	TFIIB	is	encoded	by	a	single-copy	essential	gene:	SUA7	(Pinto	et	al.,	1992).		Like	TFIIA,	TFIIB	can	directly	bind	TBP	and	stabilize	TBP	DNA-binding	(Imbalzano	et	al.,	1994).		TFIIB	also	interacts	directly	with	Pol	II	and	TFIIF	(Buratowski	and	Zhou,	1993;	Ha	et	al.,	1993).		Through	these	interactions,	TFIIB	plays	an	important	role	in	PIC	formation.		In	the	step-wise	model	of	PIC	formation,	TFIIB	recognizes	the	complex	formed	between	TBP,	TFIIA,	and	DNA	(Buratowski	et	al.,	1989;	Maldonado	et	al.,	1990)	(Figure	1.3).		TFIIB	may	then	in	turn	enable	Pol	II	and	the	rest	of	the	GTFs	to	enter	the	PIC	(Buratowski	et	al.,	1989;	Killeen	et	al.,	1992).		TFIIB	interaction	with	Pol	II	also	guides	transcription	initiation	and	TSS	selection	(Pardee	et	al.,	1998).		Finally,	TFIIB	can	interact	with	the	activation	domains	(ADs)	of	transcription	activators	and	thus	may	serve	as	a	coactivator	in	some	gene	contexts	(Chiang	et	al.,	1996).			 TFIID:		TFIID	(MW	~1MDa)	consists	of	at	least	19	polypeptides	depending	on	the	species,	including	TBP	and	various	Taf	subunits,	some	of	which	are	present	in	two	or	more	copies	within	the	complex	(Sanders	et	al.,	2002a;	Tansey	and	Herr,	1997;	Tora,	2002).		In	S.	
cerevisiae,	the	model	organism	used	for	this	dissertation	research,	TFIID	possesses	14	distinct	Tafs	(Taf1	→	14)	(Sanders	et	al.,	2002a).		The	genes	encoding	each	of	the	TFIID	subunits	are	essential	except	for	TAF14	(Klebanow	et	al.,	1996,	1997;	Moqtaderi	et	al.,	1996;	Poon	et	al.,	1995;	Ray	et	al.,	1991;	Reese	et	al.,	1994;	Sanders	and	Weil,	2000).		Additionally,	Taf14,	which	is	also	a	component	of	other	transcription-related	complexes	including	TFIIF	(Henry	et	al.,	1994;	Sanders	et	al.,	2002b),	is	not	present	in	the	TFIID	complexes	of	other	organisms	(Tora,	2002).			
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	 While	in	yeast,	TFIID	exists	as	one	holo-TFIID	complex	(Sanders	and	Weil,	2000)	which	will	be	described	in	more	detail	in	a	later	section	of	this	Chapter,	in	metazoan	systems	the	situation	is	much	more	complicated.		One	factor	complicating	the	definition	of	what	constitutes	the	TFIID	complex	in	metazoans	is	the	existence	of	alternate	versions	of	both	Tafs	and	TBP	in	differentiated	tissue	(D’Alessio	et	al.,	2009).		The	earliest	of	the	alternative	Tafs	to	be	identified	was	Taf4b,	which	was	originally	identified	in	B	cells	(Dikstein	et	al.,	1996)	and	is	required	for	cell-type	specific	gene	activation	in	ovaries	and	testes	(Geles	et	al.,	2006).		Since	then,	other	tissue-specific	versions	of	Tafs	and	TBP	have	been	identified,	including	cannonball/can	(Taf5	paralog),	no	hitter/nht	(Taf4	paralog),	
meiosis	I	arrest/mia	(Taf6	paralog),	spermatocyte	arrest/sa	(Taf8	paralog),	and	ryan	
express/rye	(Taf12	paralog)	(Hiller,	2004)	and	TBP-Related	Factor	1	(TRF1)	in	Drosophila	(Crowley	et	al.,	1993).		Tissue	differentiation	in	metazoans	may	also	result	in	the	replacement	of	canonical	TFIID	with	a	TFIID	sub-complex	such	as	the	Taf3/TRF	complex	which	was	found	to	replace	TFIID	in	differentiated	myotubes	(Deato	and	Tjian,	2007).		These	TFIID	sub-complexes	and	alternative	TFIID	subunits	likely	provide	interaction	surfaces	for	other	transcription	factors	that	are	required	for	tissue-specific	gene	activation	but	are	not	available	in	the	canonical	holo-TFIID	complex.		Consistent	with	this	idea,	holo-TFIID	is	unable	to	substitute	for	Taf3/TRF3	to	activate	muscle-specific	gene	transcription	
in	vitro	(Deato	et	al.,	2008)	and	some	mammalian	activators	are	reportedly	unable	to	function	in	yeast	which	lack	alternative	Tafs/TFIID	(Attardi	and	Tjian,	1993;	Ponticelli	et	al.,	1995).			 No	matter	its	exact	composition,	one	of	the	primary	functions	of	TFIID	is	promoter	recognition	(Albright	and	Tjian,	2000).		In	this	role,	TFIID	is	akin	to	the	σ	subunits	(σ70		and	
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alternative	σ	variants	(Burgess	et	al.,	1969;	Fox	et	al.,	1976;	Haldenwang	et	al.,	1981))	of	bacterial	RNA	Polymerase,	which	are	required	for	consensus	and	alternative	promoter	DNA	recognition	in	prokaryotes	(Sugiura	et	al.,	1970).			As	its	name	implies,	TBP	binds	the	
TATA	DNA	elements	of	core	promoters	(Hahn	et	al.,	1989).		PIC	formation	absolutely	requires	TBP	promoter	association	because	the	other	GTFs	cannot	bind	promoter	DNA	in	the	absence	of	TBP	(Buratowski	et	al.,	1989).		TBP	is	capable	of	binding	consensus	TATA-containing	DNA	independently	of	the	other	TFIID	subunits,	a	property	that	has	been	used	to	achieve	in	vitro	transcription	using	purified	components	(He	et	al.,	2016;	Myers	et	al.,	1997).		However,	the	Taf	subunits	likely	play	an	important	role	in	TFIID	binding	to	most	of	the	promoters	it	occupies,	which	contain	non-consensus	TATA	elements	(Huisinga	and	Pugh,	2004).		Some	of	the	Taf	subunits	have	indeed	been	shown	to	directly	interact	with	either	core	promoter	DNA	elements	or	promoter-proximal	nucleosomes.		Specifically,	at	least	in	metazoans,	Taf2	binds	the	promoter	INR	element	(Chalkley	and	Verrijzer,	1999;	Verrijzer	et	al.,	1994,	1995)	while	Taf6	and	Taf9	interact	with	the	DPE	promoter	DNA	element	(Burke	and	Kadonaga,	1997).		Additionally,	Taf3	in	metazoans	and	Taf14	in	yeast	may	contribute	to	TFIID	promoter	occupancy	through	interactions	with	modified	promoter-proximal	nucleosomes	mediated	via	their	plant	homeobox	domain	(PHD)	and	Yaf9,	ENL,	AF9,	Taf14,	Sas5	(YEATs)	domains	respectively	(Andrews	et	al.,	2016;	Feigerle	and	Weil,	2016;	Lauberth	et	al.,	2013;	Shanle	et	al.,	2015;	Vermeulen	et	al.,	2007).		These	Taf-DNA	and	Taf-chromatin	interactions	likely	facilitate	TFIID	promoter	binding	particularly	on	gene	promoters	that	lack	a	consensus	TATA	box.			 Like	TFIIA	and	TFIIB,	TFIID	can	function	as	a	coactivator	(Chen	et	al.,	1994;	Gill	et	al.,	1994;	Pugh	and	Tjian,	1990;	Thut	et	al.,	1995).		This	coactivator	function	requires	the	
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TFIID	Taf	subunits	since	TBP	alone	does	not	respond	to	transcription	activators	(Dynlacht	et	al.,	1991;	Pugh	and	Tjian,	1990;	Tanese	et	al.,	1991).		As	such,	there	has	been	and	continues	to	be	much	interest	in	the	field	of	transcription	in	defining	activator-Taf	interactions	and	their	biochemical	consequences.		Indeed,	TFIID	has	been	viewed	as	an	ideal	coactivator	target	in	transcription	regulation	(Albright	and	Tjian,	2000).			The	many	Taf	subunits	of	TFIID	offer	a	multitude	of	interaction	surfaces	for	transcription	activator	binding,	and	activator-Taf	interactions	likely	aid	TBP	promoter	association	(which,	as	described	above,	is	rate-limiting	in	PIC	formation	(Buratowski	et	al.,	1989))	with	the	genes	that	depend	on	TFIID.		Due	to	the	importance	of	TFIID	for	this	dissertation,	these	ideas,	along	with	other	details	regarding	TFIID	structure	and	coactivator	function,	will	be	further	described	in	the	“TFIID	Structure	and	Coactivator	Function”	section	appearing	later	in	this	Chapter.		 TFIIE:		TFIIE	is	a	heterotetrameric	complex	(~184	kDa)	(Inostroza	et	al.,	1991)	consisting	of	two	copies	each	of	the	subunits	Tfa1	and	Tfa2	encoded	by	single	copy	essential	genes	(Feaver	et	al.,	1994).		TFIIE	interaction	with	the	promoter	causes	a	conformational	change	in	promoter	DNA	required	for	transcription	initiation	(Buratowski	et	al.,	1991;	Holstege	et	al.,	1996).		TFIIE	also	interacts	directly	with	Pol	II	and	the	GTF	TFIIH	(Maxon	et	al.,	1994).		TFIIE	interaction	with	TFIIH	stimulates	TFIIH	kinase	and	helicase	activities	required	for	transcription	initiation	(Lu	et	al.,	1992;	Ohkuma	and	Roeder,	1994).		 TFIIF:		The	156	kDa	yeast	GTF	TFIIF	is	made	up	of	three	subunits.		Two	of	those	subunits	(Tfg1	and	Tfg2)	(Henry	et	al.,	1992)	are	unique	to	TFIIF	and	one	(Taf14)	is	shared	with	TFIID	(Henry	et	al.,	1994).		TFG1	and	TFG2	are	essential	(Henry	et	al.,	1994).		
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Meanwhile,	TAF14	is	neither	essential	(though	taf14∆	cells	grow	very	slowly)	(Henry	et	al.,	1994)	nor	present	in	metazoan	TFIIF	(Flores	et	al.,	1989).		TFIIF	associates	tightly	with	Pol	II	in	the	context	of	the	PIC	(Rani	et	al.,	2004).		This	TFIIF-Pol	II	interaction	enables	Pol	II	incorporation	into	the	PIC	and	TSS	selection	(Flores	et	al.,	1991;	Ghazy	et	al.,	2004).		The	TFIIF-Pol	II	interaction	also	stimulates	both	the	initiation	and	elongation	phases	of	transcription	(Conaway	et	al.,	2000;	Ghazy	et	al.,	2004).				 TFIIH:	TFIIH	is	a	532	kDa	complex	consisting	of	10	subunits	in	budding	yeast:	Ssl2,	Rad3,	Tfb1,	Tfb2,	Ssl1,	Tfb3,	Ccl1,	Tfb4,	Kin28,	and	Tfb5	(Murakami	et	al.,	2012;	Ranish	et	al.,	2004;	Svejstrup	et	al.,	1994).		All	subunits	are	encoded	by	essential	genes	with	the	exception	of	TFB5	(Feaver	et	al.,	1997;	Gileadi	et	al.,	1992;	Gulyas	and	Donahue,	1992;	Higgins	et	al.,	1983;	Naumovski	and	Friedberg,	1983;	Park	et	al.,	1992;	Simon	et	al.,	1986;	Valay	et	al.,	1993;	Yoon	et	al.,	1992).		TFIIH	functions	as	both	a	helicase	and	a	kinase	(Guzder	et	al.,	1994;	Lu	et	al.,	1992);	TFIIH	helicase	and	kinase	activities	are	both	stimulated	by	the	TFIIH-TFIIE	interaction	described	above.		These	enzymatic	activities,	which	in	bacteria	are	contained	within	the	RNA	polymerase	itself	(Risher	and	Blumenthal,	1980;	Wigneshweraraj	et	al.,	2003),	are	required	for	transcription	initiation.		The	TFIIH	subunit	Ssl2	provides	the	helicase	activity	that	unwinds	template	DNA,	allowing	Pol	II	to	locate	the	TSS	(Guzder	et	al.,	1994).		Meanwhile,	the	Kin28	subunit	provides	the	kinase	activity	and	is	responsible	for	the	important	Rpb1	CTD	heptad	repeat	Ser	5	phosphorylation	(Hengartner	et	al.,	1998;	Lu	et	al.,	1992)	described	above.				
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The	Role	of	Chromatin	in	Eukaryotic	Transcription	Regulation		 The	process	of	transcription	in	eukaryotic	cells	occurs	on	DNA	that	has	been	packaged	into	chromatin	(Struhl,	1999).		This	chromatin	compaction	both	allows	the	roughly	2m	of	DNA	possessed	by	eukaryotic	cells	to	fit	inside	a	nucleus	only	microns	in	diameter	and,	as	importantly,	impacts	transcription	regulation	(Venkatesh	and	Workman,	2015;	Zaret	and	Carroll,	2011).		Chromatin	compaction	is	achieved	through	multiple	levels	of	chromatin	structure,	the	most	basic	and	well	understood	of	which	is	the	nucleosome	(Woodcock	and	Ghosh,	2010).		A	canonical	nucleosome	structure	consists	of	147bp	of	DNA	wrapped	1.5	times	around	a	histone	octamer	formed	by	two	copies	of	each	of	the	histone	proteins	H2A,	H2B,	H3,	and	H4	(Kornberg,	1974;	Luger	et	al.,	1997).		Perhaps	not	surprisingly,	the	packaging	of	DNA	into	these	nucleosome	structures	is	largely	inhibitory	to	transcription	(Han	and	Grunstein,	1988;	Lorch	et	al.,	1987).			This	is	due	to	the	fact	that	most	DNA	binding	proteins	cannot	recognize	their	cognate	cis	elements	when	packaged	into	a	nucleosome	(Archer	et	al.,	1991;	Morse,	2003;	Simpson,	1990).		Eukaryotic	cells	modulate	this	inhibitory	effect	in	two	ways:	(1)	altering	nucleosome	positioning	and	(2)	nucleosome	post-translational	modification	(summarized	in	Figure	1.4A,B).		 The	role	of	nucleosome	positioning	in	transcription	regulation	is	particularly	evident	in	the	case	of	genes	whose	activation	requires	nucleosome	remodeling	(see	Figure	
1.4A).		These	genes	are	conditionally	silenced	by	the	blocking	of	the	binding	sites	for	key	transcription	regulators	with	nucleosomes.		For	example,	in	budding	yeast,	the	PHO5	gene	is	repressed	under	phosphate	rich	conditions	in	part	by	nucleosome	occlusion	of	both	the	promoter	TATA	element	and	a	binding	site	for	the	Pho4	transcription	activator	(UASPHO4)(Almer	and	Hörz,	1986;	Almer	et	al.	,	1986;	Bergman	and	Kramer,	1983;	Bergman	
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et	al.,	1986;	Venter	et	al.,	1994).		PHO5	expression	becomes	activated	when	these	nucleosomes	are	removed.		In	wild-type	cells,	the	nucleosomes	occluding	TATA	and	UASPHO4	DNA	are	removed	by	ATP-dependent	chromatin	remodeling	factors,	a	class	of	enzymes	that	use	the	energy	of	ATP	hydrolysis	to	remodel	nucleosomes	and	includes	the	RSC,	Swi/Snf,	and	INO80	complexes	(Lorch	and	Kornberg,	2015),	that	are	brought	to	PHO5	under	phosphate	starvation	conditions	(Barbaric	et	al.,	2007).		Alternatively,	PHO5	activation	may	be	achieved	in	the	absence	of	phosphate	starvation	conditions	by	the	genetic	disruption	of	the	histone	chaperones	responsible	for	maintaining	the	nucleosome	occlusion	of	the	PHO5	promoter	
TATA	and	enhancer	(i.e.	UASPHO4)	(Adkins	and	Tyler,	2006).		 	
Figure	1.4.	Nucleosome	Positioning	and	Post	Translational	
Modification	Contribute	to	Transcription	Regulation.			
A,	Model	for	how	nucleosome	positioning	contributes	to	transcription.		A	nucleosome	positioned	over	the	promoter	and	TSS	may	block	PIC	formation.		However,	the	action	of	ATP-dependent	chromatin	remodeling	factors	can	reposition	nucleosomes	to	create	a	nucleosome	free	promoter	that	can	be	bound	by	the	GTFs	(TFIID	in	light	green,	other	GTFs	same	colors	as	in	Figure	1.3)	and	Pol	II	(medium	blue).		B,	Model	for	how	nucleosome	post-translational	modification	contributes	to	transcription.		The	+1	nucleosome	(located	just	downstream	of	the	promoter)	is	the	target	for	nucleosome	post-translational	modifications.		Histone	code	“writers”	such	as	methyltransferases	and	acetyltransferases	may	add	post-translational	marks	to	the	+1	nucleosome	guided	in	part	by	the	presence	of	H2A.Z	in	this	nucleosome	rather	than	H2A.		These	modified	nucleosomes	may	serve	as	binding	sites	for	GTFs	(such	as	TFIID	via	the	PHD	domain	of	its	Taf3	subunit	or	the	YEATS	domain	of	Taf14),	which	may	enhance	binding	of	the	GTFs	and	therefore,	Pol	II,	to	the	promoter.				
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	 Meanwhile,	transcription	of	constitutively	active	genes	seems	to	be	aided	by	the	placement	of	their	promoters	within	nucleosome	free	regions	(NFRs)	(Choder	et	al.,	1984;	Jakobovits	et	al.,	1980;	Saragosti	et	al.,	1980;	Yuan	et	al.,	2005).		The	mechanisms	for	establishing	this	NFR	remain	unclear,	although	three	contributing	components	have	been	proposed	(Venters	and	Pugh,	2009):	(1)	poly	dA-dT	tracts,	which	intrinsically	disfavor	nucleosome	formation	(Kunkel	and	Martinson,	1981;	Prunell,	1982),	(2)	transcription	factors	that	bind	nucleosomal	consensus	sequences	and	open	chromatin	(Cirillo	et	al.,	1998,	2002;	Perlmann	and	Wrange,	1988;	Yu	and	Morse,	1999;	Zaret	and	Carroll,	2011),	and	(3)	ATP-dependent	chromatin	remodelers.		In	a	recent	study,	NFRs	very	similar	to	those	observed	in	vivo	were	reconstituted	in	vitro	using	purified	yeast	genomic	DNA,	histones,	the	yeast	transcription	factors	Abf1	and	Reb1	that	can	affect	chromatin	structure	(Ganapathi	et	al.,	2011),	and	chromatin	remodelers	(Krietenstein	et	al.,	2016).	The	difference	between	the	nucleosome	positioning	observed	in	vivo	and	in	the	reconstituted	system	may	be	due	to	other	factors	that	likely	contribute	to	NFR	maintenance	and	may	refine	NFR	positioning	such	as	PIC	promoter	occupancy,	the	act	of	Pol	II	transcription,	and	the	activity	of	factors	associated	with	the	Pol	II	CTD.		 The	post-translational	modification	of	the	histone	tails	that	protrude	out	of	nucleosomes	provides	another	avenue	through	which	nucleosomes	may	affect	transcription	(Figure	1.4B).		Nucleosome	post-translational	modification	(PTM)	may	contribute	to	transcription	in	one	of	two	ways:	(1)	by	altering	nucleosome	structure	or	(2)	by	creating	a	binding	site	for	a	transcription	factor	(Bannister	and	Kouzarides,	2011).		Many	different	histone	PTMs	(which	include	ubiquitylation,	methylation,	and	acylation	(commonly	acetylation)),	the	protein	factors	that	deposit/“write”,	remove/“erase”,	or	
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recognize/”read”	them,	and	their	impact	on	transcription	have	been	studied.		The	+1	nucleosome	(the	nucleosome	immediately	downstream	of	the	NFR)	appears	to	be	a	“hub”	for	post-translational	modification,	which	may	be	guided	at	least	in	part	by	the	H2A.Z	which	replaces	H2A	at	this	nucleosome	(Raisner	et	al.,	2005).		For	example,	deposition	of	the	H2BK123ub	mark	at	the	+1	nucleosome	catalyzed	by	Rad6/Bre	(Dover	et	al.,	2002;	Hwang	et	al.,	2003;	Sun	and	Allis,	2002;	Wood	et	al.,	2003)	is	associated	with	transcription	activation,	perhaps	because	its	reported	enhancement	of	nucleosome	stability	(Chandrasekharan	et	al.,	2009)	improves	the	ability	of	proteins	that	contribute	to	activated	transcription	to	associate	with	this	nucleosome.		One	of	these	proteins	is	the	Set1/COMPASS	complex,	which	requires	H2BK123ub	to	deposit	the	H3K4me3	mark	(Krogan	et	al.,	2002;	Miller	et	al.,	2001)	that	is	associated	with	actively	transcribed	gene	promoters	(Pokholok	et	al.,	2005;	Roguev	et	al.,	2001;	Santos-Rosa	et	al.,	2002;	Strahl	et	al.,	1999)	and	is	recognized	by	the	Taf3	PHD	(Lauberth	et	al.,	2013;	Vermeulen	et	al.,	2007).		H4	acetylation	at	the	5’	end	of	genes	(Pokholok	et	al.,	2005)	catalyzed	by	the	acetyltransferase	NuA4	is	also	associated	with	gene	activation	(Allard	et	al.,	1999).		Meanwhile,	H3K36me3	deposited	by	the	Set2	methylase	in	gene	bodies	(Kizer	et	al.,	2005;	Krogan	et	al.,	2003;	Strahl	et	al.,	2002)	helps	repress	spurious	intragenic	transcription	by	creating	a	binding	site	for	factors	that	help	maintain	nucleosome	occupancy	in	the	wake	of	Pol	II	transcription	(Carrozza	et	al.,	2005;	Keogh	et	al.,	2005).		Taken	together,	the	studies	of	these	and	other	histone	PTMs	supports	a	model	wherein	“activating”	and	“repressing”	PTMs	act	together	to	influence	appropriate	access	of	transcription	factors	to	the	DNA	underlying	nucleosomes.		
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Transfactors	Confer	Gene-Specific	Transcription	Regulation		 Although	the	basal	transcription	machinery	and	chromatin	clearly	play	important	roles	in	transcription	regulation,	it	is	members	of	a	class	of	proteins	termed	transfactors	that	confer	gene	specificity	to	transcriptional	control	by	selectively	responding	to	discrete	cell-external	and/or	cell-internal	molecular	cues	(Struhl,	1995).		Transfactors,	whose	importance	is	underscored	by	the	designation	of	some	members	of	this	class	of	proteins	in	metazoans	as	“master	regulators”	of	development	and	differentiation	(Chan	and	Kyba,	2013;	Davis	et	al.,	1987;	Tapscott	et	al.,	1988),	achieve	their	effect	on	transcription	regulation	through	the	use	of	(minimally)	two	modular	functionally	distinct	domains	(Ptashne,	1988).		One	of	these	domains	is	a	DNA-Binding	Domain	(DBD),	the	minimal	protein	domain	required	to	bind	the	specific	consensus	sequence	of	a	transfactor	(Keegan	et	al.,	1986),	generally	with	extremely	high	affinity	(Kd	=	10-11-10-12	M)	(Letovsky	and	Dynan,	1989;	Sawadogo,	1988;	Vignais	et	al.,	1990;	Wu	et	al.,	1987).				 Since	transfactor-DNA	binding	largely	determines	which	gene(s)	that	transfactor	will	regulate,	many	transfactor	DBD	structure	characterization	studies	have	been	performed	with	the	long-term	goals	of	understanding	how	endogenous	transfactors	work	and	providing	guidelines	for	the	design	of	synthetic	transcription	factors	(Todeschini	et	al.,	2014).		The	characterization	of		>1500	protein-DNA	complex	structures	have	greatly	improved	our	understanding	of	how	DNA	recognition	is	achieved.		In	general,	these	studies	have	revealed	two	modes	of	protein-DNA	recognition:	(1)	base-readout,	where	a	DBD	directly	recognizes	DNA	bases	and	(2)	shape	readout,	where	a	DBD	recognizes	a	sequence-dependent	DNA	shape	(Rohs	et	al.,	2010).		Most	transfactor	DBDs	possess	one	of	three	structural	motifs,	each	of	which	uses	both	modes	of	protein-DNA	recognition:	(1)	zinc-
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finger,	(2)	helix-turn-helix/homeodomain,	or	(3)	basic	leucine	zipper	(bZIP)	(Hahn	and	Young,	2011).		Out	of	these,	zinc-finger	transfactors	are	the	most	abundant	in	yeast	and	human	(Hahn	and	Young,	2011;	Vaquerizas	et	al.,	2009).		Zinc	finger	DNA-binding	has	been	described	well	enough	to	produce	zinc-finger-DNA	interaction	codes	that	have	been	frequently	utilized	to	generate	zinc	finger	DBDs	with	altered	DNA-binding	specificity	(Gupta	et	al.,	2012;	Nguyen	et	al.,	2007;	Sera	and	Uranga,	2002;	Zhu	et	al.,	2013).		In	contrast,	there	are	only	a	few	altered	DNA-binding	specificity	variants	that	use	the	other	structural	motifs,	including	the	leucine	zipper	DBD	of	yeast	Gcn4	(Kim	et	al.,	1993)	and	the	helix-turn-helix	DBD	of	λ	phage	Cro	(Nilsson	and	Widersten,	2004).		 DBD	structure	analyses	have	been	complemented	by	in	vitro	selection	and	genomic	DNA-binding	approaches	aimed	at	defining	the	sequences	each	transfactor	can	and	does	bind	in	vivo	where,	as	described	above,	chromatin	may	occlude	potential	binding	sites	(Todeschini	et	al.,	2014).		As	mentioned	in	the	“DNA	Elements	Guide	Pol	II	Transcription	Regulation”	section,	these	studies	have	defined	the	consensus	sequences	for	many	enhancer/silencer-binding	transfactors	(Jolma	et	al.,	2013;	Sandelin,	2004).		However,	some	limitations	in	our	understanding	of	what	constitutes	a	binding	site	for	a	particular	transfactor	remain.		For	example,	a	recent	study	showed	that	the	sequences	recognized	by	the	Drosophila	Hox	proteins	is	altered	upon	binding	the	Hox	cofactor	Extradentical	(Exd),	providing	evidence	that	transfactor-cofactor	interactions	likely	influence	transfactor	DNA	recognition	in	vivo	(Slattery	et	al.,	2011).	Recognition	site	flanking	sequences,	which	can	impact	DNA	recognition	through	influencing	DNA	shape	readout	(Gordân	et	al.,	2013)	and	DNA-bendability	(Leonard	et	al.,	1997),	represent	another,	perhaps	underappreciated	factor	in	protein-DNA	recognition	and	transfactor	activity.	
	 25	
	 In	addition	to	a	DBD,	transfactors	usually	possess	(at	least	one)	activation	domain	(AD)	and/or	a	silencing	domain	(SD)	depending	on	whether	a	transfactor	is	a	transcription	activator,	a	transcription	repressor,	or	both.		ADs,	whose	structure	and	function	will	be	detailed	here	due	to	the	emphasis	of	my	thesis	project	on	transcription	activation,	are	domains	that	generally	activate	transcription	when	fused	to	a	DBD	module.		This	DBD	module	can	be	either	the	transfactor’s	native	DBD	or,	more	frequently,	a	heterologous	DBD	such	as	that	of	the	yeast	Gal4	or	bacterial	LexA	DBDs	(Ma	and	Ptashne,	1987;	Seipel	et	al.,	1992).		Essentially,	ADs	transmit	the	signal	for	activation	to	the	rest	of	the	transcription	machinery	(Ptashne,	1988),	a	process	usually	accomplished	via	direct	interaction(s)	between	the	domain	and	a	transcription	coregulator.				 The	ADs	of	several	transfactors	have	been	identified	over	the	last	~30	years	of	study.	ADs	are	typically	30-100	amino	acids	(aa’s)	in	length;	they	can	be	classified	into	one	of	three	groups	based	on	the	kinds	of	aa’s	that	make	up	20-25%	of	the	domain:	(1)	acidic,	(2)	proline-rich,	and	(3)	glutamine-rich	(Mitchell	and	Tjian,	1989;	Titz,	2006).		Site-directed	mutagenesis	has	been	performed	on	members	of	all	three	AD	groups	in	order	to	identify	important	AD	aa’s.		These	factors	include	the	herpes	virus	activators	VP16	and	ZTA	(aka	ZEBRA),	the	mammalian	activators	Sp1,	p53,	and	glucocorticoid	receptor	(GR),	and	the	yeast	activators	Gcn4	and	Gal4.		These	studies	have	generally	revealed	that,	while	the	overall	properties	conferred	by	the	dominant	aa	type	do	contribute	somewhat	to	AD	function,	these	ADs	depend	primarily	on	small	clusters	of	2-3	hydrophobic	aa’s,	usually	the	aromatics	Tryptophan	(W),	Tyrosine	(Y),	and	Phenylalanine	(F)	(Almlöf	et	al.,	1997;	Cress	and	Triezenberg,	1991;	Deng	et	al.,	2001;	Drysdale	et	al.,	1995;	Gill	et	al.,	1994;	Leuther	et	al.,	1993;	Lin	et	al.,	1994;	Regier	et	al.,	1993).			
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	 Biophysical	characterization	of	these	ADs	has	demonstrated	that	these	domains	are	unstructured	in	solution;	however,	upon	interaction	with	a	coregulator	target,	ADs	appear	to	adopt	an	α–helical	conformation	around	the	important	hydrophobic	residues	(Brzovic	et	al.,	2011;	Jonker	et	al.,	2005;	Krois	et	al.,	2016;	Radhakrishnan	et	al.,	1997;	Uesugi	et	al.,	1997).		Although	among	ADs,	transcriptional	activation	correlates	with	the	strength	of	AD-coregulator	target	binding	(Chang	et	al.,	1995;	Warfield	et	al.,	2014),	direct	AD-coregulator	interaction	is	a	low-affinity	interaction,	with	the	Kds	of	10-5-10-7	M	(Brzovic	et	al.,	2011;	Jonker	et	al.,	2005;	Krois	et	al.,	2016).		It	has	been	hypothesized	that	this	property	of	AD-coregulator	binding	may	be	important	in	vivo	to	permit	transcription	activators	to	dissociate	from	the	transcription	complex	once	transcription	initiation	has	occured.		It	may	also	allow	ADs	to	dissociate	and	bind	a	different	coregulator	target	(Berlow	et	al.,	2015;	Jonker	et	al.,	2005).		Indeed,	some	ADs,	such	as	viral	activator	VP16,	bind	multiple	coregulators	in	vitro,	although	it	is	not	clear	which,	if	any,	of	these	interactions	are	physiologically	relevant	(Jonker	et	al.,	2005;	Stringer	et	al.,	1990;	Vojnic	et	al.,	2011).		Meanwhile,	ADs	that	have	been	so	characterized	(the	yeast	activators	Gal4	and	Gcn4)	contact	only	a	few	coregulators	in	vivo,	and	not	all	of	these	interactions	are	required	for	transcription	(Bhaumik	and	Green,	2003;	Bhaumik	et	al.,	2004;	Fishburn	et	al.,	2005;	Reeves	and	Hahn,	2005).				 Given	that	coregulator	target	binding	is	theoretically	mediated	primarily	by	just	a	few	of	the	hydrophobic	aa’s	in	each	AD,	it	is	surprising	that	ADs	display	any	specificity	in	coregulator	binding/activity.		Indeed,	how	so	few	aa’s	achieve	any	target	binding	specificity	is	a	major	unanswered	question	in	the	field	of	transcription	(Hahn	and	Young,	2011).		A	recent	study	conducted	by	the	Hahn	lab	attempted	to	address	this	question	using	synthetic	
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derivatives	of	a	Gcn4	AD	(Warfield	et	al.,	2014).		Consistent	with	previous	analysis	of	the	VP16	AD	(Cress	and	Triezenberg,	1991),	these	workers	found	that	replacing	the	key	Gcn4	AD	hydrophobic	aa’s	with	different	hydrophobic	aa’s	negatively	impacted	AD	activity,	reinforcing	the	notion	that	the	particular	identities	of	these	aa’s	are	critical	determinants	of	AD	function	(Warfield	et	al.,	2014).		These	workers	also	found	that	adding	extra	hydrophobic	aa’s	to	the	Gcn4	AD	increased	AD	activity	and	AD-coregulator	binding	without	fundamentally	altering	the	structure	formed	between	the	AD	and	its	coregulator	target	(Warfield	et	al.,	2014).		While	admittedly,	these	results	leave	open	the	question	of	how	an	AD	achieves	coregulator	target	specificity,	they	do	serve	as	a	powerful	reminder	of	the	importance	of	the	key	AD	aa’s	in	determining	AD	activity.		 Transcription	Activation	Mechanisms		 Identifying	AD-coregulator	interactions	and	understanding	their	mechanistic	outcomes	is	an	active	area	of	research	(Green,	2005;	Hahn	and	Young,	2011;	Weake	and	Workman,	2010).		The	biochemical	processes	that	coregulators	use	to	relay	the	signal	from	the	transfactor	AD	to	the	rest	of	the	transcription	machinery	following	the	critical	first	step	of	AD-coregulator	interaction	are	not	well	understood.		The	identity	of	the	particular	coregulator	target	may	determine	in	part	which	processes	are	utilized.		Indeed,	transcription	coregulators	are	a	diverse	class	of	proteins	that	can	be	classified	as	either	coactivators	or	corepressors	depending	on	whether	the	signal	they	relay	from	the	transfactor	to	the	rest	of	the	transcription	machinery	triggers	activation	or	repression.		Some	characterized	coregulators	like	TFIIA	and	TFIID	are	obligate,	critical	components	of	the	transcription	machinery	(Chen	et	al.,	1994;	Kobayashi	et	al.,	1995;	Lieberman,	1994;	
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Lieberman	et	al.,	1997;	Ozer	et	al.,	1996;	Tanese	et	al.,	1991),	whereas	others	such	as	SAGA,	Mediator,	Swi/Snf,	p300,	Rpd3,	and	OCA-B	target	chromatin	and/or	other	coregulators	(Brownell	et	al.,	1996;	Kadosh	and	Struhl,	1998;	McKenna	et	al.,	2015;	Meyer	et	al.,	2010;	Ren	et	al.,	2011;	Tomar	et	al.,	2008;	Wallberg	et	al.,	2002).		Based	on	studies	of	both	prokaryotic	(Browning	and	Busby,	2004)	and	eukaryotic	transcription	(Ptashne	and	Gann,	1990),	two	models	of	transcription	activation	have	been	proposed	to	explain	how	AD-coregulator	interaction	affects	PIC	activity:	(1)	“recruitment”/cooperative	binding	and	(2)	conformational	change	(Figure	1.5).	 	
Figure	1.5.	Mechanisms	of	Transcription	Activation.		A,	The	“Cooperative	binding/Recruitment”	model	of	transcription	activation.		In	this	model	of	activation,	a	coactivator	displays	at	best	weak	binding	to	a	gene	promoter.		However,	direct	interaction	between	an	enhancer	DNA-binding	transcription	activator	and	the	coactivator	greatly	enhancers	coactivator	association	with	the	target	gene.	“Recruitment”	of	this	coactivator	may	then	either	indirectly	enhance	transcription	by	creating	a	more	favorable	chromatin	environment	or	directly	enhancing	transcription	by	completing	a	rate-limiting	step	in	PIC	formation	B,	The	“Conformational	change”	model	of	transcription	activation.		In	this	model,	a	coactivator	may	associate	with	a	target	gene	independently.		However,	the	key	step	in	this	model	is	a	coactivator	conformational	change	driven	by	direct	interaction	between	the	activator	and	coactivator.		This	conformational	change	may	occur	either	off	DNA	(as	shown	here)	or	on	DNA.		
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	 The	“recruitment”/cooperative	binding	model	(Figure	1.5A)	was	the	first	proposed	and	is	the	best-studied	activation	mechanism	(Hahn	and	Young,	2011;	Klein	and	Struhl,	1994a;	Ptashne	and	Gann,	1997;	Pugh	and	Tjian,	1990).		In	this	model,	PIC	formation/function	is	enhanced	as	a	result	of	cooperative	binding	of	a	transcription	activator	and	a	coactivator	to	target	gene	DNA.		Because	this	cooperative	binding	occurs	due	to	a	direct	binding	interaction	between	a	DNA-bound	transcription	activator	AD	and	the	coactivator,	the	activator	is	said	to	“recruit”	the	coactivator	to	the	target	gene.		Early	support	for	this	model	was	provided	by	a	series	of	in	vivo	studies	that	achieved	dramatic	enhancement	of	transcription	in	yeast	using	artificial	proteins	generated	by	fusing	a	DBD	to	subunits	of	three	multi-subunit	coactivator	complexes	considered	important	because	essentially	all	protein-coding	genes	depend	on	at	least	one	of	them:	TFIID,	SAGA,	and	Mediator	(Andrau	et	al.,	2006;	Basehoar	et	al.,	2004;	Chatterjee	and	Struhl,	1995;	Holstege	et	al.,	1998;	Huisinga	and	Pugh,	2004;	Keaveney	and	Struhl,	1998;	Klages	and	Strubin,	1995;	Xiao	et	al.,	1995).		Since	then,	studies	of	native	activation	have	provided	evidence	that	enhanced	coactivator	binding	to	a	target	gene	can	stimulate	PIC	formation/function	either	indirectly	by	creating	a	favorable	chromatin	environment	or	by	directly	contributing	to	PIC	formation.		 The	transcription	activation	of	the	yeast	PHO5	gene	described	previously	serves	as	an	example	of	a	transcription	activation	mechanism	wherein	coactivator	recruitment	indirectly	stimulates	PIC	formation/function.		Under	phosphate	starvation	conditions,	the	
PHO5	transcription	activator	protein	Pho4	enters	the	nucleus	of	the	cell	and	binds	its	recognition	sequence	(UASPHO4)	located	upstream	of	the	PHO5	ORF	(Barbaric	et	al.,	1998;	O’Neill	et	al.,	1996).		Once	there,	Pho4	does	not	need	to	interact	with	the	general	
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transcription	machinery	to	activate	PHO5.		Instead,	its	interaction	with	chromatin-modifying	factors	results	in	the	eviction	of	PHO5	promoter	nucleosomes	such	that	the	PIC	is	able	to	form	on	the	PHO5	promoter	and	initiate	transcription	(Barbaric	et	al.,	2007;	Gregory	et	al.,	1999;	Svaren	et	al.,	1994)	(cf		Figure	1.4A).		Indeed,	as	stated	above,	simply	remodeling	PHO5	promoter	nucleosomes	results	in	PHO5	activation	in	the	absence	of	the	Pho4	transcription	activator	(Adkins	and	Tyler,	2006).		 Meanwhile,	given	that	TBP,	which	is	a	subunit	of	both	TFIID	(Sanders	et	al.,	2002a)	and	SAGA	(Grant	et	al.,	1997),	nucleates	PIC	formation	(Buratowski	et	al.,	1989)	and	the	proposed	requirement	of	Mediator	for	transcription	initiation	in	vivo	(Koleske	and	Young,	1994),	it	is	thought	that	activator	recruitment	of	these	coactivators	stimulates	transcription	primarily	by	directly	increasing	PIC	formation/function.		Early	support	for	this	model	came	from	work	performed	by	the	Tjian	lab	using	the	Drosophila	model	system	demonstrating	that	TBP-Taf	complex	recruitment	to	the	promoter	required	transcription	activator	ADs	and	specific	Taf	subunits	(Sauer	et	al.,	1995a,	1995b).		Although	not	direct	tests	of	cooperative	binding,	other	in	vivo	evidence	consistent	with	the	direct	recruitment	model	comes	from	ChIP	studies	showing	that	the	yeast	activators	Gal4	and	Gcn4	as	well	as	their	respective	coactivator	targets	SAGA	and	Mediator	are	required	for	coactivator	occupancy	and	target	gene	transcription	(Bhaumik	and	Green,	2001;	Bhaumik	et	al.,	2004;	Herbig	et	al.,	2010;	Jedidi	et	al.,	2010;	Larschan	and	Winston,	2001).		Finally,	perhaps	the	best	evidence	for	native	activator-dependent	coactivator	recruitment	directly	enhancing	PIC	activity	comes	from	a	recently	published	study	of	transcription	regulation	by	human	TFIID	and	HEB,	a	transcription	activator	that	regulates	cell-fate	determination	(Chen	et	al.,	2013).		This	study	identified	regions	of	both	HEB	and	the	TFIID	subunit	Taf4	required	for	
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HEB-TFIID	interaction	and	transcription	of	HEB-dependent	genes.		Most	importantly,	this	study	also	demonstrated	via	gel	shift,	immobilized	template	assay,	and	DNase	footprinting	that	HEB-Taf4	interaction	was	required	for	cooperative	binding	of	TFIID	to	enhancer-promoter	DNA	(Chen	et	al.,	2013).			 In	addition	to	coactivator	“recruitment,”	direct	activator-coactivator	interaction	has	been	proposed	to	stimulate	transcription	via	triggering	a	conformational	change	(Figure	
1.5B).		Evidence	for	this	model	of	transcription	activation	comes	from	electron	microscopy	(EM)	structural	analyses	of	complexes	formed	between	Mediator	and	several	mammalian	activator	proteins,	including	VP16,	SREBP,	p53,	thyroid	receptor	(TR),	and	vitamin	D	receptor	(VDR)	(Meyer	et	al.,	2010;	Taatjes	et	al.,	2002,	2004).		The	structure	of	Mediator	in	these	activator-Mediator	complexes	is	different	from	the	structure	of	Mediator	alone;	interestingly,	Mediator	structure	varies	even	among	the	different	activator-Mediator	complexes	(Taatjes	et	al.,	2002,	2004).		Activator-Mediator	binding	has	also	been	shown	via	mass	spec	to	enable	Mediator	interaction	with	other	coactivators	(Ebmeier	and	Taatjes,	2010).		How	these	Mediator	conformational	changes	and	changed	Mediator-cofactor	interactions	affect	PIC	activity	(or	even	if	they	occur	in	functional	transcription	complexes)	is	currently	unclear.		A	recent	EM	structural	analysis	of	p53	and	Mediator	showed	that	the	p53	domain	required	for	activation	triggered	the	formation	of	a	pocket	within	Mediator.	Since	this	pocket	was	located	in	the	region	of	Mediator	that	binds	Pol	II,	these	investigators	proposed	that	pocket	formation	enabled	the	enhanced	Pol	II	promoter	escape	observed	in	the	presence	of	p53	(Meyer	et	al.,	2010).	However,	the	affect	of	p53	on	Mediator-Pol	II	binding	was	not	tested	biochemically.		More	information	regarding	how	Mediator	achieves	conformational	changes	is	needed	in	order	to	generate	Mediator	mutants	defective	in	
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conformational	change	that	can	be	used	to	test	the	transcriptional	consequences	of	Mediator	conformational	change	in	both	in	vitro	and	in	vivo	assays.			 	 TFIID	Structure	and	Coactivator	Function		 While	the	cooperative	binding	and	conformational	change	models	may	generally	describe	much	of	Pol	II	transcription	activation,	neither	model	has	been	rigorously	tested	using	iterative	genetic,	biochemical,	and	structural	approaches.		Further,	much	of	the	data	supporting	both	models	was	obtained	using	deletion	variants	of	the	transcription	activators	and	coactivators	in	question.		Such	mutants	provide	imprecise	tools	for	dissecting	the	mechanistic	consequences	of	activator-coactivator	binding.		More	rigorous	testing	should	be	performed	using	coactivator,	and	most	importantly,	transcription	activator	AD	point	mutant	variants.		Such	rigorous	testing	is	particularly	warranted	for	the	TFIID	coactivator	whose	function	is	required	for	90%	of	protein-coding	yeast	genes	(Huisinga	and	Pugh,	2004)	and	whose	multiple	subunits	make	contacts	critical	for	both	transcription	activation	and	for	structural	integrity	of	the	TFIID	complex.		 As	stated	in	“Basal	Transcription	Factors,”	the	TFIID	structure	formed	by	its	many	subunits	may	make	it	ideally	suited	to	serve	the	coactivator	function.		The	yeast	TFIID	used	for	my	project	is	a	1.2MDa	complex	consisting	of	TBP	and	14	Taf	subunits	(Taf1	→	14)	(Sanders	and	Weil,	2000;	Sanders	et	al.,	2002a)	(Figure	1.6A).		The	genes	encoding	all	TFIID	subunits	except	for	TAF14	are	essential	(Klebanow	et	al.,	1996,	1997;	Moqtaderi	et	al.,	1996;	Poon	et	al.,	1995;	Ray	et	al.,	1991;	Reese	et	al.,	1994;	Sanders	and	Weil,	2000).		Tafs	4,	5,	6,	9,	10,	and	12	are	present	in	two	copies	within	TFIID	and	Taf14	is	present	at	potentially	more	than	two	copies	(Sanders	et	al.,	2002a)	(Figure	1.6B).			
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	 Cryo-Electron	microscopy	(Cryo-EM)	analyses	of	yeast	TFIID	structure	have	revealed	that	TFIID	exists	as	an	asymmetric	structure	resembling	a	catcher’s	mitt	(Papai	et	al.,	2009,	2011).		This	mitt	shape	has	been	divided	into	4	lobes:	A,	B,	C,	and	D	(Figure	1.6C).		Using	immunolabeling	and	difference	mapping,	the	locations	of	all	TFIID	subunits	except	Taf14	have	been	roughly	mapped	within	the	context	of	the	TFIID	structure.		With	few	exceptions,	localization	of	all	TFIID	subunits	is	consistent	with	their	known	biochemically-defined	stoichiometry	and	subunit	interactions	(Birck	et	al.,	1998;	Gangloff	et	al.,	2001;	Hisatake	et	al.,	1995;	Sanders	et	al.,	2002a;	Selleck	et	al.,	2001;	Werten	et	al.,	2002).	EM	structural	analyses	of	human	TFIID	show	that	it	too	forms	a	similar	four-lobed	structure		(Bieniossek	et	al.,	2013a;	Louder	et	al.,	2016).			Indeed,	biochemical,	structural,	and	
Figure	1.6.	Yeast	TFIID	Structure	and	Subunit	Composition.		A,	TFIID	subunit	(Taf1	→ Taf14	and	TBP)	composition	as	revealed	by	SDS-PAGE	and	Sypro-Ruby	staining	of	TFIID.		This	TFIID	was	purified	by	Dr.	Jordan	T.	Feigerle.	B,	TFIID	subunit	stoichiometry	(mole	subunit/mole	TFIID)	as	determined	by	quantification	of	each	subunit	on	a	stained	SDS-PAGE	gel.		C,		The	structure	of	the	TFIID	complex	obtained	at	a	resolution	of	23	Angstroms	using	cryo-EM	(image	adapted	from	Papai	et	al.,	2010).		The	four	lobes	(A,	B,	C,	and	D)	are	indicated.		Additionally,	the	localization	of	a	few	of	the	Taf	subunits/Taf	domains,	including	Tafs	4,	5,	and	12,	which	are	important	for	the	work	presented	in	this	dissertation,	is	indicated.		
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bioinformatics	analyses	of	TFIID	and	its	subunits	have	repeatedly	demonstrated	that	TFIID	structure	and	function	are	highly	conserved	in	all	eukaryotes	(Bai	et	al.,	1997;	Bieniossek	et	al.,	2013b;	Birck	et	al.,	1998;	Durso	et	al.,	2001;	Gangloff	et	al.,	2001;	Hisatake	et	al.,	1995;	Klebanow	et	al.,	1997;	Louder	et	al.,	2016;	Malkowska	et	al.,	2013;	Matangkasombut	et	al.,	2000;	Papai	et	al.,	2009;	Scheer	et	al.,	2012;	Trowitzsch	et	al.,	2015;	Werten	et	al.,	2002)	(Figure	1.7).					 While	TBP	and	some	of	the	Taf	subunits	may	be	important	for	promoter	DNA-binding,	TFIID	coactivator	function	occurs	through	direct	interaction	between	Tafs	and	activator	proteins.			Early	studies	performed	in	metazoan	systems	by	the	Tjian	lab	have	shown	that	TBP	alone	does	not	respond	to	transcription	activators;	instead	TFIID	Tafs	are	required	for	activated	transcription	(Dynlacht	et	al.,	1991;	Pugh	and	Tjian,	1990;	Tanese	et	al.,	1991).		Several	lines	of	evidence	suggest	that	Tafs	are	required	for	activated	transcription	because	of	their	direct	interaction	with	activators.		The	metazoan	activators	Sp1,	p53,	NTF-1,	and	c-Jun	all	interact	directly	with	Tafs	(Chen	et	al.,	1994;	Liu	et	al.,	2009;	Thut	et	al.,	1995).		Meanwhile,	transcription	levels	are	eliminated/reduced	in	the	absence	of	the	direct	Taf	target	of	these	activators	within	TFIID	sub-complexes	formed	in	vitro	and/or	by	an	activator	AD	mutation	that	reduces	activator	binding	to	its	Taf	target	(Chen	et	al.,	1994;	Gill	et	al.,	1994;	Thut	et	al.,	1995).		 Based	on	the	results	of	these	direct	activator-Taf	interaction	studies,	the	requirement	of	TBP	promoter	association	for	PIC	formation	(Buratowski	et	al.,	1989),	and	the	observed	correlation	between	TBP	occupancy	and	transcription	(Kuras	and	Struhl,	1999),	it	has	been	hypothesized	that	activator-mediated	“recruitment”	of	TBP	via	TFIID	
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Figure	1.7.	Structure	and	Function	Conservation	of	TFIID	Subunits.		Schematics	of	the	primary	sequence	information	derived	from	UniProt	of	the	conserved	TFIID	subunits	(Taf1	→	Taf13)	and	TBP	from	human	(h)	and	Saccharomyces	cerevisiae	(sc)	are	shown,	along	with	notes	on	conserved	function	and	whether	or	not	the	subunit	is	exclusive	to	TFIID.		Conserved	sequences	are	highlighted	in	red,	while	non-conserved	sequences	are	indicated	by	white	boxes	or	empty	regions.		Functional	domains	are	indicated.	Kin	=	Kinase,	TAND	=	Taf1	N-terminal	Domain,	HAT	=	Histone	Acetyl	Transferase,	IDR	=	Intrinsically	Disordered	Region,	WD40	=	WD40	Repeats,	HFD	=	histone	fold	domain,	CORE	=	highly	conserved	(90%)	TBP	C-terminal	sequence.	
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Taf-activator	interaction	represents	a	likely	mechanism	of	transcription	regulation.		Consistent	with	this	idea,	as	described	in	“Transcription	Activation	Mechanisms,”	the	Tjian	lab	showed	that	Drosophila	activator-TFIID	Taf	interaction	enhanced	TFIID	promoter	binding	(Sauer	et	al.,	1995a,	1995b).	The	mammalian	ETO-Taf4	also	described	in	“Transcription	activation	mechanisms”	(Chen	et	al.,	2013)	and	an	acetylated	p53-Taf1	interaction	study	(Li	et	al.,	2007)	have	also	demonstrated	that	TFIID	coactivator	function	operates	via	the	direct	recruitment/cooperative	binding	mechanism.		 TFIID	may	indeed	coactivate	transcription	via	recruitment	in	the	cases	described	above.		However,	observations	made	by	other	studies	raise	the	possibility	that	cooperative	binding/”recruitment”	is	not	the	exclusive	mechanism	by	which	TFIID	coactivates	gene	transcription.		First,	one	yeast	study	performed	using	chimeric	reporter	genes	demonstrated	that	it	was	the	promoter,	not	the	enhancer	binding	site	for	a	transcription	activator,	that	determined	whether	a	gene	was	TFIID-dependent	or	SAGA-dependent	(Cheng	et	al.,	2002),	suggesting	that	these	coactivators	may	bind	promoter	DNA	independently	of	their	recruitment	by	activators.		Second,	although	EM	analyses	of	the	metazoan	p53-TFIID,	c-Jun-TFIID,	and	Sp1-TFIID	complexes	showed	no	dramatic	TFIID	conformational	changes	(Liu	et	al.,	2009),	another	study	revealed	via	DNase	I	footprinting	that	a	TFIIA-TFIID-DNA	isomerization	step	mediated	by	the	Epstein-Barr	virus	transcription	activator	ZEBRA	was	required	for	PIC	assembly	and	transcription	activation	(Chi	and	Carey,	1996).		This	isomerization	step	may	represent	a	conformational	change	missed	in	the	TFIID	EM	analyses	either	due	to	the	use	of	different	activator	proteins	or	the	absence	of	TFIIA	and/or	DNA.		Finally,	the	Nogales	lab	has	found	that	human	TFIID	binds	promoter	DNA	in	a	rearranged	conformation	(Cianfrocco	et	al.,	2013;	Louder	et	al.,	2016),	
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and	conversion	to	this	rearranged	conformation	is	enhanced	in	the	presence	of	the	p53	activator	(Coleman	et	al.,	2017).		Taken	together,	these	observations	support	continued	investigation	of	TFID	coactivator	function	to	determine	whether	it	operates	via	recruitment,	conformational	change,	or	both	mechanisms	of	transcription	activation.		 Although	essentially	all	of	the	discoveries	regarding	TFIID	coactivator	function	to	date	have	been	derived	from	metazoan	systems,	yeast	provides	an	excellent	model	system	for	continued	investigations	of	TFIID	coactivator	function.		As	stated	above,	the	discoveries	in	metazoans	systems	were	made	using	deletion	mutant	variants.		While	important	findings	can	and	have	been	uncovered	using	such	variants,	studies	performed	using	such	deletion	variants	do	suffer	from	some	amount	of	imprecision,	particularly	when	an	AD-coactivator	interaction	involves	multiple	ADs	and/or	coactivator	targets.		In	yeast,	it	has	historically	been	much	faster	and	easier	to	generate	mutants,	particularly	the	point	mutant	variants	required	for	rigorous	activation	mechanism	testing.		Importantly,	it	is	also	relatively	easy	in	yeast	to	perform	iterative	and	complementary	genetic,	biochemical,	and	biophysical	experiments	to	carefully	characterize	such	point	mutant	variants.		Additionally,	in	contrast	to	metazoan	cells	whose	TFIID	subunit	composition	may	vary	(Fong	et	al.,	2012),	the	composition	of	yeast	TFIID	appears	to	be	largely	invariant	(Sanders	and	Weil,	2000).		The	reliability	of	yeast	TFIID	existing	in	a	defined	subunit	composition	and	stoichiometry	greatly	facilitates	the	design	of	experiments	to	carefully	test	TFIID	coactivator	function.		Meanwhile,	the	evolutionary	conservation	of	TFIID	in	all	eukaryotes	suggests	that	discoveries	made	in	yeast	are	likely	generalizable	to	metazoans.	The	Weil	lab	began	pursuing	investigations	of	TFIID	coactivator	function	in	yeast	prior	to	my	joining	the	lab	for	precisely	these	reasons.	
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Transcription	Regulation	of	the	TFIID-Dependent	Ribosomal	Protein	(RP)	Genes		 As	a	first	step	to	investigate	TFIID	coactivator	function	in	budding	yeast,	our	lab	sought	a	gene	or	set	of	genes	for	which	TFIID	served	as	a	coactivator.		The	RP	gene	regulon	emerged	as	a	candidate	set	of	genes	likely	to	meet	this	criterion.		Multiple	studies	have	demonstrated	that	this	gene	regulon,	which	consists	of	the	138	genes	that	encode	the	protein	components	of	the	ribosome	(Warner,	1999),	depends	on	TFIID	(Garbett	et	al.,	2007;	Holstege	et	al.,	1998;	Irvin	and	Pugh,	2006;	Kuras	et	al.,	2000;	Layer	and	Weil,	2013;	Layer	et	al.,	2010;	Li	et	al.,	2000,	2002;	Mencıá	et	al.,	2002;	Ohtsuki	et	al.,	2010;	Papai	et	al.,	2010;	Shen	and	Green,	1997;	Shen	et	al.,	2003;	Singh	et	al.,	2004;	Tsukihashi	et	al.,	2001).		Additionally,	TFIID	occupancy	can	be	conferred	on	a	reporter	containing	a	TFIID-independent	promoter	by	fusing	this	reporter	gene	to	two	binding	sites	for	the	transcription	factor	Repressor	Activator	Protein	1	(Rap1)	derived	from	an	RP	gene	(Garbett	et	al.,	2007;	Li	et	al.,	2000;	Mencıá	et	al.,	2002).		This	occupancy	is	likely	achieved	through	direct	interaction	between	TFIID	and	Rap1	(Garbett	et	al.,	2007;	Layer	and	Weil,	2013;	Layer	et	al.,	2010;	Papai	et	al.,	2010).		Rap1	binding	sites	are	required	for	transcription	of	93%	of	the	RP	genes	(Knight	et	al.,	2014;	Lieb	et	al.,	2001;	Rudra	and	Warner,	2004),	and	thus,	part	of	the	observed	RP	gene	dependence	upon	TFIID	is	likely	to	be	due	to	a	coactivator	function	triggered	through	direct	interaction	with	Rap1.			 In	addition	to	their	observed	TFIID	dependence,	the	yeast	RP	genes	also	possess	several	characteristics	that	make	them	an	interesting	case	study	for	transcription	activation.		Since	the	RP	genes	represent	the	protein	component	of	the	translation	machinery,	a	basic	requirement	for	cell	life	and	growth,	the	cell	dedicates	prodigious	resources	to	their	transcription	regulation.		Indeed,	RP	gene	transcription	has	been	
	 39	
estimated	to	account	for	up	to	50%	of	all	Pol	II	initiation	events	in	the	yeast	cell	during	log	phase	growth,	making	this	gene	class	one	of	the	most	robustly	transcribed	gene	classes	in	the	cell	(Warner,	1999).		These	genes	are	coordinately	regulated	to	ensure	generation	of	a	functional	ribosome	(Lempiäinen	and	Shore,	2009)	and	transcription	is	tightly	coupled	to	growth	and	nutrient	signals	to	ensure	that	the	correct	amount	of	ribosomes	for	a	given	condition	is	produced	(Marion	et	al.,	2004;	Rudra	and	Warner,	2004;	Rudra	et	al.,	2005;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004a).		 Although	little	is	known	regarding	RP	gene	transcription	in	metazoans	aside	from	their	similar	transcription	output	requirements	(Rudra	and	Warner,	2004)	and	apparent	TFIID-dependence	(ENCODE	Project	Consortium,	2012),	many	of	the	factors	that	guide	RP	gene	regulation	in	yeast	have	been	identified	and	described.		One	of	these	factors	is	Rap1,	which,	as	described	above	occupies	the	enhancer	element	of	129	out	of	138	of	the	RP	genes	(Knight	et	al.,	2014;	Lieb	et	al.,	2001;	Rudra	and	Warner,	2004).		54	of	these	genes	have	one	Rap1	binding	site	while	the	other	75	have	two	Rap1	binding	sites	(Knight	et	al.,	2014).		Rap1	binding	to	RP	genes	is	a	prerequisite	for	binding	of	the	other	RP	gene	transcription	factors	(Hall	et	al.,	2006;	Knight	et	al.,	2014;	Zhao	et	al.,	2006),	a	role	achieved	perhaps	through	its	possible	nucleosome	remodeling	activity	(Ganapathi	et	al.,	2011).		The	8	RP	genes	that	aren’t	occupied	by	Rap1	depend	on	the	transcription	factor	Abf1	instead	for	this	activity.	(Ganapathi	et	al.,	2011;	Knight	et	al.,	2014).		The	DNA	binding	factor	Hmo1	binds	the	enhancer	of	many	of	the	RP	genes,	and	where	it	binds,	is	required	for	the	DNA-binding	of	another	RP	gene	transcription	factor	Fhl1	(Hall	et	al.,	2006;	Knight	et	al.,	2014).		Fhl1	also	occupies	RP	genes	that	don’t	bind	Hmo1,	suggesting	that	there	must	also	be	Hmo1-independent	mechanisms	of	Fhl1	DNA-binding	(Knight	et	al.,	2014;	Reja	et	al.,	2015).		
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Unlike	Rap1	and	Hmo1,	Fhl1,	and	the	transcription	factor	it	recruits	via	its	forkhead-associated	domain	to	RP	genes,	Ifh1	(Wade	et	al.,	2004a),	exclusively	participate	in	RP	gene	transcription	and	are	therefore	thought	to	modulate	some	of	the	unique	characteristics	of	RP	gene	regulation.		Indeed,	the	results	of	several	studies	show	that	Ifh1	plays	the	important	roles	of	linking	RP	gene	transcription	to	stress,	nutrient	signaling,	Pol	I	transcription	of	rRNA,	and	Pol	III	transcription	of	5S	rRNA	(Albert	et	al.,	2016;	Rudra	et	al.,	2005;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004a).		Other	important	RP	gene	transcription	regulators	include	the	transcription	factor	Sfp1,	which	aids	in	the	RP	gene	transcriptional	response	to	stress	and	nutrient	signals	(Marion	et	al.,	2004),	and	the	histone	acetyltransferase	NuA4	(Allard	et	al.,	1999;	Reid	et	al.,	2000;	Uprety	et	al.,	2016).		 Based	on	which	of	these	factors	are	bound	to	its	UAS,	each	of	the	RP	genes	has	been	recently	classified	into	one	of	three	types:	Category	I	(Rap1+,	Hmo1+),	Category	II	(Rap1+,	Hmo1-),	and	Category	III	(Rap1-,	dependends	on	Abf1)	(Figure	1.8)	(Knight	et	al.,	2014;	Reja	et	al.,	2015).		Recent	genomic	analyses	of	RP	gene	UAS-promoter	architectures	
I.) Rap1+, Hmo1+ : RPGPromoter HMO1 FHL1 RAP1
RPGPromoter  FHL1 RAP1II.) Rap1+, Hmo1- :
RPG ABF1III.) Rap1- : Promoter
Figure	1.8.		Three	Types	of	RPGs.		Schematics	of	the	three	types	of	RP	genes	as	defined	by	recent	genomic	analyses.		RP	genes	are	divided	into	one	of	these	three	categories	based	on	the	occupancy	of	the	DNA-binding	factors	Rap1,	Fhl1,	and	Abf1.		Category	I	contains	69	members,	Category	II	contains	60	members,	and	Category	III	contains	9	members.		Although	only	one	Rap1	binding	site	is	indicated	here,	several	Category	I	and	Category	II	RP	genes	contain	two	Rap1	binding	sites.		
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identified	an	interesting	feature	of	all	three	types	of	RP	genes;	the	UAS-promoter	is	unusually	MNase	sensitive	(Knight	et	al.,	2014;	Reja	et	al.,	2015).		A	later	study	detected	MNase	sensitivity	at	other	promoters	and	correlated	MNase	sensitivity	with	robust	transcription	levels,	such	as	those	observed	from	the	RP	gene	regulon	(Kubik	et	al.,	2015).		Using	genomic	analyses,	synthetic	chimeric	genes,	and	Rap1	anchor	away,	this	study	showed	that	promoter	DNA	and	the	transcription	factor	Rap1	contribute	to	the	formation	of	an	unusually	MNase	sensitive	region	upstream	of	RP	gene	ORFs	(Kubik	et	al.,	2015).		This	MNase	sensitive	region	was	proposed	to	represent	a	“fragile	nucleosome”	whose	occupancy	on	RP	gene	promoters	is	unusually	weak	(Knight	et	al.,	2014;	Kubik	et	al.,	2015).		These	authors	hypothesize	that	generation	of	fragile	nucleosomes	by	chromatin	remodeling	plays	a	key	role	in	mediating	high-level	RP	gene	transcription.		By	contrast,	another	study	speculated	that	RP	genes	instead	possess	an	unusually	long	NFR,	where	the	MNase	sensitive	region	represents	the	binding	of	Fhl1,	Ifh1,	Sfp1,	and	Hmo1	instead	of	a	nucleosome	(Reja	et	al.,	2015).		Either	mechanism	points	to	the	critical	importance	of	Rap1	in	RP	gene	transcription	as	proposed	by	earlier	studies	demonstrating	that	Rap1	is	the	only	activator	absolutely	required	for	transcription	of	the	RP	genes	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004a).		Thus,	Rap1	is	the	key	to	unlocking	the	molecular	mechanism	of	RP	gene	transcription	activation.		To	determine	whether	it	is	interaction	with	the	TFIID	coactivator,	chromatin	remodeling,	and/or	enhanced	binding	of	the	other	RP	gene	transcription	factors	that	are	the	main	drivers	of	high-level	RP	gene	transcription,	the	Rap1	AD	must	be	mapped	and	its	direct	coactivator	targets	must	be	identified.		
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Repressor	Activator	Protein	1	(Rap1)	Structure	and	Interaction	with	TFIID		 The	Rap1	transfactor	was	originally	identified	over	30	years	ago	as	a	budding	yeast	RP	gene	enhancer-binding	protein	(Huet	et	al.,	1985).		Budding	yeast	Rap1	is	encoded	by	an	essential	gene	(Shore	and	Nasmyth,	1987).		As	the	name	“Repressor	Activator	Protein	1”	implies,	Rap1	performs	both	key	repression	and	activation	functions	in	the	cell.		In	addition	to	its	role	in	RP	gene	transcription	activation	described	above,	Rap1	plays	critical	roles	in	the	transcription	activation	of	the	SAGA-dependent	glycolytic	enzyme	(GE)-encoding	genes	(Basehoar	et	al.,	2004;	Chambers	et	al.,	1989,	1995),	telomere	stabilization,	meiotic	DNA	recombination	and	mating	type	locus	silencing	(Morse,	2000;	Shore,	1994).		Consistent	with	these	diverse	activities,	genome-wide	microarray	and	ChIP	studies	have	documented	the	presence	of	Rap1	on	RP	genes,	GE	genes,	telomeres,	and	even	some	genes	required	for	Pol	I	and	Pol	III	transcription	(Lickwar	et	al.,	2012a;	Lieb	et	al.,	2001;	Rhee	and	Pugh,	2011).		Many	structure-function	studies	have	been	performed	on	Rap1	since	its	discovery	in	order	to	shed	light	on	how	Rap1	contributes	to	these	diverse	cellular	activities.		These	analyses	divide	the	827	aa	Rap1	protein	into	three	major	domains:	a	central	DBD	(aa’s	361-599	(Henry	et	al.,	1990)),	an	N-terminus	(aa’s	1-360),	and	a	C-terminus	(aa’s	600-827)	(Figure	1.9A).		 Of	these	three	major	domains,	the	DBD	is	probably	the	best	understood	in	terms	of	DNA	binding	site,	structure,	and	activity.		Rap1	recognizes	its	DNA	binding	site	via	its	DBD	with	an	affinity	comparable	to	those	observed	for	other	transcription	factors	(Kd	=	1.3x10-
11	M)	(Vignais	et	al.,	1990).		This	DBD	is	the	only	essential	domain	of	Rap1,	although	yeast	expressing	just	the	Rap1	DBD	are	extremely	slow	growing	(Garbett	et	al.,	2007;	Graham	et	al.,	1999).		Several	studies	of	the	DNA	sequence	element	recognized	by	the	Rap1	DBD	
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(UASRap1)	have	been	conducted.		These	studies	have	defined	a	13-base	pair	UASRap1	consensus	sequence	5’-(A/G)1(C/A)2A3(C/T)4C5C6(A/G)7(C/A)8N9C10A11(C/T)12(C/T)13-3’	(Lascaris	et	al.,	1999;	Lieb	et	al.,	2001;	Vignais	et	al.,	1990)	and	determined	the	contribution	of	each	consensus	sequence	nucleotide	to	Rap1-UASRap1	DNA-binding	(Vignais	et	al.,	1990)	and	Rap1-dependent	reporter	gene	activity	(Nieuwint	et	al.,	1989).		Biologically	important	functional	differences	in	the	sequences	of	UASRap1	sites	involved	in	transcription	activation,	transcription	repression,	and	telomere	functions	have	also	been	identified	(Idrissi	et	al.,	1998,	2001;	Kasahara	et	al.,	2007a;	Lickwar	et	al.,	2012b;	Vignais	et	al.,	1987).				 Multiple	co-crystal	structures	of	the	Rap1	DBD	(Henry	et	al.,	1990)	in	complex	with	DNA	have	been	solved,	shedding	light	on	how	Rap1	achieves	UASRap1	recognition.		These	structures	revealed	that	the	Rap1	DBD	is	composed	of	two	very	similar	homeodomain	motifs	and	an	unstructured	tail	that	make	multiple	specific	protein-DNA	contacts	
Figure	1.9	Map	of	Known	Rap1	Functional	Domains	and	TFIID	Taf4,	5,	and	12	subunit	Rap1	
Binding	Domains	(RBDs).		A,	Rap1	is	divided	into	three	major	domains:	an	N-terminus,	a	central	DBD,	and	a	C-terminus	(aa	locations	indicated).		The	non-essential	N-terminus	is	further	subdivided	into	over-lapping	BRCT	and	DNA-Bending	(DNA-Bend)	domains.		The	C-terminus	is	subdivided	into	Tox,	SD,	and	a	possible	AD	(labeled	AD?).		B,	Localization	of	the	RBDs	in	the	TFIID	subunits	shown	to	interact	directly	with	Rap1	(Tafs	5,	12,	and	4)	to	activate	RP	gene	transcription.		With	the	exception	of	Taf12,	these	RBDs	are	located	in	aa	that	are	essential	and	conserved.		
A. B.
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throughout	the	Rap1-DNA	complex	(König	et	al.,	1996;	Matot	et	al.,	2012;	Taylor	et	al.,	2000).		These	contacts	do	not	appear	to	vary	radically	among	the	complexes	formed	between	Rap1	and	variant	UASRap1	sites	(Taylor	et	al.,	2000).		Rap1	must	also	be	able	to	form	most	of	these	contacts	with	UASRap1	sites	when	they	are	occluded	by	a	nucleosome	since	Rap1	is	capable	of	efficiently	binding	nucleosomal	UASRap1	sites	in	vitro	and	in	vivo	(Koerber	et	al.,	2009;	Rossetti	et	al.,	2001).		The	ability	of	Rap1	to	bind	nucleosomal	UASRap1	sites	may	be	key	to	Rap1-driven	transcription	activation,	at	least	for	the	HIS4	gene	where	the	Rap1	DBD	alone	is	sufficient	to	open	chromatin	and	activate	transcription	(Ganapathi	et	al.,	2011;	Yu	and	Morse,	1999;	Yu	et	al.,	2001).		 Unlike	the	Rap1	DBD,	the	Rap1	N-terminus	appears	completely	dispensable	since	deletion	of	the	Rap1	N-terminus	has	no	obvious	effect	on	cell	growth	(Graham	et	al.,	1999).		Although	its	lack	of	impact	on	growth	suggests	that	the	Rap1	N-terminus	does	not	contribute	critically	to	Rap1	essential	cellular	activities,	a	few	studies	have	proposed	functions	for	the	Rap1	N-terminus.		An	early	study	implicated	aa’s	44-274	in	Rap1	DNA-bending	activity	(Müller	et	al.,	1994).		Meanwhile,	sequence	alignments	have	identified	a	Breast	Cancer	1	C-terminal	(BRCT)	domain	within	aa’s	121-208	of	the	Rap1	N-terminus	(Callebaut	and	Mornon,	1997;	Zhang	et	al.,	2011),	and	a	Gal4	DBD-Rap1	BRCT	domain	fusion	protein	weakly	activates	transcription	and	remodels	chromatin	(Miyake	et	al.,	2000).		Although	this	transcription	activation	effect	could	be	artificial,	the	results	of	other	analyses	are	consistent	with	a	role	for	the	Rap1	N-terminus	in	the	activation	of	some	Rap1-dependent	genes.		The	Rap1	N-terminus	facilitates	binding	of	the	glycolytic	transcription	activator	glycolysis	regulatory	protein	1	(Gcr1)	to	DNA	(López	et	al.,	1998),	and	Rap1	N-terminal	deletion	results	in	synthetic	lethality	when	combined	with	GCR1	deletion	(Mizuno	
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et	al.,	2004).		Thus,	the	Rap1	N-terminus	may	contribute	to	glycolytic	gene	transcription	activation,	perhaps	via	its	BRCT	domain.		 Like	the	N-terminus,	the	Rap1	C-terminus	is	not	essential,	although	cells	that	lack	the	Rap1	C-terminus	display	a	very	slow	growth	phenotype	(Garbett	et	al.,	2007;	Graham	et	al.,	1999).		Studies	of	the	Rap1	C-terminus	have	divided	it	into	three	partially	overlapping	regions:	(1)	a	Tox	domain	(aa’s	596-630)	whose	deletion	abolishes	Rap1	over-expression	toxicity	(Freeman	et	al.,	1995),	(2)	a	silencing	domain	(SD)	located	in	the	very	C-terminus	(Chen	et	al.,	2011;	Feeser	and	Wolberger,	2008;	Graham	et	al.,	1999;	Kyrion	et	al.,	1992;	Moretti	et	al.,	1994a),	and	(3)	a	potential	activation	domain	(aa’s	630-695)	(Hardy	et	al.,	1992a).		Although	SD	deletion	has	little	reported	impact	on	cell	viability	(Chen	et	al.,	2011;	Feeser	and	Wolberger,	2008;	Graham	et	al.,	1999;	Kyrion	et	al.,	1992;	Moretti	et	al.,	1994a),	it	is	important	for	multiple	telomere	functions	as	well	as	HML/HMR	mating	type	silencing	(Feeser	and	Wolberger,	2008;	Kyrion	et	al.,	1992).		The	SD	achieves	these	functions	through	direct	binding	of	the	silent	information	regulator	(Sir)	and	Rap1	interacting	factor	(Rif)	proteins,	which	serve	to	modulate	telomere	length	and	repress	gene	transcription	(Chen	et	al.,	2011;	Feeser	and	Wolberger,	2008;	Hardy	et	al.,	1992b,	1992a;	Kyrion	et	al.,	1992;	Moretti	et	al.,	1994a).		Meanwhile,	the	potential	Rap1	AD	was	mapped	using	Gal4	DBD-Rap1	fusion	proteins	(Hardy	et	al.,	1992a).		Deletion	of	these	potential	AD	aa	within	the	context	of	the	intact	Rap1	protein	does	induce	slow	growth;	however,	mRNA	transcript	analysis	actually	revealed	an	increase	in	transcript	levels	of	the	RP	genes	tested	over	wild-type	(Graham	et	al.,	1999).			Additionally,	several	studies	performed	after	the	original	Gal4	DBD-Rap1	fusion	AD	mapping	reported	that	Rap1-heterolgous	DBD	fusions	fail	to	robustly	drive	reporter	gene	transcription	in	vivo	(Klein	and	Struhl,	1994b;	Mencıá	et	al.,	2002;	Zhao	
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et	al.,	2006).		These	data,	especially	in	light	of	studies	demonstrating	the	sufficiency	of	the	Rap1	DBD	in	HIS4	activation	(Ganapathi	et	al.,	2011;	Yu	and	Morse,	1999;	Yu	et	al.,	2001),	left	open	the	questions	of	whether	or	not	Rap1	possessed	an	AD,	and	if	so,	what	Rap1	aa’s	constituted	such	an	AD.		 Because	of	the	ambiguity	regarding	the	existence	of	a	Rap1	AD,	the	Weil	lab	began	investigating	the	possibility	of	RP	gene	activation	driven	by	direct	Rap1-TFIID	interaction	encouraged	by	the	multiple	demonstrations	of	the	absolute	dependence	of	RP	gene	transcription	on	Rap1	(Schwalder	et	al.,	2004;	Wade	et	al.,	2004a),	the	observation	that	Rap1	binding	sites	were	necessary	and	sufficient	for	TFIID	promoter	occupancy	(Mencıá	et	al.,	2002),	and	the	opportunity	to	dissect	TFIID	coactivator	function	in	yeast.		These	efforts	were	rewarded;	direct	Rap1-TFIID	interaction	(Kd,app	=	~300nM)	was	detected	via	pull-down	assay.		Further	pull-down	assays	performed	using	Rap1	truncation	mutants	revealed	that	this	Rap1-TFIID	interaction	depended	upon	both	the	Rap1	DBD	and	the	Rap1	C-terminus.		Meanwhile,	far	western	analyses	revealed	that	Rap1-TFIID	interaction	occurred	via	TFIID	Taf	subunits	4,	5,	and	12	(Garbett	et	al.,	2007).		The	mapped	Rap1	Binding	Domain	(RBD)	of	Taf12	was	not	essential,	however,	mutation	of	the	Tafs	4	and	5	RBDs	(Figure	1.9B)	where	shown	to	drastically	reduce	Rap1-Taf4/12	and	Rap1-Taf5	binding,	RP	gene	transcript	levels,	and	yeast	cell	growth	rate	(Garbett	et	al.,	2007;	Layer	et	al.,	2010).		Interestingly,	the	Kds	measured	for	the	Rap1-Taf5	and	Rap1-Taf4/12	interaction	were	~	1	x	10-9	M	(Layer	et	al.,	2010),	indicating	an	unusually	tight	binding	compared	to	other	activator-coactivator	binding	interactions	whose	Kds	have	been	measured	at	1	x	10-5-10-7	M	(Brzovic	et	al.,	2011;	Jonker	et	al.,	2005;	Krois	et	al.,	2016).		Finally,	deletion	of	the	Rap1	C-terminus	(aa’s	600-827)	also	resulted	in	decreased	RP	gene	and	Rap1-dependent	reporter	
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gene	transcript	levels	(Garbett	et	al.,	2007).		Taken	together,	these	data	support	the	hypothesis	that	direct,	specific,	high-affinity	Rap1-TFIID	interaction	drives	RP	gene	transcription.		 Rap1,	TFIID,	and	TFIIA	RP	Gene	Activation	Mechanism		 Having	demonstrated	the	dependence	of	RP	gene	transcription	on	direct	Rap1-TFIID	interaction	(Garbett	et	al.,	2007;	Layer	et	al.,	2010),	our	lab	sought	to	address	the	mechanistic	consequences	of	Rap1-TFIID	interaction.		The	goal	of	these	studies	was	to	determine	how	TFIID	served	as	a	coactivator	on	the	RP	genes.		Cooperative	binding	was	tested	first	since	the	strongest	prior	studies	of	TFIID	coactivator	function	suggested	that	TFIID	coactivates	target	genes	via	the	cooperative	binding	(i.e.	“recruitment”)	model	of	transcription	activation	(Li	et	al.,	2007;	Liu	et	al.,	2009;	Sauer	et	al.,	1995a,	1995b).		However,	repeated	DNase	I	footprinting	and	gel	shift	DNA	binding	analyses	performed	using	Rap1,	TFIID,	and	TFIIA	(which	is	required	for	TFIID-promoter	binding)	failed	to	demonstrate	any	cooperative	binding	(Krassi	A.	Garbett,	unpublished	observation).					 To	try	to	gain	more	insight	into	TFIID	coactivator	function	on	RP	genes,	EM	analyses	were	performed	on	binary,	ternary,	and	quaternary	complexes	formed	using	Rap1,	TFIID,	TFIIA,	and	DNA	in	collaboration	with	the	lab	of	Dr.	Patrick	Schultz	at	the	IGBMC	in	Strasbourg,	France.		Analyses	of	Rap1-TFIID	and	Rap1-TFIID-DNA	complexes	revealed	two	Rap1	densities,	each	of	which	interacted	with	a	face	of	TFIID	lobe	B	(Papai	et	al.,	2010)	(Figure	1.10A).		This	co-localization	of	Rap1	with	a	TFIID	lobe	that	contains	one	copy	of	Tafs	4,	5,	and	12	(Leurent	et	al.,	2002,	2004;	Papai	et	al.,	2010)	is	consistent	with	the	results	of	the	Rap1-Taf	interaction	studies	described	above	(Garbett	et	al.,	2007;	Layer	et	al.,	
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2010).		The	Rap1	density	located	on	the	DNA-proximal	face	of	TFIID	lobe	B	accommodates	the	crystal	structure	of	the	Rap1	DBD	(König	et	al.,	1996;	Matot	et	al.,	2012;	Taylor	et	al.,	2000).		This	localization	is	consistent	with	Rap1	DNA-binding	and	Rap1	DBD-TFIID	interaction	(Garbett	et	al.,	2007).		Importantly,	this	Rap1	DBD	localization	does	not	place	the	Rap1	DBD	in	proximity	with	TBP,	which	has	been	mapped	to	lobes	A	and	C	of	TFIID	(Leurent	et	al.,	2004)	and	whose	interaction	with	the	Rap1	DBD	may	repress	transcription	(Bendjennat	and	Weil,	2008).		The	second	Rap1	density	located	on	the	opposite	face	of	TFIID	lobe	B	could	be	the	Rap1	C-terminus	or	the	DBD	of	a	second	Rap1	molecule.		Consistent	with	the	analyses	of	other	activator-TFIID	complexes	that	had	been	performed	prior	to	the	Rap1-TFIID	study	(Liu	et	al.,	2009),	no	TFIID	conformational	rearrangements	
Figure	1.10.	Model	of	Rap1-TFIID,	TFIIA-TFIID,	and	Rap1-TFIID-TFIIA	EM	Used	to	Propose	the	
“Lock	to	Load”	Model	of	RP	Gene	Transcription	Activation.		A,	Localization	of	Rap1	within	the	Rap1-TFIID	structure.		TFIID	is	shown	in	yellow	while	densities	corresponding	to	DNA	are	shown	in	green.		Rap1	(red	densities)	is	localized	to	both	faces	(outer	and	inner)	of	TFIID	lobe	B,	which	contains	one	copy	of	Tafs	4,	5,	and	12	(cf		Figure	1.6A)	shown	to	interact	directly	with	Rap1	in	biochemical	analyses.		The	inner	Rap1	density	fits	the	Rap1	DBD	crystal	structure	and	is	thought	to	represent	the	Rap1	DBD.		The	outer	Rap1	density	may	be	the	Rap1	C-terminus.		B,		Localization	of	TFIIA	in	the	TFIIA-TFIID-DNA	complex	compared	with	the	Rap1-TFIIA-TFIID-DNA	complex	(i.e.	–Rap1	(blue)	and	+	Rap1	(purple),	indicating	the	TFIIA	conformational	change	observed	when	Rap1	is	added	to	the	complex.		C,		Final	“Lock	to	Load”	complex	thought	to	represent	the	critical	step	in	RP	gene	transcription	activation	proposed	based	on	results	of	EM	analyses	of	TFIID-containing	complexes.		TFIID	is	shown	in	yellow,	Rap1	is	shown	in	red,	conformation	changed	TFIIA	is	shown	in	purple,	DNA	densities	observed	in	EM	are	shown	in	green,	and	the	hypothesized	enhancer-promoter	DNA	loop	is	indicated	by	the	red	and	blue	lines.		Note:	all	images	used	in	this	figure	have	been	adapted	from	Papai	et	al.,	2010.			
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were	detected	in	either	the	Rap1-TFIID	or	the	Rap1-TFIID-DNA	complexes.		 Meanwhile,	analyses	of	TFIID-TFIIA-DNA	complexes	revealed	a	globular	TFIIA	density	located	near	lobe	C	of	TFIID	(Papai	et	al.,	2010),	placing	TFIIA	in	proximity	to	TBP	consistent	with	known	TFIIA-TBP	interaction	(Geiger	et	al.,	1996;	Tan	et	al.,	1996).		Excitingly,	comparison	of	this	TFIID-TFIIA-DNA	structure	with	the	Rap1-TFIID-TFIIA-DNA	structure	revealed	a	130°	rotation	of	TFIIA	around	its	TFIID	interaction	site	(Figure	
1.10B),	indicative	of	a	TFIIA	conformational	change	(Papai	et	al.,	2010).		This	conformational	change	places	TFIIA	in	proximity	to	directly	interact	with	the	density	corresponding	to	the	Rap1	DBD.		However,	a	direct	Rap1-TFIIA	interaction	has	yet	to	be	detected.		Thus,	although	TFIIA	changes	conformation	and	performs	a	coactivator	role	in	some	contexts	(Kobayashi	et	al.,	1995;	Ozer	et	al.,	1996),	the	direct	Rap1-TFIID	interaction	supports	the	notion	that	TFIID	serves	a	coactivator	function	in	this	case	by	forming	the	structural	scaffold	upon	which	TFIIA	rearrangement	occurs.				 The	Weil	lab	has	hypothesized	that	the	TFIIA	conformational	change	observed	within	the	Rap1-TFIID-TFIIA-DNA	complex	represents	a	key	step	in	RP	gene	activation.		The	lab	has	termed	this	model	the	“Lock	to	Load”	model	(Figure	1.10C)	of	transcription	activation	because	the	TFIIA	conformational	change	“locks”	enhancer-promoter	DNA	into	a	loop,	which	in	turn	could	enhance	subsequent	PIC	formation	or	loading.		This	enhanced	PIC	formation	may	be	required	for	the	high	levels	of	transcription	of	RP	genes.		Importantly,	by	proposing	a	TFIID-dependent	conformational	change	model	of	transcription	activation,	“Lock	to	Load”	challenges	the	dogma	that	TFIID	coactivates	transcription	strictly	via	cooperative	binding.		Consistent	with	this	model,	the	lab	has	shown	that	RP	gene	transcription	depends	on	direct	specific	high-affinity	TFIID-Rap1	(Layer	et	al.,	2010)	and	
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TFIID-TFIIA	(Layer	and	Weil,	2013)	interactions.			Also	consistent	with	this	model,	a	class	of	TFIIA	mutants	that	can	stimulate	DNA-binding	but	fail	to	activate	transcription	and	form	DNA	loops	have	been	identified	(Papai	et	al.,	2010),	suggesting	that	loop	formation	is	indeed	an	important	step	in	transcription	activation.		Importantly	however,	if	indeed	“Lock	to	Load”	represents	a	critical	step	in	RP	gene	activation,	formation	of	the	rearranged	Rap1-TFIID-TFIIA-DNA	complex	should	depend	on	direct	interactions	between	the	Rap1	AD	and	the	various	components	of	TFIID	and/or	TFIIA.		Specific	Aims		 As	stated	multiple	times	throughout	this	Chapter,	the	Rap1	AD	had	never	been	unambiguously	mapped,	preventing	any	identification	of	the	Rap1	AD	coactivator	target(s)	prior	to	my	thesis	research.		I	believed	that	carefully	defining	the	Rap1	AD	would	contribute	importantly	to	our	understanding	of	transcription	activation	for	two	key	reasons.		First,	Rap1	is	the	key	RP	gene	transcription	activator,	and	mapping	the	Rap1	AD	represents	an	important	unrealized	step	in	dissecting	the	molecular	mechanisms	required	for	transcription	activation	of	this	important	highly	transcribed	class	of	genes.		Second,	Rap1	AD	mapping	would	set	up	future	rigorous	testing	of	the	lab’s	novel	“Lock	to	Load”	model	of	transcription	activation	described	above	in	“Rap1,	TFIID,	and	TFIIA	RP	Gene	Activation	Mechanism.”		Ideally,	my	efforts	to	define	the	key	Rap1	AD	amino	acids	would	result	in	the	generation	of	separation-of-function	mutants	that	could	be	used	to	determine	the	consequences	of	Rap1	AD	interaction	with	the	multiple	possible	coactivator	targets	within	the	“Lock	to	Load	complex	(specifically	TFIID	Tafs	4,	5,	and	12	and	TFIIA).		
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	 To	address	my	goal	of	mapping	the	Rap1	AD,	I	proposed	the	following	specific	aims:		 Aim	1:	Generate	an	altered	DNA-Binding	specificity	Rap1	variant	(Rap1AS)	to	provide	a	tool	to	unambiguously	dissect	Rap1	structure-function	relationships.		 Aim	2:	Map	and	characterize	the	Rap1	AD	and	investigate	its	interaction	with	TFIID	and/or	TFIIA.			 The	results	of	my	studies	performed	to	accomplish	these	Aims	are	described	in	Chapters	II-III.		Future	directions	to	follow	up	on	the	findings	of	these	studies	are	discussed	in	Chapter	IV.	 														
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CHAPTER	II		GENERATION	OF	AN	ALTERED	DNA-BINDING	SPECIFITY	VARIANT	OF	RAP1		Considerations	in	Dissecting	Rap1	Structure-Function	Relationships		 As	stated	in	Chapter	I,	prior	to	my	thesis	work,	the	published	studies	performed	using	traditional	approaches	left	open	the	questions	of	which	Rap1	domain(s)	and	by	what	molecular	mechanism(s)	Rap1	turns	on	target	gene	transcription.		Several	observations	supported	the	notion	that	Rap1	is	indeed	a	bona	fide	transcription	activator	and	thus	must	possess	an	AD	whose	interaction	with	a	coactivator(s)	contributes	importantly	to	RP	gene	transcription.		Both	UASRap1	mutation	and	acute	Rap1	nuclear	depletion	reduce	mRNA	levels	by	50-90%	depending	on	the	gene	in	question	(Chambers	et	al.,	1989;	Knight	et	al.,	2014;	Mencıá	et	al.,	2002;	Scott	and	Baker,	1993),	demonstrating	that	Rap1	DNA-binding	is	required	for	ongoing	transcription	of	these	genes.		Rap1	binds	the	purified	coregulators	Swi/Snf	and	TFIID	(Garbett	et	al.,	2007;	Tomar	et	al.,	2008).		Importantly	for	our	work,	RP	gene	transcription	absolutely	requires	Rap1	(Garbett	et	al.,	2007;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004a)	and	depends	significantly	upon	Rap1-TFIID	interaction	(Layer	et	al.,	2010).		Collectively,	these	data	motivated	me	to	identify,	characterize,	and	ultimately	generate	mutant	variants	of	an	AD	within	Rap1	to	dissect	the	molecular	mechanism(s)	by	which	it	turns	on	transcription	and	as	importantly	test	our	“Lock	to	Load”	model	of	RP	gene	transcription	activation	(Papai	et	al.,	2010).		 	As	an	alternative	approach	to	identify	an	AD	within	budding	yeast	Rap1,	I	devised	a	strategy	to	generate	an	altered	DNA-binding	specificity	variant	of	the	protein	termed	
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Rap1AS.		My	goal	was	to	identify	a	form	of	Rap1	that	exhibited	true	Altered	Specificity	(AS)	of	DNA	binding.		A	true	altered	DNA-binding	specificity	Rap1AS	would	not	efficiently	bind	at	‘WT’	UASRap1	elements,	but	could	bind	and	drive	the	expression	of	an	integrated	selectable	reporter	gene	from	a	distinct,	mutated	form	of	the	UASRap1	enhancer.		Because	of	this	true	altered	DNA-binding	specificity,	Rap1AS	would	obviate	the	complications	that	arise	as	a	result	of	the	myriad	Rap1	activities	required	for	the	proper	expression	of	hundreds	of	essential	Rap1-dependent	genes	as	well	as	regulation	of	telomere	function	described	in	Chapter	I.				 Rap1AS	would	allow	for	the	straightforward	molecular	genetic	dissection	of	Rap1	structure-function	relationships	by	scoring	function/expression	of	the	Rap1AS-dependent	reporter	gene	in	cells	containing	engineered	deletion	or	point-mutated	variant	forms	of	Rap1AS.		Breakthroughs	in	the	understanding	of	transcription	mechanisms	have	been	made	through	the	generation	and	utilization	of	altered	DNA-binding	specificity	mutants	of	other	essential	transcription	factors,	in	both	prokaryotes	and	eukaryotes.		Examples	include	AS	variants	of	bacteriophage	l	cro	protein	(Nilsson	and	Widersten,	2004),		E.	coli	Trp	repressor	(Pfau	et	al.,	1994)	and	sigma	factor	σ	70	(Gregory	et	al.,	2005);	yeast	TBP	(Strubin	and	Struhl,	1992)	and	transcription	factor	Gcn4	(Kim	et	al.,	1993),	mammalian	estrogen	receptor	(ER)	(Mader,	S	et	al.,	1989;	Voss	et	al.,	2011),	and	Drosophila	transcription	factor	Engrailed	(Chu	et	al.,	2012).	These	altered	DNA-binding	variant	proteins	proved	key	in	unlocking	the	molecular	mechanisms	by	which	these	disparate	DNA-binding	proteins	operate.		 In	this	Chapter,	I	describe	my	approach	to	Rap1AS	generation,	some	of	which	was	originally	published	in	the	Journal	of	Biological	Chemistry	(JBC)	(Johnson	and	Weil,	2017)	©	
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the	American	Society	for	Biochemistry	and	Molecular	Biology.		This	approach	consists	of	the	structure-guided	site-directed	mutagenesis	of	UASRap1	DNA	and	the	gene	encoding	the	Rap1	protein	itself,	coupled	with	a	sensitive	yeast	screening	strategy.		Using	my	approach,	I	was	able	to	identify	a	true	altered	DNA-binding	specificity	variant	of	Rap1,	termed	Rap1AS.		This	Rap1AS	variant	possessed	all	the	characteristics	desired	for	use	as	a	tool	for	Rap1	AD	mapping	and	will	likely	also	prove	valuable	to	investigators	who	study	Rap1	function	in	transcription	repression,	telomere	length	regulation,	chromatin	opening,	and	meiotic	recombination	(Morse,	2000;	Rudra	and	Warner,	2004;	Shore,	1994).		 Methods	
	General	Cloning	Approach		 All	cloning	experiments	used	to	generate	E.	coli	expression	plasmids,	yeast	expression	plasmids,	and	yeast	genomic	integration	constructs	were	performed	using	restriction	enzyme	based	methods.		The	details	for	the	generation	of	individual	vectors	are	provided	below	or	in	Chapter	III	according	to	their	appearance	in	this	dissertation.		Cassette	swap	was	performed	where	possible	due	to	the	presence	of	desired	DNA	sequence	with	compatible	restriction	endonuclease	recognition	sequences	to	transfer	a	portion	of	an	already-existing	vector	into	another.		Generally,	where	cassette	swap	was	not	possible,	a	DNA	sequence	of	interest	was	generated	via	PCR	using	primers	containing	the	desired	restriction	enzyme	sites	and	either	the	Pyrococcus	furiosis	(Pfu)	polymerase	(Dabrowski	and	Kur,	1998;	Lu	and	Erickson,	1997)	or	Q5	high-fidelity	DNA	polymerases	(New	England	Biolabs	(NEB))	according	to	standard	protocols.		To	prepare	inserts	for	cloning,	PCR	
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generated	fragments	(or,	in	the	case	of	a	cassette	swap,	vector	DNAs)	were	subjected	to	restriction	enzyme	digest.		The	vector	to	receive	the	insert	was	digested	with	the	same	restriction	enzyme(s)	and	treated	with	Antarctic	Phosphatase	(NEB)	according	to	the	manufacturer’s	instructions	to	reduce	self-ligation.		Both	vector	and	insert	DNAs	were	agarose	gel	purified	and	gel	extracted	using	a	Qiagen	Gel	Extraction	Kit	and	either	Qiagen	or	Denville	Scientific	gel	extraction	columns	according	to	the	manufacturers’	instructions.		For	general	(i.e.	not	library)	cloning	reactions,	ligations	of	vector	and	insert	DNA	were	performed	in	10µL	reaction	volumes	using	20-50ng	vector	DNA,	a	2-3	fold	molar	excess	of	insert	DNA,	1X	T4	DNA	ligase	buffer	(NEB),	and	T4	DNA	ligase	(NEB)	for	30min	to	overnight	at	room	temperature	prior	to	transformation	into	E.	coli	(see	below)	and	selection	on	antibiotic-containing	plates.		Isolated	clones	were	analyzes	via	restriction	enzyme	digest	and	sequencing	to	confirm	the	presence	of	the	desired	construct.		
E.	coli	and	Yeast	Cell	Culture	and	Basic	Manipulations		 E.	coli	manipulations-	The	following	E.	coli	strains	were	used	for	various	experiments	in	this	dissertation:	DH5α	(genotype:	fhuA2	lac∆U169	phoA	gInV44	Φ80lacZDM15	gyrA96	recA1	relA1	endA1	thi-1	hsdR17,	Vanderbilt	Molecular	Biology	Core),	Rosetta	II	DE3	(genotype:	F-	ompT	hsdSB(rB-	mB-)	gal	dcm	(DE3)	pRARE2	(CamR),	Novagen),	USO	omega	selection	(genotype:	SB3930	lac-,	∆hisB463,	∆pyrF,	∆rpoZ:zeo	[F’	
proAB	lacIZ∆M15	Tn10	(Tet)],	(Noyes	et	al.,	2008)),	and	ElectroMAX	DH10B	cells	(genotype:	F-mcrA	D	(mrr-hsdRMS-mcrBC)	Φ80lacZDM15	ΔlacX74	recA1	endA1	araD139	Δ(ara,	leu)7697	galU	galK	λ-rpsL	nupG,	Life	Technologies).		
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	 All	plasmid	propagation	and	cloning	(except	for	that	performed	to	generate	libraries)	was	done	using	chemically	competent	DH5α	cells	(Vanderbilt	Molecular	Biology	Core).		Standard	chemical	transformation	reactions	were	performed	to	generate	clones	using	these	cells.		In	brief,	5µL	of	ligation	reaction	was	mixed	with	50µL	of	cells	in	15mL	polypropylene	round-bottom	tubes	(Fisher	Scientific)	and	incubated	on	ice	for	30min.		Cells	were	heat	shocked	for	30s	at	42°C	and	recovered	in	950µL	Super	Optimal	broth	with	Catabolite	repression	(SOC)	medium	(2%	w/v	tryptone,	0.5%	w/v	yeast	extract,	10mM	NaCl,	2.5mM	KCl,	10mM	MgCl2,	10mM	MgSO4,	and	20mM	dextrose)	for	1hr	at	30°C	with	shaking	at	250rpm.		For	simple	plasmid	propagation,	a	shorter	1min	transformation	protocol	(Golub,	1988),	which	uses	just	10µL	of	cells,	at	least	10ng	of	intact	plasmid	DNA,	and	100µL	of	SOC,	and	eliminates	the	ice	and	recovery	incubation	steps,	was	utilized.		Plasmid	selections	were	performed	overnight	on	30-50%	of	each	standard	chemical	transformation	reaction	or	100%	of	each	1min	transformation	using	Luria	Bertani	(LB)	plates	(1%	w/v	tryptone,	0.5%	w/v	yeast	extract,	0.5%	NaCl)(Sezonov	et	al.,	2007)	supplemented	with	a	final	concentration	of	100µg/mL	Ampicillin	(Amp)	or	50µg/mL	Kanamycin	(Kan)	depending	on	which	antibiotic	resistance	marker	(AmpR	or	KanR)	was	present	on	the	plasmid	to	be	maintained.		Plasmids	were	amplified	via	growth	of	colonies	selected	on	antibiotic	plates	in	5mL	LB	+	antibiotic	for	12-16hrs	at	37°C	with	shaking	at	250rpm	and	isolated	using	a	Qiagen	Mini-Prep	kit	and	a	Qiagen	Mini-Prep	column	(or	multiple	columns	when	>10µg	of	vector	DNA	was	required)	according	to	the	manufacturer’s	instructions.		 Rosetta	II	DE3	cells	(Novagen)	were	used	for	recombinant	protein	expression.		Competent	Rosetta	II	DE3	cells	were	generated	via	the	Inoue	method	(Inoue	et	al.,	1990).		
	 57	
The	transformation	efficiency	of	these	Rosetta	II	DE3	cells	was	generally	much	lower	than	that	of	E.	coli	stains	such	as	DH5α	that	are	typically	used	for	cloning		(1	x	103	transformants/µg	DNA	compared	to	the	transformation	efficiency	of	1	x	108	transformants/µg	typically	obtained	in	chemically	competent	DH5α	prepared	using	the	Inoue	method.		To	compensate	for	this,	a	greater	amount	(200-500ng)	of	protein	expression	vector	DNA	(individual	constructs	described	below)	was	added	to	30-50µL	of	Rosetta	II	DE3	cells	in	standard	chemical	transformation	reactions	performed	largely	otherwise	as	described	above	for	DH5α	cells.		Following	the	1hr	recovery	in	SOC,	50-80%	of	each	transformation	was	plated	on	LB	+	34µg/mL	Chloramphenicol	(Cam)	and	10µg/mL	Kan.		When	expressing	proteins,	individual	colonies	formed	on	these	selection	plates	were	grown	for	3-5	hrs	in	5mL	LB	+	34µg/mL	Cam	and	10µg/mL	Kan	and	then	overnight	in	20mL	LB	+	34µg/mL	Cam	and	10µg/mL	Kan	at	37	oC	with	shaking	at	250rpm.		The	optical	density	at	600nm	(OD600)	of	each	overnight	culture	was	measured	using	a	NanoDrop	2000c	spectrophotometr	(Thermo	Scientific);	this	measurement	was	used	to	guide	the	inoculation	of	fresh	LB	+	34µg/mL	Cam	and	10µg/mL	Kan	to	an	OD600	of	0.03.		These	fresh	cultures	were	grown	at	37°C	with	shaking	at	250rpm	to	an	OD600	of	0.5-1,	at	which	point	1M	stock	Isopropyl-β-D-1-thiogalactopyranoside	(IPTG)	was	added	to	each	culture	to	a	final	concentration	of	1mM	to	begin	induction.		Protein	inductions	were	allowed	to	proceed	for	4hrs	at	37oC	with	shaking	at	250rpm	at	which	point	cells	were	harvested	via	centrifugation	for	10min	at	4,000rpm	in	a	J6-HC	(Beckman	Coulter).		For	small-scale	inductions	(5-50mL	cultures),	supernatants	were	discarded	and	pellets	were	stored	at	-80°C.		For	large-scale	inductions	(0.5-1L	cultures),	supernatants	were	discarded	and	pellets	were	resuspended	in	
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sterile	water.		Resuspended	pellets	were	transferred	to	50mL	conical	tubes	and	re-pelleted	by	centrifugation	prior	to	the	final	supernatant	removal	and	pellet	storage	at	-80°C.			 USO	omega	selection	cells	(Noyes	et	al.,	2008)	were	used	for	all	bacterial	omega	one-hybrid	experiments.		These	cells	contain	genes	encoding	resistance	to	Tetracycline	(Tet)	and	Zeocin	(Zeo)	(see	genotype	above);	USO	omega	cells	used	for	omega	one-hybrid	screening	additionally	contained	a	KanR	plasmid.		Electrocompetent	USO	omega	selection	cells	were	prepared	in-house	using	a	published	protocol	(Dower	et	al.,	1988).		This	protocol	results	in	the	production	of	electrocompetent	cells	with	high	transformation	efficiencies	(1	x	109-	1	x	1010	transformants/µg	DNA)	regardless	of	strain	background.		Additionally,	in	contrast	to	chemical	transformation	efficiency	decreases	outside	of	a	1pg	–	1	x	103	pg	DNA	input	range	(Hanahan,	1983),	the	transformation	efficiency	of	electrocompetent	cells	is	maintained	over	a	wider	range	of	DNA	input	(1pg	–	1	x	106	pg)	(Dower	et	al.,	1988),	reducing	the	number	of	transformation	reactions	needed	to	generate	a	large	number	of	transformants.		 To	prepare	electrocompetent	USO	omega	selection	cells,	cells	were	grown	overnight	in	2X	Yeast	Extract	Tryptone	(YT)	Broth	(1.6%	w/v	tryptone,	1%	w/v	yeast	extract,	0.5%	NaCl)	with	appropriate	antibiotic	selection	(final	concentrations	of	10µg/mL	Tet,	50µg/mL	Zeo,	and	10µg/mL	Kan	(where	a	KanR	plasmid	was	present)	at	37°C	with	shaking	at	250rpm.		The	next	day,	overnight	cultures	were	used	to	inoculate	fresh	2X	YT	containing	the	same	antibiotic	selection	as	the	overnight	growth	to	a	starting	OD600	of	0.0625.		These	fresh	cultures	were	grown	at	37°C	with	shaking	at	250rpm	until	they	reached	an	OD600	of	0.5-0.6,	at	which	point	cultures	were	immediately	immersed	in	an	ice	water	bath	where	they	were	incubated	for	30min.		After	the	incubation,	cells	were	transferred	to	centrifuge	
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bottles	(pre-chilled	in	an	ice	water	bath)	and	cells	were	pelleted	via	centrifugation	for	10min	at	4°C	in	a	J6-HC	centrifuge	(Beckman	Coulter).		Supernatant	was	removed	and	pellets	from	250mL	culture	were	resuspended	in	100mL	sterile	H2O	pre-chilled	at	4°C.		The	centrifugation	and	100mL	sterile	4°C	H2O	pellet	resuspension	steps	were	repeated.			Cells	were	once	again	pelleted	via	centrifugation,	supernatants	were	removed,	and	pellets	were	resuspended	in	20mL	sterile	10%	glycerol	pre-chilled	at	4°C.		Cells	resuspended	in	20mL	sterile	10%	glycerol	were	pelleted	again	by	centrifugation,	supernatant	was	removed,	and	pellets	were	resuspended	in	5mL	sterile	10%	glycerol.		Each	pellet	resuspended	in	5mL	sterile	10%	glycerol	was	then	distributed	in	4	X	1.25mL	aliquots	in	1.5mL	Eppendorf	tubes.		Cells	were	re-pelleted	by	spinning	for	1min	at	13,000rpm,	4°C	in	an	Eppendorf	Centrifuge	5417C,	resuspended	in	a	final	volume	of	80µL	sterile	10%	glycerol,	immediately	frozen	on	dry	ice,	and	stored	at	-80°C	until	use.		Electroporation	reactions	were	performed	on	40µL	cells	incubated	for	1min	on	ice	with	100-200ng	of	DNA	resuspended	in	1mM	Tris-Cl	(pH	8.5)	(to	keep	ions	in	the	reaction	to	a	minimum)	in	a	0.1cm	Gene	Pulser	Cuvette	(BioRad)	using	a	Gene	Pulser	(BioRad)	set	at	25µF	and	2.5kV	and	a	Pulse	Controller	(BioRad)	set	at	200	ohms.		Immediately	following	pulse	delivery,	cells	were	resuspended	in	1mL	SOC.		Cells	were	recovered	and	plasmid	selections	were	performed	as	described	for	the	standard	chemical	transformation	above.		Using	this	method,	electrocompetent	cells	with	a	transformation	efficiency	of	~1	x	109	transformants/µg	intact	DNA	were	routinely	generated.		 Electrocompetent	USO	selection	cells	and	ElectroMAX	DH10B	cells	(Life	Technologies)	were	used	to	generate	plasmid	DNA	libraries	for	screening	because	of	their	extremely	high	transformation	efficiency	(1	x	109-1	x	1010	transformants/µg	intact	
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plasmid).			The	protocol	for	omega	one	hybrid	system	library	generation	(Meng	and	Wolfe,	2006)	was	used	to	create	all	Rap1	variant	libraries.		In	this	protocol,	multiple	electroporation	reactions,	each	containing	150-300ng	worth	of	library	ligation	DNA,	were	performed	as	described	for	the	USO	selection	cells	above.		Each	electroporation	reaction	was	resuspended	in	1mL	SOC.		Prior	to	recovery,	all	electroporation	reactions	performed	using	library	DNA	were	combined	and	added	to	a	greater	volume	of	SOC,	resulting	in	a	5-fold	dilution	of	the	library	culture.		After	recovering	this	diluted	culture	for	1hr	at	37°C	with	shaking	at	250rpm,	a	small	aliqot	(20µL)	was	titrated	onto	multiple	selective	media	plates	to	estimate	the	library	size.		To	select	for	and	begin	propagation	of	library	variant	plasmids,	LB	containing	the	appropriate	selective	antibiotic	was	added	directly	to	the	recovered	SOC	culture	to	increase	its	volume	2.5X.		This	culture	was	grown	for	3hrs	at	37°C	with	shaking	at	250rpm.		Following	this	expansion,	another	20µL	of	culture	was	titrated	on	selective	media	to	confirm	library	expansion	and	half	of	the	culture	(estimated	to	contain	at	least	one	complete	copy	of	the	library)	was	pelleted	and	frozen	as	glycerol	stock	for	possible	later	library	propagation.		The	remaining	culture	(also	estimated	to	contain	at	least	one	complete	copy	of	the	library)	was	allowed	to	continue	to	expand	until	it	reached	an	OD600	of	0.6-2	(much	less	than	an	OD600	of	5,	at	which	point	E.	coli	cell	density	reaches	saturation	and	antibiotic	selection	for	the	plasmid	cannot	be	guaranteed).		Cell	cultures	were	pelleted	and	frozen	at	-20°C	overnight.		Library	DNA	was	isolated	from	these	pellets	using	multiple	Qiagen	mini-prep	columns	(10mL	cell	culture	pellet	representing	20	OD600	units/column)	and	a	Qiagen	Mini-Prep	kit.		
	 Yeast	manipulations-	Several	yeast	strains	were	generated	as	described	below	to	perform	the	experiments	presented	in	this	dissertation.		All	yeast	manipulations	were	
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performed	the	same	irrespective	of	strain	background.		All	growth	steps	were	performed	at	30°C	and,	for	liquid	cultures,	with	shaking	at	250rpm.		Where	no	selectable	markers	for	a	yeast	strain	were	available,	yeast	were	grown	on	either	solid	or	liquid	Yeast	Extract	Peptone	Dextrose	(YPD,	1%	w/v	yeast	extract,	2%	w/v	peptone,	2	%	w/v	dextrose).		Selection	for	yeast	bearing	a	drug	resistance	cassette	such	as	HPHMX4,	which	encodes	resistance	for	Hygromycin	B	(Corning),	or	KANMX4,	which	encodes	resistance	for	G418	Sulfate	(Corning)	were	performed	on	YPD	+	200µg/mL	Hygromycin	B	and	YPD	+	200µg/mL	G418	Sulfate,	respectively.		Selection	for	yeast	bearing	genes	encoding	auxotrophic	markers	such	as	Tryptophan	(Trp),	Histidine	(His),	Leucine	(Leu),	Adenine	(Ade),	and	Uracil	(Ura)	were	performed	using	Synthetic	Complete	(SC)	medium	(0.67%	w/v	yeast	nitrogen	base	without	aa’s,	2%	w/v	dextrose,	and	0.2%	w/v	aa	dropout	mix)	(Murthy	et	al.,	1975)	lacking	the	amino	acid	produced	by	the	auxotrophic	marker	gene.		 Yeast	transformations	performed	to	introduce	plasmid	DNA	or	genomic	integration	cassettes	following	the	high-efficiency	yeast	transformation	protocol	(Gietz	and	Schiestl,	2007).		In	this	protocol,	yeast	cultures	inoculated	with	a	single	colony	were	grown	overnight	at	30°C	with	shaking	at	250rpm	to	saturation	in	appropriate	selective	media.		The	next	day,	overnight	yeast	cultures	were	used	to	start	fresh	cultures	again	using	appropriate	selective	media	(5mL/transformation	reaction)	at	an	OD600	of	0.125.		Cultures	were	grown	for	5hrs	at	30°C	with	shaking	at	250rpm	at	which	point	they	reached	an	OD600	of	0.5-1.		Cultures	were	pelleted	by	centrifugation	for	5min	at	4,000rpm	in	a	J6-HC	centrifuge	(Beckman	Coulter).		Supernatants	were	removed	and	cell	pellets	were	resuspended	in	sterile	H2O	(1mL/transformation	reaction)	and	transferred	in	1mL	aliquots	to	1.5mL	Eppendorf	tubes.		Cells	were	re-pelleted	via	centrifugation	for	30s	at	13,000rpm	in	an	
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Eppendorf	Centrifuge	5417C,	supernatants	were	aspirated,	and	pellets	were	resuspended	in	a	360µL	transformation	mix	consisting	of	240µL	50%	PEG	3500,	36µL	1M	LiAc,	50µL	1mg/mL	salmon-sperm	DNA,	at	least	100ng	of	DNA,	and	sterile	water	added	to	the	final	360µL	volume.		Cells	resuspended	in	a	transformation	reaction	were	heat	shocked	for	40min	at	42°C.		Following	heat	shock,	cells	were	pelleted	by	spinning	for	30s	at	13,000rpm.	Transformation	reaction	mix	was	removed	via	aspiration,	cell	pellets	were	resuspended	in	1mL	sterile	H2O,	and	10-100%	of	a	reaction	(depending	on	whether	the	DNA	being	introduced	was	a	plasmid	or	integration	construct)	was	plated	on	appropriate	selective	media.		Selective	plates	were	grown	for	36-38hrs	at	30°C.		As	a	negative	control,	a	no	DNA	transformation	reaction	was	performed	to	confirm	that	only	cells	that	had	taken	up	the	DNA	of	interest	survived	the	selection.		Rap1	Bacterial	Omega	One-Hybrid	Vectors		 The	bacterial	omega	one-hybrid	system	depends	on	the	function	of	two	vectors:	(1)	an	AmpR	plasmid	that	drives	the	expression	of	a	bacterial	RNA	Polymerase	ω	subunit-transcription	factor	DBD	fusion	under	the	control	of	a	mutant	lac	promoter	used	to	drive	a	low	level	expression	of	fusion	proteins	whose	expression	at	higher	levels	might	otherwise	be	toxic	to	the	cell	(pB1H2,	Addgene,	(Noyes	et	al.,	2008)),	and	(2)	a	KanR	plasmid	that	contains	HIS3	and	URA3	reporters	driven	by	a	weak	lac	promoter	and	transcription	factor	binding	site	(pH3U3,	Addgene,	(Noyes	et	al.,	2008)).		A	pB1H2	RAP1	DBD	plasmid	was	generated	by	cloning	a	Pfu	polymerase	PCR	generated	KpnI	to	XbaI	fragment	containing	the	DNA	sequences	encoding	the	Rap1	DBD	(RAP1	nts	1081-1788,	encoding	aa’s	361-596	(Henry	et	al.,	1990))	in	frame	with	the	pB1H2	ω	subunit	sequence.		Meanwhile,	pH3U3	
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UASRap1	variants	were	generated	by	cloning	EcoRI	to	NcoI	variants	of	the	UASRap1	sequence	(5’-AATTCATATACACCCATACATTGACGC-	3’;	UASRap1	sequences	underlined)	generated	by	annealing	synthetic	oligonucleotides	(IDT)	into	the	pH3U3	multiple	cloning	site	(MCS)	located	upstream	of	the	promoter	and	reporter	gene	sequences.		Yeast	Strains		 All	of	the	yeast	strains	used	in	this	chapter	are	listed	in	Table	2.1.	These	strains	were	derived	from	a	rap1∆	null	strain	created	in	the	BY4741	background	(Brachmann	et	al.,	1998),	often	via	the	utilization	of	the	pRS	series	of	yeast	expression	vectors	(Brachmann	et	al.,	1998).		Because	budding	yeast	RAP1	is	a	single	copy	essential	gene	(Shore	and	Nasmyth,	1987),	these	strains	carry	RAP1	covering	plasmids.		The	plasmid	covering	rap1∆	in	these	strains	was	either	a	previously	generated	pRS415	MYC5-RAP1	plasmid	(Garbett	et	al.,	2007)	or	a	pRS416	FLAG3–	RAP1	vector	created	by	inserting	a	FLAG3	tag	flanked	by	EcoRI	restriction	sites	generated	by	annealing	synthetic	oligonucleotides	obtained	from	IDT	at	the	EcoRI	site	located	between	the	RAP1	promoter	and	RAP1.		Both	constructs	express	RAP1	under	the	control	of	the	native	RAP1	promoter	(RAP1	nt	position	-433	to	+	1	(Graham	et	al.,	1999)	and	terminator	(RAP1	nt	position	+2485	to	+2533).				 TAF1	was	genomically	tagged	in	these	strains	with	an	HA3	epitope	to	facilitate	its	possible	study	via	ChIP	assay.		
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To	generate	the	HA3-TAF1	tagging	construct,	PCR	was	performed	using	Q5	polymerase	on	a	previously	existing	pRS313	HA3-TAF1	plasmid	(Bai	et	al.,	1997)	to	generate	an	XmaI	to	NotI	fragment	containing	the	TAF1	promoter	(nt	position	-900	to	+1	(Bai	et	al.,	1997)),	HA3	epitope,	and	TAF1	nts	+2-+1648.		This	fragment	was	cloned	using	the	general	approach	outlined	above	into	the	pRS306	integration	vector.		The	resulting	pRS306	HA3-TAF1	plasmid	was	linearized	via	digestion	with	MscI	(NEB)	which	cuts	once	within	the	TAF1	ORF	and	integrated	into	the	yeast	genome	via	transformation,	ends-in	recombination	(Hastings	et	al.,	1993),	and	selection	for	the	URA3	marker	provided	by	the	pRS306	vector.		The	URA3	marker	was	recycled	via	counter-selection	on	SC	media	containing	uracil	and	0.1%	5-Fluoroorotic	Acid	(5-FOA),	a	compound	that	selects	against	cells	that	express	the	Orotidine-5’-phosphate	decarboxylase	enzyme	encoded	by	the	URA3	gene	(Boeke	et	al.,	1987;	Längle-Rouault	and	Jacobs,	1995).		Cells	that	maintained	HA3-TAF1	following	counter-selection	to	remove	URA3	were	identified	via	immunoblotting	(see	“Immunoblotting”	below)	using	anti-HA	3F10	(Roche	catalog	no.	11867423001)	and	anti-β-actin	(Abcam	catalog	no.	ab8224)	loading	control	antibodies.		 To	enable	selection	for	HIS3	reporter	integration	independent	of	HIS3	expression	in	the	BY4741	background	(Brachmann	et	al.,	1998),	the	TRP1	gene	(which	provides	the	selectable	marker	on	HIS3	reporter	integration	constructs)	was	replaced	with	the	KANMX4	drug-resistance	cassette.		This	replacement	was	performed	using	a	pFA6a-based	plasmid	(Wach	et	al.,	1994)	generated	by	my	colleague	Dr.	Chirie	Sumanasekara	termed	pFA6a	
KANMX	trp1∆	by	the	addition	of	~1kb	of	TRP1	upstream	and	downstream	sequences	on	either	side	of	the	KANMX4	cassette.	This	plasmid	was	digested	with	the	SacII	and	SalI-HF	enzymes	used	to	clone	the	TRP1	homology	arms,	transformed	into	yeast,	integrated	via	
	 65	
ends-out	recombination	(Hastings	et	al.,	1993),	and	selected	on	YPD	+	200µg/mL	G418	Sulfate.		Transformants	possessing	KANMX4	replacement	of	the	TRP1	gene	were	identified	by	screening	on	SC-Trp	and	confirmed	by	PCR.		 The	various	UASRap1-HIS3	reporter	genes	were	derived	from	a	similar	reporter	characterized	in	previous	studies	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002).		This	reporter	contains	two	copies	of	the	Rap1	binding	site	(UASRap1)	derived	from	the	RPS8A	gene,	a	promoter	(TATA),	the	HIS3	reporter	gene,	a	TRP1	selectable	marker,	and	~1.5kb	flanking	arms	with	homology	to	the	HIS3	locus,	including	the	DED1	gene	located	3’	of	HIS3.		To	generate	reporter	variants	with	mutant	UASRap1	binding	sites,	the	48bp	NcoI	to	SacII	DNA	fragment	encompassing	the	two	UASRap1	binding	sites	in	the	WT	UASRap1-HIS3	reporter	generated	in	previous	studies	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002)	was	replaced	with	a	48bp	NcoI	to	SacII	DNA	fragment	containing	3T4A	or	3G5G	UASRap1	binding	sites	generated	by	annealing	double-stranded	synthetic	oligonucleotides	obtained	from	IDT.		The	∆UAS	reporter	was	generated	by	replacing	the	NcoI	to	EcoRI	fragment	encompassing	the	UASRap1	and	TATA	sequences	with	an	NcoI	to	EcoRI	fragment	containing	just	the	TATA	sequence	generated	by	PCR	using	UASRap1-HIS3	as	a	template.		All	reporters	were	digested	with	SpeI	and	SalI,	transformed	into	yeast,	and	integrated	into	the	HIS3::DED1	locus	via	ends-out	recombination	(Hastings	et	al.,	1993).		Transformants	were	selected	on	SC-Trp	and	correct	integration	of	the	reporter	was	confirmed	via	PCR.		Test	Rap1	Yeast	Expression	Vectors		 The	test	RAP1	yeast	expression	vectors	are	the	same	as	the	pRS415	MYC5	RAP1	expression	vector	described	in	“Yeast	Strains”	above	except	those	generated	for	a	purpose	
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other	than	testing	omega	one-hybrid	screen	hits	in	yeast	contain	the	SV40	nuclear	localization	signal	(NLS;	PKKKRKV	(Kalderon	et	al.,	1984))	inserted	by	replacing	the	EcoRI	to	XhoI	fragment	of	pRS415	MYC5	RAP1,	which	contains	the	RAP1	ORF,	with	an	EcoRI	to	XhoI	fragment	containing	NLS	RAP1	generated	via	PCR.		Mutant	RAP1	test	expression	vectors	used	in	this	chapter	were	created	in	one	of	two	ways:	(1)	replacing	the	BlpI	to	BglII	fragment	of	RAP1	in	pRS415-MYC5-NLS-RAP1	with	a	BlpI	to	BglII	fragment	of	a	pBluescript	
RAP1	variant	whose	DBD-encoding	sequences	had	been	replaced	with	those	of	a	RAP1	DBD	isolated	in	an	omega	one-hybrid	screen	(see	“Bacterial	Omega	One-hybrid	Rap1AS	Screen”	below	for	details)	or	(2)	replacing	the	BlpI	to	SphI	fragment	of	RAP1	in	plasmid	pRS415-
MYC5-NLS-RAP1	with	the	BlpI	to	SphI	fragment	of	a	mutant	RAP1	generated	via	targeted	randomization	Rap1	library	construction	(see	below).		Rap1	Expression	and	Purification	for	Gel	Shift	DNA-Binding	Assays		 To	prepare	Rap1	for	DNA	binding	assays,	Rap1	ORF	sequences	were	excised	from	pRS416-Rap1	yeast	expression	plasmids	generated	in	this	study	(see	“Targeted	Randomization	Mutagenesis	of	Rap1	DBD	and	Construction	of	Rap1	Variant	Expression	Library”)	or	a	previous	study	(Garbett	et	al.,	2007)	with	EcoRI	and	XhoI	and	ligated	into	similarly	digested	pET28a	expression	vector,	in-frame	with	the	vector	encoded	N-terminal	His6	tag.		Plasmids	were	transformed	and	propagated	at	37°C	in	the	E.	coli	Rosetta	II	(DE3)	expression	strain	(Novagen)	in	LB	media	(Sezonov	et	al.,	2007)	supplemented	with	a	final	concentration	of	10µg/mL	Kan	and	34µg/mL	Cam.		His6-Rap1	expression	was	induced	for	4hr	following	addition	of	IPTG	to	1mM.		Cell	pellets	from	500	ml	of	culture	were	resuspended	in	20ml	of	Lysis/Wash	buffer	(25mM	HEPES	NaOH	(pH	7.6),	10%	v/v	
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glycerol,	300mM	NaCl,	0.01%	v/v	NP-40,	1mM	Benzamidine,	0.2	mM	PMSF).		Cells	were	lysed	by	treatment	with	lysozyme	(final	concentration	of	1mg/mL)	and	sonication.		After	centrifugation,	each	cleared	lysate	was	incubated	with	2.5	ml	Ni-NTA	agarose	(Qiagen)	pre-equilibrated	with	an	equal	volume	of	Lysis/Wash	Buffer.	Proteins	were	bound	for	3	hours	at	4°C,	washed	3X	with	Lysis/Wash	buffer,	transferred	to	a	disposable	column	(Bio-Rad),	and	bound	proteins	eluted	using	Lysis/Wash	buffer	containing	200mM	Imidazole.		Rap1	Gel	Shift	DNA-Binding	Assays		 10ng	(~100fmol)	of	purified	His6-Rap1	WT/variant	proteins	were	incubated	with	0.6ng	(~50fmol,	~35,000dpm)	of	19bp	32P-labeled	duplex	DNA	containing	a	Rap1	binding	site	(either	WT:	5’-ATATACACCCATACATTGA-3’	or	the	3T4A	mutant		5’-ATATACTACCATACATTGA-	3’;	UASRap1	sequences	underlined;	mutated	residues	bolded)	in	the	presence	or	absence	of	variable	amounts	of	unlabeled	WT	or	3T4A	UASRap1	DNA	(see	Figure	legends)	for	20min	at	room	temperature	in	Binding	buffer	(20mM	HEPES	KOH	(pH	7.6),	10%	v/v	glycerol,	100mM	KCl,	0.1mM	EDTA,	1mM	DTT,	25	µg/mL	BSA,	2.5	µg/ml	Poly(dG-dC)	(double-stranded,	alternating	copolymer,	Sigma)	in	a	final	volume	of	20µl.		Reactions	were	loaded	on	0.5X	TBE-buffered	(44.5mM	Tris,	44.5mM	Boric	acid,	1mM	EDTA	(pH	8.0))	6%	polyacrylamide	gels	and	electrophoresed	for	45	min	at	200	V	at	room	temperature,	and	the	gels	vacuum	dried.		32P-DNA	signals	were	detected	via	K-screen	imaging	using	a	Pharos	FX	imager	(Bio-Rad).		The	intensity	of	the	bands	representing	Rap1-32P-DNA	complexes	were	quantified	using	Quantity	One	software	(Bio-Rad).		 	
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Rap1	DBD	Error-Prone	(EP)-PCR	Mutagenesis	and	Library	Construction		 Random	mutagenesis	of	the	RAP1	DBD	was	accomplished	via	EP-PCR	performed	according	to	the	protocol	utilized	to	mutagenize	the	Taf4	and	Taf5	RBDs	in	order	to	generate	temperature	sensitive	(Ts+)	Taf4	and	Taf5	variants	(Cadwell	and	Joyce,	1992,	1994;	Layer	et	al.,	2010).		Random	PCR	mutagenesis	was	performed	in	100	µL	reactions	using	the	same	primers	used	to	clone	the	Rap1	DBD	in	frame	with	the	pB1H2	ω	subunit	sequence	at	a	final	concentration	of	0.3µM	and	5	units	Thermus	aquaticus	(Taq)	DNA	Polymerase	(the	thermostable	DNA	Polymerase	with	the	highest	error	rate)	in	mutagenic	PCR	buffer	(7mM	MgCl2,	10mM	Tris-HCl	(pH	8.3),	50mM	KCl,	0.5mM	MnCl2,	0.2mM	dGTP,	0.2mM	dATP,	1mM	dCTP,	1mM	dTTP).		The	increased	MgCl2	concentration,	increased	Taq	units,	addition	of	MnCl2,	and	uneven	dNTP	concentrations	provided	by	the	mutagenic	PCR	buffer	over	the	standard	Taq	PCR	buffer	(1.5mM	MgCl2,	50mM	KCl,	10mM	Tris-HCl	(pH	8.3),	0.2mM	dGTP,	0.2mM	dATP,	0.2mM	dCTP,	0.2mM	dTTP,	2.5	units	Taq)	increase	the	error	rate	of	Taq	from	10-3/nucleotide	to	7	X	10-3/nucleotide	(Cadwell	and	Joyce,	1994).		Multiple	rounds	of	PCR	were	performed	using	20,	25,	and	30	cycles	in	order	to	vary	the	number	of	mutations	introduced	into	the	RAP1	DBD,	with	mutant	RAP1	DBDs	generated	using	20	PCR	cycles	generally	possessing	fewer	mutations	than	those	generated	using	30	PCR	cycles.		 Mutagenic	PCR	products	were	digested	with	KpnI	and	XbaI	restriction	enzymes	and	ligated	into	similarly	digested	pB1H2,	a	plasmid	that	drives	expression	of	ω-transcription	factor	DBD	fusion	proteins	using	a	mutant	lac	promoter	(see	above;	“Rap1	Bacterial	Omega	One-Hybrid	Vectors”).		Ligation	products	were	purified	using	a	Qiagen	PCR	purification	kit	and	Qiagen	PCR	purification	columns	to	remove	the	salt	in	the	ligation	buffer	and	
	 69	
electroporated	into	USO	selection	cells.		Multiple	electroporation	reactions	were	used	to	create	a	library	of	~1	x	106	that	was	expanded	according	to	the	procedure	described	above	in	“E.	coli	and	Yeast	Cell	Culture	and	Basic	Manipulations.”		Sanger	sequencing	of	library	expression	plasmid	isolated	from	ten	individual	clones	was	used	to	confirm	the	random	introduction	of	mutations	into	the	sequences	encoding	the	Rap1	DBD.		Targeted	Randomization	Mutagenesis	of	the	Rap1	DBD	and	Library	Construction		 Codon	randomization	of	N401,	S402,	R404,	H405,	R408,	and	V409	of	the	RAP1	DBD	was	achieved	by	overlap	extension	PCR	(Heckman	and	Pease,	2007)	using	the	mutagenic	oligonucleotide	(see	also	Figure	2.3):	5’CATTATGTGCCTAACCACACGGGTNNSNNSATT	
NNSNNSCGATTTNNSNNSTATCTTTCCAAAAGACTAGAGTACG3’,	its	reverse	complement,	and	two	flanking/outside	primers	containing	either	KpnI	and	StuI	restriction	sites	(for	the	omega	one-hybrid	screening	library)	or	BlpI	and	StuI	restriction	sites	(for	the	yeast	screening	library).		Mutagenic	PCR	products	were	digested	with	SphI-HF	and	either	KpnI	or	BlpI	restriction	enzymes	and	ligated	into	similarly	digested	pB1H2-RAP1	or	pRS416-RAP1,	respectively.		The	pB1H2-RAP1	plasmid	drives	expression	of	an	ω-RAP1	DBD	fusion	protein	using	a	mutant	lac	promoter	(see	above;	“Rap1	Bacterial	Omega	One-Hybrid	Vectors”)	while	pRS416-RAP1	drives	RAP1	expression	using	the	native	RAP1	enhancer-promoter	(see	above;	“Yeast	strains”).		Ligation	products	were	purified	using	a	Qiagen	PCR	purification	kit	and	Qiagen	PCR	purification	columns	to	remove	the	salt	in	the	ligation	buffer	and	electroporated	into	ElectroMAX	DH10B	cells	(Life	Technologies,	see	genotype	above	in	“E.	
coli	and	Yeast	Cell	Culture	and	Basic	Manipulations”).		Multiple	electroporation	reactions	were	used	to	create	a	library	of	~1	x	108	independent	bacterial	clones,	a	number	that	
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exceeds	the	8.6	x	107	variations	theoretically	generated	by	the	codon	randomization	of	six	amino	acids,	using	the	protocol	described	above	in	“E.	coli	and	Yeast	Cell	Culture	and	Basic	Manipulations.”		Sanger	sequencing	of	library	expression	plasmid	isolated	from	ten	individual	clones	was	used	to	confirm	that	the	mutagenesis	targeted	the	expected	amino	acids.		Bacterial	Omega	One-hybrid	Rap1AS	Screen		 To	screen	for	a	mutant	RAP1	variant	that	could	drive	expression	of	a	reporter	gene	containing	a	mutant	Rap1	binding	site	(i.e.	UASRAP1	5G	or	UASRAP1	3T4A)	in	the	omega	one-hybrid	system,	plasmid	libraries	generated	by	either	EP-PCR	or	targeted	randomization	were	introduced	into	USO	selection	cells	containing	a	KanR	pH3U3	UASRap1	reporter	plasmid	via	electroporation	using	the	settings	outlined	above	in	“E.	coli	and	Yeast	Cell	Culture	and	Basic	Manipulations.”	After	recovering	electroporated	cells	for	1hr	10min	in	SOC	at	37°C	with	shaking	at	250rpm,	a	small	aliquot	(20µL)	of	cells	was	titrated	onto	a	2	X	YT	+	100µg/mL	Amp	and	25µg/mL	Kan	to	estimate	the	number	of	cells	carrying	both	the	KanR	pH3U3	UASRap1	reporter	plasmid	and	an	AmpR	pB1H2-RAP1	expression	plasmid.	The	remaining	cells	were	pelleted	by	centrifugation	for	10min	at	4,000rpm	in	a	J6-HC	centrifuge	(Beckman	Coulter)	and	resuspended	in	1mL/electroporation	reaction	NM	(1X	M9	Salts	(42mM	Na2HPO4,	22mM	KH2PO4,	8.6mM	NaCl,	19mM	NH4Cl),	4mg/mL	glucose,	200mM	adenine-HCl,	1X	amino	acid	mixture	(0.013%	w/v	Phe,	0.005%	w/v	Lys,	0.011%	w/v	Arg,	0.001%	w/v	Gly,	0.003%	w/v	Val,	0.004%	w/v	Ala,	0.002%	w/v	Trp,	0.003%	w/v	Thr,	0.036%	w/v	Ser,	0.02%	w/v	Pro,	0.004%	w/v	Asn,	0.005%	w/v	Asp,	0.081%	w/v	K-Glu,		0.13%	w/v	Gln,	0.003%	w/v	Tyr,	0.003%	w/v	Ile,	0.003%	w/v	Leu),	1mM	MgSO4,	
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10mg/mL	thiamine,	10mM	ZnSO4,	100mM	CaCl2,	10µM	IPTG)	+	0.1%	w/v	His,	0.0025%w/v		Ura,	100µg/mL	Amp,	and	25µg/mL	Kan.		Growth	of	these	cells	was	allowed	to	proceed	for	1hr	at	30°C	with	shaking	at	250rpm.		After	this	growth	step,	cells	were	washed	3	X	with	sterile	H2O	using	repeated	centrifugation,	supernatants	were	aspirated,	and	pellet	were	resuspended	in	sterile	H2O.		A	small	aliquot	(20µL)	of	cells	was	titrated	onto	NM	+	0.1%	w/v	His,	0.0025%	w/v	Ura,	100µg/mL	Amp,	and	25µg/mL	Kan	to	estimate	the	number	of	cells	in	the	screen	while	the	remaining	cells	were	screened	on	selective	media	(NM-His	+	0.25,	0.5,	1,	2.5	5,	10,	25,	50,	or	100mM	3-Amino-1,	2,	4-Triazole	(3-AT)	(Sigma))	and	incubated	for	3-7	days	at	30°C.		 	Over	the	course	of	the	3-7	day	incubation,	colony	formation	on	selective	plates	containing	cells	transformed	with	pB1H2-RAP1	variants	was	monitored	and	compared	to	colony	formation	on	selective	plates	representing	“background”	pH3U3	UASRap1	reporter	expression	(USO	cells	containing	a	pH3U3	UASRap1	reporter	plasmid	and	ω-RAP1	DBD	WT	expression	plasmid)	prepared	in	parallel.		Plasmids	were	recovered	from	colonies	that	appeared	on	selective	media	earlier	than	“background”	using	a	Qiagen	Mini-Prep	kit.		The	purified	plasmid	preparations	were	treated	with	the	restriction	endonuclease	XhoI	(NEB),	which	cuts	the	pH3U3	UASRap1	reporter	plasmid	but	NOT	the	pB1H2-RAP1	expression	plasmid.		The	digest	was	used	to	transform	E.	coli	to	AmpR	and	the	resulting	plasmids	isolated	to	generate	putative	Rap1AS-encoding	pB1H2-RAP1	mutant	plasmids.		The	pB1H2-
RAP1	plasmids	recovered	in	this	step	were	retransformed	into	USO	selection	cells	containing	the	cognate	pH3U3	UASRap1	reporter	plasmid	and	retested	for	growth	on	1,	2.5,	5,	10,	and	25mM	3-AT	to	confirm	that	3-AT	resistant	growth	was	conferred	by	the	mutant,	pB1H2-RAP1	plasmid.		RAP1	sequences	from	pB1H2-RAP1	plasmids	passing	this	filter	were	
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transferred	into	yeast	expression	vectors	for	analysis	in	yeast.		To	accomplish	this	transfer,	an	AfeI	to	BsrGI	fragment	containing	sequences	encoding	a	mutant	Rap1	DBD	was	generated	via	PCR	using	pB1H2-RAP1	plasmids	isolated	from	the	omega	one-hybrid	screen	as	a	template.		These	PCR	products	were	cloned	into	an	Afe1/BsRGI	restriction	enzyme	digested	pBluescript	II	KS+	plasmid	containing	a	full-length	RAP1	with	Afe1	and	BsRG1	restriction	sites	introduced	via	silent	mutations	on	either	side	of	the	sequences	encoding	the	DBD	in	overlap	extension	PCR	(Heckman	and	Pease,	2007).		The	BlpI	to	BglII	fragment	encompassing	the	Rap1	DBD-encoding	sequences	of	the	Bluescript	II	KS+	RAP1	variants	were	transferred	into	a	similarly	digested	yeast	pRS415	UASRap1	MYC5	RAP1	expression	vector.		These	pRS415	UASRap1	MYC5	RAP1	expression	vectors	were	transformed	into	yeast	containing	a	UASRap1-HIS3	reporter	variant	whose	mutant	UASRap1	sites	matched	the	pH3U3	
UASRap1	site	used	to	isolate	the	RAP1	expression	plasmid	in	the	omega	one-hybrid	screen	and	tested	for	3-AT	resistant	growth	in	yeast.			 	Yeast	Rap1AS	Screen		 To	screen	for	a	mutant	RAP1	variant	that	could	drive	expression	of	a	reporter	gene	containing	a	mutant	Rap1	binding	site	(i.e.	UASRAP1	3T4A)	in	yeast,	the	Rap1	yeast	expression	vector	library	generated	via	targeted	randomization	of	Rap1	DBD	codons	was	introduced	into	yeast	strain	3T4A-HIS3	#1	(see	Table	2.1	above).		A	small	aliquot	(10µL)	of	transformation	reaction	was	plated	onto	Sc-Ura	to	estimate	the	number	of	URA3-marked	mutant	RAP1	expression	vectors	that	had	been	introduced	into	yeast	via	the	transformation	while	the	rest	was	plated	onto	selective	media	for	screening	(SC	media	containing	5mM	3-AT)	(Sigma).		Plates	were	incubated	for	4	days	at	30°C.		Colonies	were	
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then	replica	plated	to	SC	media	plates	containing	5mM	3-AT	and	0.1%	5-FOA	to	determine	whether	growth	of	the	colony	on	5mM	3-AT	required	Rap1	produced	from	the	URA3-marked	pRS416	RAP1	library	plasmid.		RAP1	expression	plasmids	were	recovered	from	colonies	that	grew	on	5mM	3-AT	and	failed	to	grow	on	5mM	3-AT	+	0.1%	5-FOA	using	a	yeast	mini-prep	protocol	developed	in	the	Weil	lab	(Singh	and	Weil,	2002).		These	purified	plasmid	preparations	were	treated	with	the	restriction	endonuclease	BsRGI	(NEB)	that	cuts	the	pRS415-MYC5-RAP1	covering	plasmid,	but	not	the	pRS416-RAP1	library	plasmid.		The	digest	was	used	to	transform	E.	coli	to	AmpR	and	the	resulting	plasmids	isolated	to	generate	putative	Rap1AS-encoding	pRS416-RAP1	mutant	plasmids.		The	recovered	pRS416-RAP1	plasmids	were	retransformed	into	yeast	strain	3T4A-HIS3	#1	and	retested	for	growth	on	5mM	3-AT	to	confirm	that	3-AT	resistant	growth	was	conferred	by	the	mutant,	pRS416-RAP1	plasmid.	 	Yeast	Cell	Growth	Assays		 For	plate	assays,	yeast	strains	were	grown	overnight	to	saturation,	serially	diluted	1:4	in	sterile	water	in	96-well	plates,	and	spotted	using	a	pinning	tool	(Sigma)	onto	non-selective	media	plates	(SC+His),	and	selective	media	plates	(SC-His+3-AT),	and	grown	overnight	at	30°C	for	2-4	days.	Plate	images	were	acquired	using	a	ChemiDoc	MP	imager	(Bio-Rad)	and	processed	using	ImageLab	software	(Bio-Rad);	images	were	saved	at	a	resolution	of	300	DPI.		 To	generate	growth	curves,	the	OD600	of	yeast	cultures	grown	to	saturation	overnight	was	measured	using	a	NanoDrop	2000c	Spectrophotometer	(Thermo	Scientific)	
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to	determine	how	to	dilute	each	culture	to	a	starting	OD600	of	0.5.		The	OD600	of	these	diluted	cultures	was	recorded	every	hour	over	the	course	of	12hr.		Immunoblotting	
	 Total	protein	was	extracted	from	yeast	cell	pellets	containing	~1	x	107	cells	(1	OD600	unit)	via	mild	alkali	treatment	and	heating	in	standard	electrophoresis	buffer.		In	brief,	cell	pellets	were	resuspended	in	0.1M	NaOH	(Kushnirov,	2000)	and	incubated	for	10min	at	room	temperature.		Cells	were	re-pelleted,	the	0.1M	NaOH	was	removed,	and	pellets	were	incubated	for	10	min	at	75°C	in	SDS-PAGE	sample	buffer	(1X	LDS	Sample	Buffer	(Life	Technologies)	with	DTT	added	to	62.5mM).		Proteins	were	fractionated	on	denaturing	4-12%	Bis-Tris	polyacrylamide	gels	(Life	Technologies);	gels	were	equilibrated	in	transfer	buffer	(30mM	Bicine,	25mM	Bis-Tris,	1mM	EDTA,	60µM	chlorobutanol),	and	then	electrotransferred	to	PVDF	membranes	pre-equilibrated	in	transfer	buffer	(GE,	Immobilon-P.	0.45µM).		Loading	and	transfer	efficiency	was	monitored	after	transfer	by	staining	with	0.5%	w/v	Ponceau	S	in	1%	v/v	acetic	acid.		After	imaging,	stain	was	removed	using	multiple	changes	of	H2O.		Blots	were	blocked	with	5%	w/v	non-fat	milk	in	1	X	Tris-buffered	saline	(TBS)	(100mM	Tris-Cl	(pH	7.5),	150mM	NaCl).		Myc5-Rap1	was	detected	using	an	anti-Myc	antibody	conjugated	to	HRP	(Roche	#11667203001)	at	a	1:2,000	dilution.		Endogenous	actin	was	used	as	an	additional	loading	control.		Actin	was	detected	using	a	1:5,000	dilution	of	anti-ß	actin	antibody	(Abcam	#ab8224)	followed	by	incubation	with	a	1:2,500	dilution	of	HRP-conjugated	horse	anti-mouse	IgG	antibody	(Cell	Signaling	#7076S).		Both	anti-Myc	and	anti-ß-actin	antibody	incubations	were	performed	in	1	%	w/v	non-fat	milk	blocking	in	1X	TBS.		HRP-generated	immune	complexes	were	detected	by	exposing	
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blots	to	enhanced	chemiluminescence	reagent	(GE)	followed	by	exposure	to	X-ray	film.		X-ray	films	were	scanned	at	600	dpi	and	saved	as	TIFF	images.		Steady	State	RNA	Analysis		 Total	RNA	was	extracted	and	purified	from	equal	numbers	of	yeast	cells	using	the	hot	phenol	method	(Köhrer	and	Domdey,	1991).		RNA	concentration	was	measured	by	monitoring	absorbance	at	260	and	280	nm	using	a	NanoDrop	2000c	Spectrophotometer.		RNA	integrity	was	assessed	by	agarose	gel	electrophoresis,	ethidium	bromide	staining	and	scanning	using	a	Pharos	FX	imager	(Bio-Rad).		The	intensity	of	the	bands	representing	large	(26S)	and	small	(18S)	yeast	rRNAs	were	quantified	using	Quantity	One	software	(Bio-Rad).		Reverse	transcription	was	performed	using	2.5	µg	of	RNA	from	each	strain	using	Superscript	III	(Life	Technologies)	per	manufacturer	instructions.		Priming	for	cDNA	synthesis	was	achieved	using	oligo(dT)16	(Life	Technologies).		Quantitative	real-time	PCR	(qRT-PCR)	reactions	were	performed	using	equal	amounts	of	RNAs	(-/+	RT	(Reverse	Transcription)	controls)	and	cDNAs	using	IQ	RealTime	Sybr	Green	PCR	Supermix	(Bio-Rad),	an	iCycler	(Bio-Rad),	and	the	gene-specific	primers	used	in	this	chapter	are	listed	in	Table	2.2.		Relative	transcript	levels	for	each	gene	of	interest	were	determined	by	comparing	Cycle	threshold	(Ct)	values	generated	from	cDNA-containing	reactions	to	standard	curves	obtained	in	parallel	by	measuring	serial	1:10	dilutions	of	yeast	genomic	DNA	and	normalizing	to	the	reference	gene	ACT1.		Scatter	plots	generated	using	Prism	7	(GraphPad)	and	representing	data	obtained	from	both	biological	
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(individual	points)	and	technical	replicates	of	each	sample	are	expressed	relative	to	the	normalized	amount	of	a	target	gene	of	interest	in	the	indicated	positive	control	sample.		Results		Generation	of	Rap1AS	
	 I	approached	Rap1AS	generation	in	two	steps.		In	the	first	step,	I	systematically	mutagenized	specific	subsequences	of	the	UASRap1	element	in	order	to	identify	variants	that	significantly	decreased	binding	of	Rap1WT	to	UASRap1	DNA.		The	goal	of	these	experiments	was	to	identify	a	specific	‘inactivated’	UASRap1.		In	the	second	step,	I	mutagenized	RAP1	sequences	encoding	the	Rap1	DBD	and	performed	a	genetic	screen	in	cells	that	contained	a	reporter	gene	driven	by	the	‘inactivated’	UASRap1	variants	identified	in	step	one.		Using	a	growth	selection,	I	selected	for	cells	that	expressed	the	mutant	UASRap1	reporter	and	thus	likely	contained	a	mutant	RAP1	variant	that	could	bind	and	drive	gene	expression	from	the	mutant	UASRap1.			 Because	others	have	proposed	that	UASRap1	3’	sequences	(bp	7-14)	determine	whether	Rap1	exerts	activator	or	repressor	activity	when	bound	to	a	particular	genomic	locus	(Idrissi	et	al.,	1998;	Lickwar	et	al.,	2012a;	Rhee	and	Pugh,	2011),	I	focused	my	UASRap1	mutagenesis	efforts	on	the	5’	half	of	the	UASRap1.		All	possible	single	point	mutant	variants	of	UASRap1	bps	1-6	were	tested	for	the	ability	to	bind	purified	Rap1WT	via	gel	shift	competition	DNA	binding	analyses.		The	assays	used	Rap1WT	protein,	32P-labeled	duplex	WT	UASRap1	probe,	and	increasing	concentrations	of	unlabeled	WT	and	mutated	duplex	competitor	DNAs.		Consistent	with	prior	mutational	analyses	of	UASRap1	(Vignais	et	al.,	
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1990),	these	analyses	identified	a	few	UASRap1	sites	where	mutations	significantly	decreased	Rap1WT-DNA	binding	(Table	2.3	and	data	not	shown).		The	best	of	these	mutants,	5G	UASRap1	and	6G	UASRap1	were	chosen	to	serve	as	the	inactivated	UASRap1	sequences	in	my	first	screens	for	selection	of	Rap1AS	variants.		Rap1	Mutagenesis	Via	Error-Prone	PCR	and	Bacterial	Omega	One	Hybrid	Screening	Strategy	 		 Having	identified	potential	Rap1AS	binding	sites,	I	proceeded	to	the	second	step	of	my	Rap1AS	generation	strategy:	mutagenesis	of	the	RAP1	sequences	encoding	the	DBD	and	screening	to	identify	a	Rap1AS.		To	generate	mutant	RAP1	variants,	I	performed	error-prone	(EP)-PCR	(Cadwell	and	Joyce,	1992)	designed	to	introduce	mutations	randomly	into	the	Rap1	DBD.		Although	co-crystal	structures	of	the	Rap1	DBD	(Henry	et	al.,	1990)	in	complex	with	DNA	existed	(König	et	al.,	1996;	Matot	et	al.,	2012;	Taylor	et	al.,	2000),	this	unbiased	approach	was	chosen	to	allow	for	the	possibility	realized	in	enzyme	engineering	studies	that	aa	may	affect	protein	activity	even	if	structural	data	does	not	directly	implicate	them	(Daugherty	et	al.,	2000;	Zaccolo	and	Gherardi,	1999).		A	screen	based	on	the	omega	bacterial	one-hybrid	selection	system	(Figure	2.1A-D),	which	had	been	used	successfully	to	
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Figure	2.1.	Bacterial	Omega	One	Hybrid	Rap1AS	Screen.		The	bacterial	omega	one	hybrid	screen	depends	on	an	interaction	between	two	components:	(1)	a	HIS	reporter	gene	driven	by	a	weak	promoter	and	a	UAS	site	(such	as	UASRap1	shown	here)	and	(2)	an	ω–transcription	factor	DBD	fusion	protein.	A,	Because	the	promoter	upstream	of	the	HIS	gene	is	weak,	the	bacterial	RNA	Polymerase	cannot	drive	HIS3	expression	on	its	own,	resulting	in	a	His-	growth	phenotype.	B,	In	contrast,	fusion	of	the	ω	subunit	of	the	polymerase	to	a	DBD	that	can	recognize	the	UAS	(in	this	case	Rap1	DBDWT,	which	binds	UASRap1WT)	enables	HIS3	expression	and	a	His+	growth	phenotyp.	C,	A	version	of	the	HIS	reporter	containing	a	
UASRap1MUT		that	the	Rap1	DBD	cannot	bind	is	not	expressed	and	cells	are	His-.	D,	The	only	way		UASRap1MUT-
HIS3	cells	will	be	His+	is	if	they	contain	a	fusion	protein	consisting	of	ω	and	a	Rap1	mutant	DBD	(Rap1	DBD**)	that	can	bind	UASRap1MUT	because	it	possesses	altered	DNA-binding	specificity	(Rap1AS).		
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define	the	DNA	recognition	sequences	of	several	transcription	factor	DBDs	(Meng	and	Wolfe,	2006;	Meng	et	al.,	2005),	was	designed	to	identify	a	Rap1AS	variant	capable	of	functionally	interacting	with	the	5G	or	6G	UASRap1	sites.		Activity	in	the	omega	one-hybrid	system	depends	on	a	functional	interaction	between	two	components:	(1)	A	fusion	protein	consisting	of	the	bacterial	RNA	Polymerase	non-essential	subunit	ω	(Gentry	and	Burgess,	1989)	and	a	transcription	factor	DBD	fusion	protein	expressed	from	an	AmpR	plasmid	and	(2)	a	low-copy	number	HIS3	reporter	KanR	plasmid		(pH3U3)	driven	by	a	weak	promoter	and	a	UAS.		HIS3	expression	levels	are	very	low	in	the	presence	of	the	bacterial	RNA	Polymerase	alone	because	the	weak	promoter	upstream	of	HIS3	provides	a	poor	recognition	site	for	the	RNA	Polymerase	(Figure	2.1A).		However,	HIS3	expression	can	be	greatly	enhanced	by	the	incorporation	into	the	polymerase	complex	of	the	ω	subunit	fused	to	a	DBD	that	can	recognize	the	UAS	upstream	of	the	HIS3	reporter	(Dove	and	Hochschild,	1998;	Noyes	et	al.,	2008)(Figure	2.1B).		 Versions	of	the	pH3U3	HIS3	reporter	(Noyes	et	al.,	2008)	containing	the	5G	and	6G	
UASRap1	sites	were	created.		HIS3	reporter	gene	expression	can	be	selected	for	by	the	addition	of	3-Amino-Triazole	(3-AT)	to	the	growth	media.		Aminotriazole	is	a	competitive	inhibitor	of	the	HIS3	gene	product,	the	enzyme	imidazole	glycerol-phosphate	dehydratase	(Brennan	and	Struhl,	1980),	hence	simple	growth	tests	can	be	used	to	select	for	increasing	levels	of	HIS3	gene	expression	by	varying	the	concentration	of	3-AT	in	the	growth	media.		Because	Rap1WT	does	not	bind	5G	or	6G	UASRap1	efficiently	(cf.	Table	2.3),	E.	coli	containing	an	ω-Rap1DBD	that	is	not	functionally	different	than	ω-Rap1DBDWT	should	have	no	means	to	drive	5G	or	6G	UASRap1-HIS3	expression	above	background	(Figure	2.1C),	and	thus	support	growth	on	media	containing	3-AT.		By	contrast,	a	cell	expressing	an	ω-Rap1DBDAS	
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variant	that	can	bind	and	drive	efficient	pH3U3	UASRap1(5G)-HIS3	and/or	pH3U3	UASRap1(6G)-
HIS3	expression	(Figure	2.1D)	will	confer	resistance	to	3-AT	(3-ATR),	and	thus	grow	in	the	presence	of	the	inhibitor.	
	Omega	One-hybrid	Rap1AS	Screen		 The	omega	one-hybrid	Rap1AS	screen	was	performed	using	selection	strain	USO	(relevant	genotype	∆hisB	∆rpoZ,	see	“E.	coli	and	Yeast	Cell	Culture	and	Basic	Manipulations”	above.		The	EP-PCR	generated	library	of	ω-Rap1DBD	variants	was	introduced	into	USO	selection	cells	that	contained	either	the	pH3U3	UASRap1(5G)	reporter	or	pH3U3	UASRap1(6G)	reporter	plasmids	(both	possess	KanR)	via	electroporation.		An	estimated	2.4	x	108	transformants	(~100X	the	number	of	variants	present	in	my	error-prone	PCR	generated	
RAP1	library)	were	plated	on	NM-His	media	+	0.25,	0.5,	1,	2.5,	or	5	mM	3-Amino-1,	2,	4-Triazole	and	incubated	for	3	days	at	30°C.			Although	30-40	E.	coli	colonies	appeared	on	each	of	the	two	selection	plates	used	for	each	pH3U3	UASRap1		reporter	variant,	not	one	of	the	ω-Rap1DBD	variant	expression	plasmids	isolated	from	these	colonies	could	confer	3-ATR	once	reintroduced	into	USO	cells	containing	the	pH3U3	UASRap1	reporter	variant	used	for	the	selection.		Thus,	the	omega	one	hybrid	screen	of	my	EP-PCR	generated	RAP1	variants	failed	to	identify	any	“true	positive”	hits	that	could	drive	expression	of	either	a	5G	
UASRap1	or	6G	UASRap1	reporter	(data	not	shown).				 The	negative	result	from	this	first	Rap1AS	generation	attempt	motivated	me	to	reevaluate	my	strategy.		As	part	of	the	reevaluation	process,	I	analyzed	the	structure	of	the	Rap1	DBD	bound	to	various	target	DNAs.		These	Rap1-DNA	structures	show	that	the	Rap1	DBD	binds	its	recognition	motif	primarily	via	two	homeodomains	and	an	unstructured	tail	
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as	described	in	“Chapter	I”.		Additionally,	these	structures	show	that	the	UASRap1	bp	5	and	6	mutated	in	my	5G	and	6G	UASRap1	sites	are	located	between	the	two	homeodomains	and	are	contacted	by	both	the	unstructured	DBD	tail	and	a	portion	of	one	of	the	homeodomains	(Figure	2.2)	(König	et	al.,	1996;	Matot	et	al.,	2012;	Taylor	et	al.,	2000).		These	facts	challenged	the	generation	of	a	Rap1AS	that	could	recognize	either	the	5G	or	6G	UASRap1.		The	error-prone	PCR	approach	used	to	mutagenize	the	Rap1	DBD	was	unlikely	to	produce	variants	with	the	needed	changes	in	both	the	homeodomain	portion	and	the	unstructured	tail	outside	of	mutagenizing	the	DBD	beyond	recognition.		Meanwhile,	design	of	a	targeted	mutagenesis	strategy	was	difficult	because	the	regions	of	the	DBD	involved	constituted	an	unusual	recognition	module.		To	improve	my	chances	of	generating	a	Rap1AS,	I	would	need	to	generate	a	potential	Rap1AS	binding	site	whose	mutant	UASRap1	bps	were	contacted	by	a	portion	of	the	DBD	that	used	a	well-studied	recognition	motif	to	bind	DNA.		 	Identification	of	Potential	Rap1AS	Binding	Sites	Guided	by	the	Rap1	DBD-DNA	Structure		 Although	the	portion	of	the	Rap1	DBD	contacting	UASRap1	bps	5	and	6	uses	an	unusual	mode	of	DNA	recognition,	the	Rap1	homeodomains	themselves	do	indeed	
Figure	2.2.	The	Rap1	DBD-DNA	Cocrystal	Structure.		The	Rap1	DBD-DNA	cocrystal	structure	reveals	that	Rap1	binds	its	DNA	recognition	site	(top	strand,	tan	hues	and	bottom	strand,	teal	hues)	via	two	homeodomains	(homeodmain	#1	(blue)	and	homeodomain	#2	(red))	and	an	unstructured	C-tail	(purple).		bp5	and	bp6	(light	blue	circles,	labeled)	of	the	
UASRap1	site	are	located	proximal	to	both	portions	of	homeodomain	#1	and	the	C-tail.		
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constitute	highly	recognizable	DNA-binding	motifs.		Indeed,	multiple	studies	have	shown	that	within	a	homeodomain,	the	third,	or	recognition	helix	of	the	three	helix	bundle	mediates	sequence-specific	DNA	recognition	(Fraenkel	et	al.,	1998;	Wolberger	et	al.,	1991).	The	apposition	of	the	homeodomain	recognition	helix	#1,	which	contacts	the	upstream	half	of	the	Rap1	binding	sequence	and	is	the	focus	of	my	Rap1	DNA	mutagenesis	efforts	is	shown	in	Figure	2.3A.		This	recognition	helix	specifically	contacts	DNA	bp2,	bp3	and	bp4	(Figure	2.3A	(bp	labeled:	bp2,	bp3	and	bp4,	homeodomain	is	dark	blue).				 Since	no	single	mutant	variants	of	UASRap1	bp2,	bp3	and	bp4	significantly	reduced	Rap1WT-DNA	binding,	double	mutant	UASRap1	were	generated	and	tested	via	gel	shift	competition	DNA-binding	analyses.		Several	of	these	double	base	pair	mutant	UASRap1	binding	sites	caused	a	significant	decrease	in	Rap1WT-DNA	binding.		The	3T4A	UASRap1	mutant	reduced	Rap1WT	binding	by	over	20-fold	relative	to	the	WT	UASRap1	(compare	loss	of	Rap1-DNA	complex	in	the	presence	of	WT	and	3T4A	competitor	DNAs	at	2-,	5-,	10-	and	25-fold	mole	excesses;	Figure	2.3B).	This	reduction	in	affinity	(competition	strength)	was	the	largest	of	the	double	mutants	tested	(data	not	shown).		Consequently,	the	3T4A	UASRap1	was	selected	to	serve	as	the	‘inactivated’	UASRap1	sequence	in	further	screens	for	selection	of	Rap1AS	variants.			Rap1	DBD-DNA	Structure	Guided	Mutagenesis	and	Rap1AS	Yeast	Screening	Strategy		 As	a	second	mutagenesis	approach	to	generating	a	Rap1AS	variant	capable	of	binding	the	3T4A	UASRap1	site,	I	utilized	a	targeted	randomization	mutagenesis	approach	recently	employed	to	create	altered	DNA-binding	specificity	variants	of	the	Drosophila	engrailed	homeodomain	(Chu	et	al.,	2012).		The	six	aa’s	of	the	Rap1	DBD	homeodomain-1	DNA	
	 83	
Figure	2.3.		Mutation	of	WT	UASRap1	Nucleotides	3A	and	4T	to	3T	and	4A	Significantly	Decreases	
Binding	of	WT	Rap1	to	3T4A	UASRap1	DNA.		A.		The	Rap1	DBD	homeodomain-1	recognition	helix	(dark	blue;	top)	is	shown	in	complex	with	its	DNA	recognition	site	labeled	bp1,	bp2,	bp3,	bp4,	bp5,	bp6.		Top	strand,	tan	hues	(5’A1C2A3C4C5C6	3’),	bottom	strand	teal	hues.		Hydrogen	bonds	between	protein	and	DNA	are	indicated	by	dashed	green	lines;	H-bonds	mediated	by	H2O	molecules	are	indicated	by	green	dashed	lines	and	red	balls;	hydrophobic	interactions	are	indicated	by	black	dashed	lines.		The	DNA	base	pairs	mutated	to	create	the	3T4A	mutant	binding	site	are	bp3	and	bp4.	Rap1	DBD	recognition	helix	amino	acid	residues	targeted	for	codon	randomization	mutagenesis	are	indicated	by	yellow	ovals	at	amino	acid	positions:	N401,	S402,	H405,	R408	and	V409.		Image	generated	using	the	PyMol		v	1.5.04	for	the	MacOS	from	PDB	file	1IGN	(Matot	et	al.,	2012).	B.		Gel	shift	competition	DNA	binding	analyses	with	WT	UASRap1	or	3T4A	
UASRap1	DNAs.		Gel	shift	binding	reactions	were	performed	by	incubating	100	fmole	purified	recombinant	Rap1WT	with	50	fmole	(700	cpm/fmole)	duplex	32P-labeled	WT	UASRap1	DNA	(5’A1C2A3C4C5C6A7T8A9C10A11T12T13-3’)	alone	(No	Rap1,	-Rap1),	or	with	Rap1	and	either	no	competitor		(-),	or	the	indicated	fold	molar-excess	of	either	cold	WT	UASRap1		(top	gel	scan	image)	or	cold	3T4A	UASRap1	(bottom	gel	scan	image);	0.5X,	1X,	2X,	5X,	10X,	25X,	50X,	100X	or	200X	left	to	right	(WT:	blue	circles;	3T4A:	red	squares)	in	a	final	volume	of	20	µl.		Reactions	were	fractionated	on	non-denaturing	polyacrylamide	gels,	vacuum	dried,	and	imaged	using	a	Bio-Rad	FX	imager.		The	amount	of	bound	complex	from	each	reaction	was	quantified	using	Bio-Rad	Quantity	One	software.		Data	was	analyzed	using	Microsoft	Excel	and	is	expressed	as	%	Rap1WT-32P-DNA	Complex	when	no	competitor	is	present	(i.e.	+	Rap1	and	-	competitor).		A	representative	image	for	each	competition	was	chosen	from	among	three	independent	replicates.		Data	for	replicates	was	analyzed	via	Graph	Pad	Prism	7	software	and	the	plot	shown	was	generated	using	an	[Inhibitor]	vs.	response	non-linear	fit.		Error	bars	represent	SDs.		
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recognition	helix	that	face	DNA	(Figure	2.3A)	were	chosen	as	targets	for	codon-directed	randomization	mutagenesis	(An	et	al.,	2005)		(Figure	2.4A;	Rap1	aa’s	Asn401,	Ser402,	
Arg404,	His405,	Arg408	and	Val409).		Screening	this	library	in	the	omega	one-hybrid	system	identified	DBD	variants	that	could	drive	3T4A	UASRap1	reporter	expression	in	bacteria.		However,	none	of	these	variants	were	able	to	drive	3T4A	UASRap1	reporter	expression	in	the	context	of	the	full-length	Rap1	protein	in	yeast	(data	not	shown).			 As	a	result	of	the	failure	of	Rap1	DBD	variants	isolated	in	E.	coli	to	function	as	expected	in	yeast,	I	devised	a	direct	yeast	screening	strategy	that	could	rapidly	test	millions	of	full-length	Rap1	mutant	variants	for	the	ability	to	functionally	interact	with	3T4A	UASRap1	in	vivo.		As	in	the	omega	one-hybrid	screen,	the	functional	interaction	chosen	for	this	yeast	screen	utilized	a	HIS3	reporter	gene,	whose	expression	can	be	selected	for	using	3-AT.			In	the	reporter	used	for	Rap1AS	screening	in	yeast,	the	two	WT	UASRap1	DNA	binding	sites	present	in	a	previously	characterized	
UASRap1-HIS3	reporter	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002)	were	replaced	with	two	copies	of	the	3T4A	variant	UASRap1	(see	
B. Integrated HIS3 Reporter Genes 
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WT UASRAP1: (A1C2A3T4C5C6A7T8A9C10A11C12C13)x2 
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A. Rap1 DBD Mutagenesis
600 8273301
GGT AAT TCT ATT AGG CAC CGA TTT AGA GTC
Gly Asn Ser Ile Arg His Arg Phe Arg Val
GGT NNS NNS ATT NNS NNS CGA TTT NNS NNS
400 409401 402 403 404 405 406 407 408
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Figure	2.4.	Rap1	DBD	Mutagenesis	Strategy.		A.		Schematic	of	Rap1	showing	the	location	of	the	DBD	within	the	827	aa-long	protein.		Amino	acid	sequence	of	DBD	region	aa	400	to	aa	409	(black,	3	letter	code)	is	shown	along	with	the	corresponding	nt	codon	sequence	(black)	and	a	portion	of	one	of	the	primers	used	for	codon	randomization	(purple)	indicating	the	targeted	codons	(NNS,	N=	any	nt,	S	=	G	or	C).	B.		Schematic	of	integrated	UASRap1-driven	TATA-HIS3	reporter	genes	used	in	the	selection	of	the	altered	DNA-binding	specificity	variant	of	Rap1.		Two	versions	of	the	reporter	are	shown,	WT	(top)	where	HIS3	is	driven	by	tandem	copies	of	the	WT	UASRap1	enhancer	sequence:	
A1C2A3T4C5C6A7T8A9C10A11C12C13;	or	3T4A	variant	UASRap1	enhancer:	
A1C2T3A4C5C6A7T8A9C10A11C12C13;	mutated	nts	in	red.		
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Figures	2.3B,	2.4B).		Because	Rap1WT	does	not	bind	3T4A	UASRap1	efficiently	(cf.	Figure	
2.3B),	yeast	expressing	only	Rap1WT	have	no	means	to	drive	3T4A	UASRap1-HIS3	expression,	and	hence	fail	to	grow	on	media	containing	3-AT.		By	contrast,	a	cell	expressing	a	Rap1AS	variant	that	can	bind	and	drive	efficient	3T4A	UASRap1-HIS3	expression	will	confer	resistance	to	3-AT	(3-ATR),	and	thus	grow	in	the	presence	of	the	inhibitor.		Rap1AS	Yeast	Screen		 I	performed	the	Rap1AS	yeast	screen	using	the	haploid	yeast	strain	YAM23	(relevant	genotype:	his3∆,	ura3∆,	rap1∆,	3T4A	UAS::TATA::HIS3	+	pRS415-MYC5-RAP1,	Table	2.1)	that	was	transformed	to	Ura+	with	mutagenized	Rap1	DBD	library	plasmids	carried	on	the	
URA3-marked	plasmid	pRS416.		An	estimated	1	x	106	independent	Ura+	colonies	(~1%	of	the	total	library)	were	plated	onto	SC	-His	+	5mM	3-AT	selective	media	plates.		After	four	days	of	incubation	at	30°C,	158	His+,	3-ATR	colonies	were	isolated.		The	growth	phenotype	of	these	colonies	was	re-tested	by	patching	onto	SC-His	+	3-AT	plates;	136	colonies	out	of	the	original	158	isolated	indeed	possessed	3-ATR.		To	determine	whether	the	His+,	3-ATR	phenotype	displayed	by	these	colonies	was	plasmid	borne,	Rap1	mutant	expression	plasmids	were	isolated	from	the	thirty	colonies	that	had	appeared	the	soonest	on	the	3-AT-containing	selection	plates	(ranked	in	order	of	appearance	with	colony	#1	appearing	1st	and	colony	#30	appearing	30th).		Plasmids	were	recovered	from	these	30	strains	and	used	to	transform	the	original	selection	yeast	strain,	YAM23.		The	resulting	transformants	were	retested	for	growth	on	SC-His	+	5mM	3-AT	selective	media	plates.		Fourteen	of	the	thirty	recovered	Rap1	mutant	expression	plasmids	conferred	3-ATR,	and	thus	represented	putative	altered	DNA-binding	specificity	variants	of	Rap1.		
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Analysis	of	Putative	Altered	DNA-binding	Specificity	Rap1AS	Variants		 The	fourteen	Rap1	mutants	identified	in	the	screen	were	characterized	to	allow	selection	of	one	variant	for	use	as	a	Rap1AS	in	Rap1	AD	mapping	studies.		The	complete	ORFs	of	the	fourteen	plasmid	borne	rap1AS	genes	were	sequenced.		All	mutations	identified	were	within	the	targeted	Rap1	aa’s	(Figure	2.5A,	top).		Only	two	of	the	mutants	(#10	and	
11)	possessed	identical	sequences,	indicating	that	the	screen	was	likely	not	saturated.		Sequence	analyses	were	performed	to	identify	any	patterns	present	in	the	types	of	aa	changes	within	the	Rap1	variants	identified	in	the	screen	(MEME	Motif;	Figure	2.5A,	
lower).		Rap1	aa	N401	was	frequently	found	mutated	to	a	G	or	a	P	while	residue	H405	was	
Figure	2.5.		The	Rap1	Mutagenesis	Screen	Identifies	Rap1	Variants	that	Functionally	Interact	with	
3T4A	UASRap1.		A.		Amino	acid	sequence	of	mutagenized	Rap1	DBD	amino	acids	400	to	409	(yellow	highlighting)	and	fourteen	variant	forms	(#2	to	#18)	of	Rap1	identified	in	the	Rap1AS	screen.		Amino	acid	changes	in	these	variants	are	indicated	(green).		Lower,	a	motif	of	putative	Rap1AS	hit	homeodomain-1	recognition	helix	sequences	generated	using	MEME.	The	size	of	each	letter	is	proportional	to	its	frequency	of	appearance	among	the	Rap1	variant	sequences	#2	to	#18.		B.		Yeast	growth	test	to	assess	the	ability	of	various	forms	of	Rap1	(WT)	or	Variant	(#2	to	#18)	to	confer	resistance	to	5mM	3-AT	via	expression	of	either	the	WT	UASRap1-HIS3	reporter	variant	(blue)	or	the	3T4A	UASRap1-HIS3	(red)	variant,	and	either	a	second	copy	of	Rap1WT	or	the	indicated	Rap1AS	screen	hit.		Yeast	were	serially	diluted	1:4	(left	to	right)	and	spotted	using	a	pinning	tool	onto	non-selective	media	(+	His)	and	media	that	selected	from	expression	of	the	UASRap1-HIS3	reporter	(+	3-AT).		Plates	were	photographed	after	growth	at	30oC	for	two	days.	Images	are	representative	of	three	independent	biological	replicates.	
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frequently	mutated	to	W	or	S.		There	were	no	clear	aa	substitution	patterns	for	R408	and	R409.		In	spite	of	being	targeted	for	mutagenesis,	S402	and	R404	were	mutated	only	rarely	(S402)	or	not	at	all	(R404).		This	data	suggests	either	a	failure	to	efficiently	mutagenize	Rap1	aa	residue	404,	or	a	strong/absolute	requirement	of	R404	for	Rap1	DNA-binding.				 As	predicted	from	the	competition	DNA	binding	data	of	Figure	2.3B,	Rap1WT	cannot	utilize	the	3T4A	UASRap1	site	to	drive	HIS3	expression	(compare	top	two	rows	of	growth	tests,	Figure	2.5B).		By	contrast,	all	of	the	putative	Rap1AS	variants	have	the	ability	to	promote	efficient	expression	of	the	3T4A	UASRap1-HIS3	reporter	gene	to	confer	3-ATR	growth	(mutants	#2	through	#18;	Figure	2.5B).		Interestingly,	those	mutant	variants	recovered	from	colonies	that	appeared	the	earliest	during	the	screen	grow	slightly	faster	than	those	recovered	from	colonies	that	had	appeared	later	(i.e.	variant	#2	to	#14	earlier	than	variant	#17	and	#18;	Figure	2.5B).		Overall,	the	3-ATR	growth	properties	of	variants	#2	to	#14	are	comparable	to	yeast	containing	Rap1WT	and	the	WT	UASRap1-HIS3	reporter,	while	variants	#17	and	#18	grow	somewhat	slower.	To	allow	unambiguous	Rap1	AD	mapping,	a	true	altered	DNA-binding	specificity	mutant	that	fails	to	bind	WT	UASRap1	(and	thereby	interfere	with	Rap1WT	essential	function)	was	desired.		In	order	to	find	such	a	Rap1	mutant	whose	improved	3T4A	UASRap1	binding	is	accompanied	by	a	reduced	WT	UASRap1	binding,	six	of	the	fourteen	preliminarily	characterized	Rap1	screen	hits	(see	below)	were	selected	for	purification	and	gel	shift	DNA-binding	competition	assays.		Because	there	was	no	way	to	predict	a	priori,	which	if	any	of	the	Rap1	screen	hits	possessed	true	altered	DNA-binding	specificity,	six	screen	hits	were	chosen	to	cover	the	sequence	variation	present	in	the	collection	of	Rap1	mutants	whose	plasmid	borne	expression	supported	ATR.		Variant	#10	was	chosen	because	its	
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sequences	were	highly	similar	to	the	logo	that	was	generated	by	motif	analysis.		Rap1	variants	#2,	5,	13,	17,	and	18	were	selected	because	of	deviations	from	the	sequence	logo,	in	either	the	presence	of	additional	mutations	(i.e.	#5),	the	absence	of	a	mutation	that	was	present	in	other	variants	(#17	and	18),	or	an	uncommon	mutation	(i.e.	#2)	such	as	a	basic	R	residue	at	position	401	instead	of	an	uncharged	G,	P,	or	A.		All	six	of	these	Rap1	mutant	variants	bound	32P-3T4A	UASRap1	in	a	gel	shift	assay	(Figure	2.6A,	and	data	not	shown).		Out	of	the	six,	Rap1	mutants	#5,	17,	and	18	displayed	expanded	DNA-binding	specificity,	and	bound	both	WT	and	3T4A	UASRap1	sites	with	similar	affinity.		By	contrast,	Rap1	variants	#2,	10,	and	13,	whose	sequences	contrasted	with	those	of	the	expanded	specificity	variants	in	the	possession	of	a	bulky	hydrophobic	aa	(i.e.	W	or	F)	at	aa	405	and	a	mutation	at	aa	408	
Figure	2.6.		Identification	of	Rap1	Mutagenesis	Screen	Hits	with	True	Altered	DNA-binding	
Specificity.		A.		Gel	shift	competition	analysis	performed	to	compare	the	binding	affinity	of	WT	and	Rap1AS	screen	hit	variant	#2	for	binding	to	either	WT	UASRap1	or	3T4A	UASRap1	DNAs.		Assays	were	performed	(as	in	Figure	2.3B)	by	incubating	purified	Rap1WT	or	Rap1	variant	#2	with	its	cognate	binding	site,	32P-WT	
UASRap1	(blue);	or	32P-3T4A	UASRap1	(red).		Binding	reactions	also	included	either	no	competitor	(-),	or	50	fold	mole-excess	of	either	cold	WT	UASRap1	(W,	blue)	or	cold	3T4A	UASRap1	(M,	red)	as	shown.		A	representative	image	from	two	independent	replicates	is	presented.			B.		Amino	acid	sequence	of	mutagenized	Rap1	DBD	amino	acids	400	to	409	(yellow	highlighting)	in	the	three	identified	true	altered	DNA-binding	specificity	Rap1	variants	(red,	#2,	#10,	and	#13)	and	the	identified	expanded	DNA-binding	specificity	variants	(#5,	#17,	and	#18).	Amino	acids	changes	in	these	variants	are	indicated	(green).		Lower,	the	motif	of	putative	Rap1AS	hit	homeodomain-1	recognition	helix	sequences	generated	using	MEME.	The	size	of	each	letter	is	proportional	to	its	frequency	of	appearance	among	the	Rap1	variant	sequences	#2	to	#18	(cf	Figure	2.5A).		
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(Figure	2.6B),	showed	reduced	affinity	for	the	WT	UASRap1	site	(Figure	2.6A	and	data	not	shown).		In	particular,	mutant	#2	displayed	the	largest	reduction	in	WT	UASRap1	affinity	(Figure	2.6A,	and	data	not	shown).			Consistent	with	its	significantly	reduced	affinity	for	WT	UASRap1,	Rap1	mutant	#2	also	failed	to	complement	the	null	rap1	allele	(rap1∆)	in	a	plasmid	shuffle	assay	(Figure	
2.7A),	indicating	that	it	could	not	efficiently	bind	the	WT	UASRap1	of	(at	least	one)	essential	Rap1-dependent	genes	in	vivo.		As	a	final	in	vitro	test	of	the	DNA-binding	specificity	of	Rap1	mutant	#2,	a	gel	shift	competition	analysis	was	performed	using	duplex	WT	and	all	single	and	double	UASRap1	variants	of	bps	3	and	4.		Amazingly,	this	preliminary	analysis	showed	that	only	cold	competitors	that	contained	a	3T	and/or	a	4A	mutation	reduced	Rap1AS	32P-3T4A	UASRap1	DNA	binding	(Figure	2.7B).		Based	upon	all	these	data	Rap1,	variant	#2	showed	true	altered	DNA-binding	specificity	in	vitro	and	in	vivo,	and	henceforth	is	referred	to	as	Rap1AS	(or	AS).		Molecular	Genetic	Characterization	of	Rap1AS		 Rap1AS	was	subjected	to	further	characterization	to	ensure	that	it	would	serve	as	an	appropriate	reagent	for	attempted	AD	identification	and	mapping	studies.		The	AS	form	of	Rap1	was	tested	to	document	that:	(1)	Rap1AS-driven	reporter	expression	actually	requires	an	enhancer,	and	is	specific	to	the	3T4A	UASRap1	site;	(2)	Rap1AS	efficiently	drives	HIS3	reporter	expression	as	scored	at	the	mRNAHIS3	level;	(3)	Rap1AS	is	stably	expressed	at	levels	similar	to	Rap1WT;	and	(4)	when	co-expressed	with	Rap1WT,	Rap1AS	does	not	compete	with	the	WT	protein	and	cause	a	dominant,	slow	growth	phenotype.			
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	 To	demonstrate	that	Rap1AS	drives	reporter	gene	expression	efficiently	and	specifically	from	3T4A	UASRap1	as	expected	from	the	analyses	described	in	“Analysis	of	Putative	Altered	DNA-binding	Specificity	Rap1AS	Variants”,	two	new	HIS3	reporter	variants	were	constructed.		The	first,	termed	∆UASRap1,	completely	lacks	UASRap1	sites	upstream	of	
Figure	2.7.	Rap1	AS	#2	Displays	Altered	DNA-binding	Specificity	in	vivo	and	Specificity	For	
UASRap1	Variants	Containing	a	3T	and/or	4A	Mutation	in	vitro.		A.		Plasmid	shuffle	analysis	of	altered	DNA-binding	specificity	Rap1	variant	#2	performed	to	test	its	ability	to	complement	the	rap1	null	allele.		Yeast	carrying	a	chromosomal	null	RAP1	allele	(rap1∆)	and	a	URA3-marked	RAP1	covering	plasmid	were	transformed	with	a	test	variant	of	RAP1,	labeled	rap1*:	(i)	a	second	plasmid-borne	copy	of	RAP1	(labeled	WT,	blue);	(ii)	empty	plasmid	vector	(labeled	-,	black);	or	(iii)	the	same	plasmid	vector	expressing	Rap1	variant	#2	(labeled	AS#2,	red).		Yeast	were	serially	diluted	1:4	(left	to	right)	and	growth	was	scored	on	media	lacking	5-FOA	(“Unshuffled”;	relevant	genotype:	RAP1,	rap1∆,	rap1*)	or	containing	5-FOA	(“Shuffled”	relevant	genotype:	-,	rap1∆,	rap1*).		Plates	were	incubated	at	30°C	for	two	days	and	then	photographed;	a	representative	image	from	three	independent	replicates	is	shown.		
B.		Gel	shift	competition	analysis	performed	to	compare	the	binding	of	Rap1WT	and	Rap1AS	screen	hit	variant	#2	to	various	UASRap1	DNA	variants.		Assays	were	performed	(as	in	Figure	2.3B)	by	incubating	purified	Rap1WT	or	Rap1	variant	#2	with	its	cognate	binding	site,	32P-WT	UASRap1	(blue);	or	32P-3T4A	
UASRap1	(red).		Binding	reactions	also	included	either	no	competitor	(-),	or	100	fold	mole-excess	of	the	indicated	cold	UASRap1	competitor	DNAs.		Data	shown	is	representative	of	1	biological	replicate.	
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HIS3.		This	construct	tests	the	hypothesis	that	Rap1AS	might	bypass	the	requirement	for	an	enhancer,	while	simultaneously	defining	background	expression	of	the	UASRap1-TATA-HIS3	reporter.		The	second	construct	substituted	a	3G5G	UASRap1	enhancer	in	place	of	either	the	WT	or	3T4A	enhancer.	This	variant	enhancer	tested	the	functional	DNA-binding	specificity	of	Rap1AS,	which	was	selected	to	bind	the	3T4A	site.		Previous	work	has	shown	that	both	mutations	(i.e.	UASRap1	deletion,	or	3G5G	substitution)	dramatically	reduce	Rap1-driven	transcription	in	vivo	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002).		HIS3	expression	was	scored	in	appropriate	yeast	strains	by	ATR	growth	and	qRT-PCR-measured	mRNAHIS3	assays.		As	shown	in	both	growth	(Figure	2.8A)	and	mRNAHIS3	analyses	(Figure	2.8B),	Rap1WT	and	Rap1AS	were	only	able	to	robustly	drive	expression	of	the	reporter	containing	their	cognate	DNA	recognition	site	(WT	UASRap1	and	3T4A	UASRap1,	respectively).		It	is	important	to	note	that	as	detailed	in	the	“Steady	State	RNA”	section,	HIS3	mRNA	levels	are	scored	by	qRT-PCR	using	total	RNA	extracted	from	cells	grown	in	SC	+	Histidine	to	prevent	any	selection	for	reporter	gene	expression	that	occurs	when	3-AT	is	added	to	growth	media.		Interestingly,	Rap1AS	drives	expression	of	the	3T4A	UASRap1-HIS3	reporter	gene	mRNAHIS3	to	a	level	greater	than	that	observed	with	the	WT	UASRap1-HIS3	reporter	(Figure	2.8B).		Deletion	of	the	enhancer	abolished	expression	of	the	HIS3	reporter	regardless	of	the	Rap1	form	present	(WT	or	AS;	Figures	2.8A,	B).		Immunoblot	analysis	of	yeast	whole	cell	extracts	show	that	Rap1AS	was	stably	expressed	at	levels	comparable	to	Rap1WT	(Figure	2.8C;	note	that	all	constructs	contain	an	N-terminal	Myc5	tag	and	a	nuclear	localization	sequence	(NLS);	see	“Test	Rap1	Yeast	Expression	Vectors”).		Further,	growth	curves	with	pseudodiploid	cells	(Figure	2.8D;	Rap1	WT/WT;	Rap1	WT/AS)	demonstrate	that	Rap1AS	does	not	induce	a	dominant,	slow	growth	phenotype.		Based	on	this	data,	I	concluded	that	
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Rap1AS	possessed	all	of	the	characteristics	desired	for	use	as	a	tool	to	search	for	an	AD	within	Rap1.	
Figure	2.8.	Functional	characterization	of	Rap1AS.			A.		Rap1AS	specifically	drives	the	mutant	3T4A	UASRap1-HIS3	reporter.		Upper:	Test	of	the	ability	of	WT	and	AS	forms	of	Rap1	to	bind	different	enhancers	to	confer	amino-triazole	resistant	growth	using	the	assay	detailed	in	Figure	2.5B.		Yeast	strains	carrying	the	indicated	UASRap1-
HIS3	reporter	variant	(WT,	3G5G,	∆UAS	or	3T4A,	as	shown)	and	either	a	second	copy	of	Rap1WT	(blue)	or	Rap1AS	(red)	were	grown	on	non-selective	(+	His)	or	HIS3-reporter	gene	selection	(+	3-AT)	media.		Images	shown	are	representative	of	three	independent	replicates.		Lower:	detailed	structures	of	the	UASRap1-HIS3	reporters	used	in	these	growth	tests.		B.		qRT-PCR	analyses	of	the	steady	state	levels	of	HIS3	reporter	mRNA,	relative	to	ACT1	in	the	yeast	strains	tested	in	panel	A.		Data	were	obtained	by	testing	three	biological	replicates	(each	indicated	by	a	white	circle)	analyzed	in	duplicate	and	plotted	as	a	percentage	of	the	HIS3	mRNA	levels	present	in	WT	Rap1	+	WT	
UASRap1	yeast.		Mean	±	SD	is	depicted.	*	=	p	<	0.001,	**	=	p	<	0.001.		C.		Steady	state	protein	expression	levels	of	Rap1WT	and	Rap1AS.		Myc5-tagged	Rap1	forms	(top,	WT,	AS;	Test	Rap1	(Myc)	IB)	were	scored	using	immunoblotting	with	anti-Myc	IgG.	A	strain	carrying	a	plasmid	expressing	only	untagged	Rap1	was	used	as	a	specificity	control	for	the	Myc	antibody	(labeled	no	tag).		Prior	to	incubation	with	antibodies,	blots	were	stained	with	Ponceau	S	to	monitor	total	protein	loading	(bottom;	Ponceau	S).		Equal	protein	loading	was	also	monitored	via	immunoblotting	with	anti-Actin	IgG	(middle,	Actin	IB).	Images	are	representative	of	three	independent	replicates.		D.		Growth	curves	of	yeast	expressing	WT	or	AS	forms	of	Rap1	from	a	plasmid	carrying	either	a	second	copy	of	Rap1WT	or	Rap1AS	(labeled	WT/WT	or	WT/AS).		Overnight-grown	yeast	starter	cultures	were	diluted	to	a	starting	OD600	of	0.5,	and	the	optical	density	of	the	cultures	were	monitored	over	the	course	of	12	hours.		Data	shown	represents	the	average	of	three	biological	replicates.		Error	bars	represent	SDs.	
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Discussion			 Prior	work	performed	using	conventional	approaches	produced	ambiguous	data	regarding	whether	Rap1	actually	contains	a	functional	AD.		As	a	consequence,	I	decided	to	use	an	alternative	approach	to	identify	an	AD	within	budding	yeast	Rap1.		Despite	the	challenges	involved,	I	undertook	the	generation	of	an	altered	DNA-binding	specificity	variant	of	Rap1,	termed	Rap1AS.		Assuming	successful	Rap1AS	generation,	my	plan	was	to	use	Rap1AS	as	a	novel	tool	to	facilitate	the	identification	and	high-resolution	characterization	of	an	AD	within	Rap1.		 With	the	exception	of	proteins	that	bind	DNA	via	zinc	finger	motifs,	true	altered	DNA-binding	specificity	variants	are	fairly	difficult	to	generate.		This	is	underscored	by	the	fact	that	few	such	proteins	have	been	described	in	the	literature.			That	said,	successful	generation	of	altered	DNA-binding	specificity	variant	proteins	has	yielded	significant	insights	into	deciphering	the	determinants	of	protein-DNA	recognition	while	simultaneously	providing	novel	tools	to	probe	and	dissect	the	activity	of	DNA-binding	proteins.		Recognition	of	a	mutant	enhancer	or	UAS	site	requires	that	a	DBD	gain	the	ability	to	bind	the	mutant	DNA	sequence	via	alteration	in	the	ability	of	a	protein	to	bind	novel	DNA	sequences	and/or	shapes.		True	altered	DNA-binding	specificity	variants	(rather	than	expanded	DNA-binding	specificity	variants)	display	significantly	reduced	WT	DNA	sequence	binding	in	addition	to	gaining	mutant	DNA	recognition.		The	AS	Rap1	variant	identified	in	this	Chapter,	termed	Rap1AS,	exhibits	exactly	these	properties,	and	hence	was	deemed	ideal	for	initiating	efforts	to	discover	and	pinpoint	the	AD	of	Rap1	absent	the	many	
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complications	imposed	by	the	multiple	essential	cellular	functions	of	the	protein	(see	Chaper	I).		 The	steps	I	took	to	generate	Rap1AS	taught	me	useful	lessons	in	protein	engineering.		In	my	efforts	to	obtain	Rap1AS,	I	found	that	the	“rational”	approach	to	Rap1AS	design	succeeded	where	the	unbiased	mutagenesis	approach	did	not.		In	personal	communications,	scientists	from	labs	whose	focus	is	on	protein	engineering	indicated	that,	at	least	as	a	first	step	in	generating	novel	activity,	success	depends	on	a	rational	design	approach.		Indeed,	most	contemporary	protein	engineering	groups	generate	proteins	with	novel	function	using	structure-,	and	especially	in	recent	years,	computationally-guided	design	(Chu	et	al.,	2012;	Jiang	et	al.,	2008;	Kries	et	al.,	2013;	Thyme	et	al.,	2014).		Only	once	a	protein	possesses	a	desired	activity,	can	unbiased	mutagenesis	approaches	be	used	to	further	improve	that	activity,	especially	if	a	large	number	of	mutant	variants	can	be	screened	(Daugherty	et	al.,	2000;	Obexer	et	al.,	2017;	Zaccolo	and	Gherardi,	1999).	
	 Meanwhile,	analysis	of	the	aa	sequences	of	the	Rap1	AS	mutants	recovered	in	my	screen	provides	some	insights	into	the	DNA	recognition	determinants	of	WT	and	mutant	
UASRap1	DNA	base	pairs	3	and	4.		The	fact	that	consistent	aa	sequence	patterns	were	found	among	the	mutations	present	at	Rap1	aa’s	401	and	405	(see	Figure	2.6B)	in	all	of	the	Rap1	variants	suggests	that	these	aa	changes	are	required	to	enable	Rap1	binding	to	3T4A	
UASRap1.		Further,	the	comparison	of	the	sequences	of	altered	DNA-binding	specificity	Rap1	variants	#2,	#10	and	#13,	with	the	sequences	of	expanded	DNA-binding	Rap1	variants	#5,	#17,	and	#18	suggests	that	the	true	altered	DNA-binding	specificity	variants	contained	both	a	mutation	at	aa	408	and	a	bulky	hydrophobic	aa	(i.e.	W	or	F)	at	Rap1	aa	405	(cf.	
Figure	2.6B).		These	mutations	may	decrease	Rap1	mutant	binding	to	WT	UASRap1	by	
	 95	
breaking	a	favorable	water-mediated	contact	between	Rap1	R408	and	WT	UASRap1	base-pair	3	(König	et	al.,	1996)	or	by	using	a	bulky	hydrophobic	aa	at	Rap1	position	405	to	actively	exclude	binding	to	the		WT	UASRap1	element	(see	Figure	2.3A).		 In	addition	to	providing	new	knowledge	to	advance	protein-engineering	efforts,	my	work	on	the	generation	of	Rap1AS	resulted	in	the	development	of	a	tool	to	unambiguously	dissect	Rap1	structure-function	relationships.		Thus,	I	set	out	to	see	if	I	could	use	Rap1AS	to	obtain	a	high-resolution	map	of	a	putative	Rap1	AD.		The	results	of	these	efforts	(see	Chapter	III)	show	that	Rap1AS	can	indeed	be	used	to	greatly	advance	our	studies	of	Rap1	biology.				 												
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CHAPTER	III		RAP1	ACTIVATION	DOMAIN	(AD)	MAPPING	AND	IDENTIFICATION	OF	TFIID	TAF5	AS	AN	AD	COACTIVATOR	TARGET			 Important	Outcomes	of	Rap1	AD	mapping	using	Rap1AS		 As	stated	in	Chapters	I	and	II,	the	Rap1	AD	had	never	been	unambiguously	mapped	prior	to	my	thesis	research.		Thanks	to	the	Rap1AS	generated	in	Chapter	II,	I	was	well	positioned	to	conclusively	answer	the	question	of	which	domain(s)	constitute	the	Rap1	AD.		My	goal	was	to	identify	both	the	region	and	the	key	individual	aa’s	within	that	region	required	for	AD	activity.		In	addition	to	characterizing	the	AD	of	an	important	transcription	activator	that	binds	with	unusually	high	affinity	to	the	Taf4,	5,	and	12	subunits	of	the	TFIID	coactivator	(Layer	et	al.,	2010),	my	AD	mapping	would	generate	a	series	of	point	mutant	variants	that	would	provide	precise	tools	for	dissecting	Rap1-dependent	mechanisms	of	transcription	activation.		I	also	wanted	to	initiate	the	identification	of	coactivator	targets	of	the	Rap1	AD	by	testing	the	hypothesis	that	the	Rap1	AD	interacts	with	TFIIA	and/or	TFIID	Tafs	4,	5,	12	as	predicted	by	our	“Lock	to	Load”	model	and	our	prior	studies	of	RP	gene	transcription	activation	(Garbett	et	al.,	2007;	Layer	and	Weil,	2013;	Layer	et	al.,	2010;	Papai	et	al.,	2010).		Ideally,	the	Rap1	AD	point	mutant	variants	I	generated	during	my	AD	mapping	would	contain	separation-of-function	variants	that	could	be	used	in	future	studies	to	tease	apart	the	mechanistic	consequences	of	possible	Rap1	AD	interaction	with	these	multiple	coactivator	targets.	
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	 In	this	Chapter,	I	describe	a	structure-function	dissection	analysis	using	Rap1AS	performed	to	achieve	my	Rap1	AD	mapping	goal,	some	of	which	was	originally	published	in	my	JBC	manuscript	(Johnson	and	Weil,	2017)	©	the	American	Society	for	Biochemistry	and	Molecular	Biology.		In	this	approach,	I	subjected	the	gene	encoding	Rap1AS	to	systematic	deletion	and	point	mutagenesis	to	identify	a	41-aa	long	AD	within	the	C-terminal	portion	of	the	protein	that	is	responsible	for	driving	high-level	reporter	gene	expression.		This	AD	has	the	features	of	acidic	activation	domains	described	in	other	eukaryotes	as	it	contains	seven	evolutionarily	conserved	hydrophobic	residues	within	the	acidic	aa-rich	element	that	contribute	critically	to	the	activation	potential	of	Rap1AS.		Importantly,	mutation	of	all	seven	of	these	conserved	aa’s	to	alanine	within	the	context	of	WT	Rap1	(Rap1WT)	induces	a	dramatic	slow	growth	phenotype	while	simultaneously	reducing	transcription	of	RP-	and	GE-encoding	genes,	demonstrating	that	the	AD	mapped	using	Rap1AS	is	physiologically	relevant.		My	protein-protein	interaction	experiments	performed	using	Rap1WT	and	a	Rap1	AD	mutant	variant	show	that	mutation	of	key	Rap1	AD	residues	significantly	reduces	the	binding	of	the	AD	mutant	variant	of	Rap1	to	Taf5,	one	of	the	known	TFIID	coactivator	subunit	targets	of	Rap1	(Garbett	et	al.,	2007;	Layer	et	al.,	2010).		Thus,	in	addition	to	providing	a	strong	case	for	the	use	of	Rap1AS	as	a	tool	to	study	Rap1	biology,	this	work	definitively	establishes	the	fact	that	Rap1	contains	an	AD	that	is	required	for	Rap1-dependent	chromosomal	gene	transcription	and	provides	multiple,	distinct,	variant	forms	of	Rap1	that	will	prove	invaluable	for	further	dissection	of	the	molecular	mechanisms	of	Rap1-dependent	transcription	activation.				
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Methods		General	Cloning	and	Yeast	and	E.	coli	Manipulations		 The	general	cloning	approach	and	yeast	and	E.	coli	manipulations	used	in	this	Chapter	were	performed	according	to	the	approaches	described	in	Chapter	II.		Test	Rap1	Yeast	Expression	Vectors		 Yeast	expression	vectors	encoding	Rap1WT	and	Rap1AS	are	the	same	as	described	in	Chapter	II.		Truncation	and	point	mutations	were	introduced	into	the	gene	encoding	Rap1AS	(RAP1AS)	were	RAP1	generated	via	splicing	by	overlap	extension	PCR	(Heckman	and	Pease,	2007)	using	and	primers	with	BlpI	and	XhoI	ends	or	(for	deletion	of	the	Rap1	N-terminus)	primers	with	XbaI	and	XhoI	ends	and	pRS415-MYC5-NLS-RAP1AS	as	a	template.		These	mutant	RAP1AS	variant	PCR	products	were	used	to	replace	the	BlpI	to	XhoI	or	(for	deletion	of	the	Rap1	N-terminus)	XbaI	to	SphI	fragments	of	RAP1	in	plasmid	pRS415-MYC5-NLS-
RAP1AS	or	(for	expression	of	the	Rap1	DBD	only)	plasmid	pRS415-MYC5-NLS-RAP1AS∆C,	resulting	in	the	production	of	mutant	Rap1	test	expression	vectors.		Versions	of	these	mutant	Rap1	test	expression	vectors	encoding	the	Rap1WT	(rather	than	the	Rap1AS)	DBD	were	generated	either	via	the	spicing	by	overlap	extension	PCR	approach	described	above	using	pRS415-MYCX5-NLS-RAP1AS	as	a	template	or	by	replacing	the	XbaI	to	SphI	fragment	of	pRS415-MYCX5-NLS-RAP1AS	that	encompasses	the	RAP1	promoter	and	RAP1	sequences	encoding	the	N-terminus	and	DBD	with	the	XbaI	to	SphI	fragment	of	pRS415-MYC5-NLS-
RAP1.		Expression	vectors	for	testing	in	the	silencing	strain	(see	“Yeast	Strains”	below)	were	generated	by	cloning	the	XbaI	to	XhoI	fragment	of	a	pRS415-MYC5-NLS-RAP1	variant	
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(where	the	XbaI	site	was	blunted	using	DNA	Polymerase	I,	Large	(Klenow)	fragment	(NEB)	according	the	manufacturer’s	instructions)	into	pRS412	digested	with	SmaI	and	XhoI.		Yeast	Strains		 All	of	the	yeast	strains	used	in	this	Chapter	are	listed	in	Table	3.1.		All	except	yeast	strains	carrying	the	glycolytic	reporter	(named	YAM42,	YAM43,	YAM44,	and	YAM45),	silencing	reporter	(YAM46),	and	strain	background	the	silencing	reporter	strain	was	made	in	are	the	same	as	those	used	in	Chapter	II.				 The	various	UASRap1-Gcr1-HIS3	glycolytic	reporter	genes	were	derived	from	the	
UASRap1-HIS3	reporter	described	in	Chapter	II.		The	difference	between	the	UASRap1-Gcr1-HIS3	reporters	and	the	UASRap1-HIS3	reporter	is	that	UASRap1-Gcr1-HIS3	contains	one	Rap1	binding	site	(UASRap1)	site	and	one	Gcr1	binding	site	(UASGcr1)	instead	of	two	UASRap1	sites.		UASRap1-
Gcr1-HIS3	reporters	were	generated	by	replacing	the	48bp	NcoI	to	SacII	DNA	fragment	encompassing	the	two	UASRap1	binding	sites	in	the	WT	UASRap1-HIS3	reporter	generated	in	previous	studies	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002)	with	a	39bp	NcoI	to	SacII	DNA	fragment	containing	
UASRap1		and	UASGcr1	binding	
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sites	derived	from	the	PGK1	gene	generated	by	annealing	double-stranded	synthetic	oligonucleotides	obtained	from	IDT.		These	reporter	variants	were	integrated	into	the	yeast	genome	and	integration	was	confirmed	as	described	for	the	UASRap1-HIS3	reporters	above.		 The	silencing	strain	used	for	the	experiments	in	this	Chapter	was	derived	from	the	previously	described	YLS34	strain	(Sussel	and	Shore,	1991),	which	was	derived	from	W303-1B	(Thomas	and	Rothstein,	1989)	by	David	Shore’s	lab	at	the	University	of	Geneva.		To	generate	a	strain	that	would	allow	the	testing	of	both	Rap1	silencing	and	activation	via	a	growth	assay,	the	WT	UASRap1-HIS3	reporter	genes	used	in	Chapter	II	was	integrated	into	the	YLS34	genome.		For	this	integration,	WT	UASRap1-HIS3	was	digested	with	SpeI	and	KpnI.		Because	the	KpnI	restriction	site	is	located	between	the	HIS3	and	the	TRP1	genes,	this	digest	results	in	a	WT	UASRap1-HIS3	that	does	not	contain	TRP1,	which	serves	as	the	reporter	gene	for	Rap1	silencing	activity	in	YLS34	(Sussel	and	Shore,	1991).		Restriction	enzyme	digested	UASRap1-HIS3	was	transformed	into	yeast	and	integrated	into	the	HIS3	locus	via	ends-out	recombination	(Hastings	et	al.,	1993).		Transformants	were	selected	on	SC-His.		After	confirming	that	transformants	were	Trp-	as	expected	since	TRP1	was	not	present	in	the	WT	UASRap1-HIS3	integration	construct	and	silent	in	YLS34	in	the	presence	of	Rap1WT,	correct	integration	of	the	reporter	was	confirmed	via	PCR.		Yeast	Cell	Growth,	Immunoblotting,	and	Steady	State	RNA	Analysis		 Yeast	cell	growth,	immunoblotting,	and	steady-state	RNA	anlaysis	were	performed	using	the	same	methods	outlined	in	Chapter	II.		The	only	exception	to	this	is	that	Ponceau	S	staining	was	not	performed	as	a	protein-loading	control	in	addition	to	probing	for	Actin	in	immunoblots	that	do	not	appear	in	my	JBC	manuscript	(Johnson	and	Weil,	2017).	
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Nascent	RNA	Labeling	and	Purification		 Nascent	RNA	levels	in	yeast	strains	of	interest	were	assessed	using	efficient	and	reversible	RNA	labeling	and	purification	(Duffy	et	al.,	2015).		200	ml	of	each	yeast	culture	(500	OD600	units)	grown	in	YPD	to	a	cell	density	of	~	1.5	x	107	cells/mL	(2.5	OD600/ml)	were	pulse	labeled	for	2.5	minutes	with	5	mM	4-thiouracil	(s4U)	(Sigma),	harvested	via	vacuum	filtration,	and	immediately	immersed	in	a	1:1	mixture	of	phenol:	RNA	Buffer	A	(50	mM	NaAc	(pH	5.5),	10	mM	EDTA	(pH	8),	0.5%	SDS)	pre-warmed	to	65°C.		~4.8	x	108	cells	(80	OD600	units)	of	6-min	thiouracil	labeled	Schizosaccharomyces	pombe	cells	were	added	into	each	sample	prior	to	RNA	extraction	for	use	as	a	spike-in	control.		Total	RNA	from	the	resulting	S.	cerevisiae/S.pombe	mixtures	was	extracted	using	the	hot	phenol	method	(Köhrer	and	Domdey,	1991).		RNA	concentration	and	integrity	were	assessed	as	in	Chapter	II.		To	prepare	nascent	thiolated	RNA	for	separation	from	total	RNA,	400µg	of	each	RNA	in	1	ml	of	Biotinylation	Buffer	(10	mM	Tris-HCL	(pH	7.5),	1	mM	EDTA)	was	heat	denatured	at	65°C	for	10	min	and	then	chilled	for	2	min	on	ice.		RNA	was	biotinylated	for	30	min	at	room	temperature	in	the	dark	on	a	tiltboard	following	addition	of	20	µl	of	1mg/ml	(2-((Biotinoyl)	amino)-ethyl	methanethiosulfonate	(MTSEA)	(Biotium)	dissolved	in	dimethylformamide	(DMF).		Unincorporated	biotin	was	removed	by	two	chloroform	extractions	(once	with	1ml,	then	with	0.75ml),	the	second	of	which	was	performed	using	a	Heavy	Phase	Lock	Gel	(5	Prime	Inc.).		RNA	was	precipitated	using	an	equal	volume	(0.75ml)	of	isopropanol.	Isopropanol	precipitated	RNA	was	dissolved	in	100µl	of	0.1%	diethylpyrocarbonate	(DEPC)-treated	H2O	(Fisher).		RNA	was	again	heat	denatured	at	65°C	for	10	min	and	then	chilled	on	ice	for	5	min.		Biotinylated	nascent	RNAs	were	purified	using	200µl	of	a	colloidal	suspension	of	µMACs	streptavidin	beads/sample	(µMACs	streptavidin	kit,	Miltenyi	Biotec).		
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Samples	were	placed	in	a	light-tight	container	on	a	tiltboard	at	room	temperature	for	15	min.		Each	RNA/bead	mixture	was	added	to	a	separate	µMACs	streptavidin	kit	column	that	had	been	placed	in	the	µMACs	Separator	and	washed	2	X	with	0.2	ml	Nucleic	Acid	Wash	Buffer	(µMACs	streptavidin	kit,	Miltenyi	Biotec).		The	flow-through	was	collected	and	re-applied	to	the	column.		Columns	were	washed	2X	with	0.5	ml	of	the	biotinylated	RNA	Wash	Buffer	(100	mM	Tris-HCL	(pH	7.5),	10	mM	EDTA,	1	M	NaCl,	0.1%	Tween	20)	and	biotinylated	RNA	was	eluted	with	two	200ml	washes	of	0.1M	DTT.		Biotinylated	RNA	was	ethanol	precipitated	following	addition	of	40µg	molecular	biology	grade	glycogen	(Roche),	0.1X	volume	of	3M	NaOAc	(pH	5.5),	and	3X	volumes	of	100%	ethanol.		Precipitated	RNAs	were	dissolved	10mM	Tris	Cl	pH	7.5	0.1mM	EDTA.		cDNA	synthesis	was	performed	as	described	in	Chapter	II;	qRT-PCR	was	performed	and	relative	transcript	levels	determined	as	described	in	Chapter	II,	except	that	
S.	pombe	β-TUBULIN	present	in	the	samples	due	to	the	S.	pombe	cell	spike-in	was	used	as	a	reference	gene	(Bonnet	et	al.,	2014)	(see	Table	3.2	for	the	sequences	of	the	primers	used	in	these	analyses).		Rap1	Purification	for	GST	Pull-Down	Assay		 To	generate	Rap1	for	GST	pull-down	assays,	Rap1	ORFs	encoded	on	the	pRS415	expression	plasmid	were	subjected	to	PCR	to	generate	Rap1	coding	sequences	with	EcoRI	and	XhoI	ends	that	could	be	cloned	in	frame	with	the	His6-GST	tag	in	the	pBG101	
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expression	vector.		His6-GST-Rap1	variants	were	expressed	and	subjected	to	Ni-NTA	purification	as	described	for	His6-Rap1	in	Chapter	II	scaled	up	for	2L	of	E.	coli	culture.		Ni-NTA	purified	His6-GST-Rap1	variants	were	diluted	to	reduce	the	concentration	of	NaCl	in	the	Lysis/Wash	buffer	to	150mM	and	permit	binding	to	2.5mL	Sepharose	SP	Fast	Flow	(Pharmacia)	pre-equilibrated	in	a	disposable	column	(Bio-Rad)	with	4	column	volumes	of	Buffer	B150	(25	mM	HEPES	NaOH	(pH	7.6),	10%	v/v	glycerol,	150	mM	NaCl,	0.01%	v/v	NP-40,	1	mM	Benzamidine,	0.2	mM	PMSF).		After	binding,	Sepaharose	SP	was	washed	with	4	more	column	volumes	of	B150.		Bound	proteins	were	eluted	using	3	column	volumes	of	Buffer	B1000	(25	mM	HEPES	NaOH	(pH	7.6),	10%	v/v	glycerol,	1	M	NaCl,	0.01%	v/v	NP-40,	1	mM	Benzamidine,	0.2	mM	PMSF).		Taf5	Expression	and	Purification	for	GST	Pull-down	Assay		 His6-Taf5	aa	1-337	(containing	the	RBD)	was	expressed	from	a	previously	generated	pET33B	expression	vector	(Layer	et	al.,	2010)	and	Ni-NTA	purified	as	described	for	His6-Rap1	in	Chapter	II	scaled	up	for	2L	of	E.	coli	culture.		GST	Pull-down	Assays	
	 GST	pull-down	assays	were	conducted	as	200	µL	reactions	in	pull-down	buffer	(20mM	HEPES	NaOH	(pH	7.5),	150mM	NaAc,	0.05%	Triton	X-100,	10%	glycerol,	1mM	DTT,	25	ng/µL	BSA)	using	5µL	of	glutathione	sepharose	4	Fast	Flow	beads	(GE	Healthcare),	12pmol	of	His6-GST	or	6	pmol	of	His6-GST-Rap1	variant,	and	either	0	pmol	or	100	pmol	of	His6-Taf5.		Binding	reactions	were	incubated	for	1hr	at	room	temperature	on	the	tiltboard.		Following	incubation,	the	glutathione	sepharose	beads	were	pelleted	by	centrifugation	for	
	 104	
30s	at	1,000rpm	and	washed	once	with	pull-down	buffer.		Beads	were	pelleted	again	and	bead-bound	material	was	eluted	with	1	X	NuPAGE	sample	buffer	(1X	LDS	Sample	Buffer	(Life	Technologies)	with	DTT	added	to	62.5	mM).		Bead-bound	material	was	fractionated	on	4-12%	NuPAGE	gels	(Life	Technologies),	stained	with	Sypro	Ruby	(Life	Technologies),	and	imaged	with	a	Pharos	Fx	Imager	(Bio-Rad).		Binding	data	were	quantified	using	Quantity	One	software	(Bio-Rad)	and	plotted	using	Prism	7	(GraphPad).		Results		Identification	of	a	Potential	Activation	Domain	Within	aa’s	600-671	
	 The	analyses	of	Rap1	described	in	Chapter	I	led	to	the	hypothesis	that	an	AD	was	located	within	a	C-terminal	portion	of	the	protein	distinct	from	the	sequences	implicated	in	silencing	of	telomere-proximal	genes	whose	deletion	has	little	affect	on	cell	viability	(Chen	et	al.,	2011;	Feeser	and	Wolberger,	2008;	Kyrion	et	al.,	1992;	Moretti	et	al.,	1994b).		To	directly	and	systematically	test	the	hypothesis	that	these	C-terminal	sequences	(aa’s	600-671,	labeled	AD?	in	Figure	3.1A)	specifically	and	solely	conferred	AD	function	for	the	RP	genes,	a	series	of	Rap1AS	deletion	variants	were	generated.		The	Rap1	deletion	variant	series	used	for	these	first	AD-mapping	experiments	consisted	of	constructs	termed	∆N	(aa’s	1-338),	∆C	(aa’s	600-827),	∆N∆C	(aa’s	1-338,	600-827),	∆AD?	(aa’s	600-671),	and	∆SD	(aa’s	672-827)	wherein	the	RAP1AS	ORF	sequences	encoding	the	indicated	aa	sequences	were	deleted	(Figure	3.1A).				 Yeast	carrying	an	integrated	3T4A	UASRap1-HIS3	reporter	were	used	to	score	the	ability	of	intact	Rap1WT,	Rap1AS,	and	the	noted	Rap1AS	deletion	variants	to	promote	3-ATR	
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growth.		Negative	control	cells	expressing	only	Rap1WT	(which	is	unable	to	bind	3T4A	UASRap1	(see	Chapter	II)	fail	to	exhibit	3-ATR	as	expected	(Figure	
3.1B).		Rap1AS∆N∆C	phenocopies	Rap1WT	in	these	growth	analyses,	indicating	that	the	Rap1AS	DBD	alone	is	insufficient	for	reporter	expression.	Meanwhile,	Rap1AS∆N	and	Rap1AS∆SD	show	3-ATR,	phenocopying	Rap1AS	(which	binds	3T4A	UASRap1	(see	Chapter	II))	and	demonstrating	that	the	aa’s	deleted	in	these	Rap1	variants	are	not	required	for	3T4A	UASRap1-HIS3	expression.		Finally,	as	might	be	expected,	the	Rap1AS∆C	and	Rap1AS∆AD?	forms,	which	were	expressed	at	levels	comparable	to	that	of	Rap1AS	(Figure	3.1C)	were	unable	to	confer	3-ATR	(Figure	3.1B).		These	growth	data	suggest	that	an	activation	domain	indeed	resides	within	Rap1	C-terminal	aa’s	600-671	(Figure	3.1D).		 		
Figure	3.1.	Mapping	of	a	Potential	Rap1	AD	to	Amino	
Acids	600-671.		A.		Schematic	of	the	Rap1	protein.		Shown	are	the	well	characterized	Rap1	DNA	Binding	Domain	(DBD;	aa’s	339-600),	N-terminus	aa’s	1-339,	and	C-terminus	aa’s	600-827.		The	C-terminus	is	further	divided	into	a	Silencing	Domain	(SD)	as	well	as	the	region	suspected	to	contain	the	AD	(AD?	aa’s	600-
671).		B.		Growth	analysis	of	yeast	strains	carrying	the	3T4A	version	of	the	HIS3	reporter	(left	column;	UASRap1-
red;	labeled	3T4A)	and	various	forms	of	Rap1	(labeled	
Rap1,	second	column)	either	Rap1AS	(AS,	red),	Rap1WT	(WT,	blue),	or	the	indicated	Rap1AS	deletion	mutants	(∆N,	∆C,	∆N∆C,	∆AD?,	∆SD;	red).		Serial	dilutions	of	cells	were	plated	and	grown	on	non-selective	(+	His),	or	reporter	gene	selective	(+	3-AT)	media	as	in	the	growth	assays	performed	in	Chapter	II.	Images	are	representative	of	two	independent	replicates.			
C.		Immunoblot	analysis	was	of	Rap1AS	variants	performed	as	described	in	Figure	2.8.	D.		Schematic	indicating	the	location	of	the	potential	Rap1	activation	domain	(AD?;	aa’s	600-671)	mapped	through	the	deletion	mutagenesis	experiments	shown	here.		
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Expression	of	a	Glycolytic	Reporter	Depends	on	the	Rap1	N-Terminus		 Rap1	activates	both	the	TFIID-dependent	RP	genes	and	the	SAGA-dependent	GE	genes	(Chambers	et	al.,	1989,	1995;	Huisinga	and	Pugh,	2004;	Knight	et	al.,	2014;	Lieb	et	al.,	2001;	Rudra	and	Warner,	2004).		Because	these	two	robustly	transcribed	genes	depend	on	two	different	coregulators,	I	wondered	if	they	also	depended	on	the	same	or	different	Rap1	aa’s.		To	provide	a	means	to	investigate	the	possibility	that	glycolytic	and	RP	genes	depend	on	distinct	Rap1	sequences,	I	designed	a	series	of	glycolytic	reporters	(UASRap1-Gcr1-HIS3)	(Figure	3.2A).		These	reporters	were	similar	to	the	UASRap1-HIS3	reporter	used	in	the	analyses	above	and	in	Chapter	II	except	that	the	two	UASRap1	sites	in	UASRap1-HIS3	derived	from	the	RP	gene	RPS8A	were	replaced	with	UASRap1	and	UASGcr1	sites	derived	from	the	glycolytic	gene	PGK1.					 To	demonstrate	that	UASRap1-Gcr1-HIS3	depends	on	both	the	UASRap1	and	UASGcr1	and	that	a	UASRap13T4A-Gcr1-HIS3	reporter	can	be	driven	by	Rap1AS,	four	UASRap1-Gcr1-HIS3	reporters	were	generated:	(1)	UASRap1WT-Gcr1WT-HIS3	containing	WT	versions	of	UASRap1	and	
UASGcr1,	(2)	UASRap1WT-Gcr1mut-HIS3	containing	WT	UASRap1	and	a	mutant	UASGcr1	that	has	been	shown	to	drastically	reduce	expression	of	a	glycolytic	gene	in	a	previous	study	(Scott	and	Baker,	1993),	(3)	UASRap13T4A-Gcr1WT-HIS3	containing	the	Rap1AS	binding	site	and	WT	UASGcr1,	and	(4)	UASRap13T4A-Gcr1mut-HIS3	containing	UASRap13T4A	and	the	mutant	UASGcr1	(Scott	and	Baker,	1993)	(Figure	3.2A).		Growth	assays	were	performed	to	assess	the	ATR	of	yeast	containing	these	reporters	and	either	a	second	copy	of	Rap1WT	or	Rap1AS.		These	analyses	showed	that	3-ATR	depended	on	both	the	UASRap1	and	UASGcr1	sites	(Figure	3.2A).		Additionally	as	expected,	Rap1AS	conferred	ATR	to	yeast	containing	the	UASRap13T4A-Gcr1WT-
HIS3	(Figure	3.2A).			
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	 To	assess	the	contribution	of	Rap1	domains	to	glycolytic	reporter	expression,	yeast	carrying	the	integrated	UASRap13T4A-Gcr1WT-HIS3	reporter	were	used	to	score	the	ability	of	Rap1WT,	Rap1AS,	and	the	Rap1AS	deletion	variants	used	above	(Figure	3.2B)	to	promote	ATR	growth.		Surprisingly,	Rap1AS∆N	was	unable	to	support	ATR	in	UASRap13T4A-Gcr1WT-HIS3	yeast	(Figure	3.2C).		Although	Rap1AS∆N	protein	expression	levels	are	somewhat	reduced	compared	to	Rap1AS	(Figure	3.2D),	the	failure	to	support	ATR	can	likely	be	attributed	to	
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Figure	3.2.	Activation	of	the	UASRap1-Gcr1	Glycolytic	Reporter	Gene	Depends	on	the	Rap1	N-
terminus.		A.	The	UASRap1-Gcr1-HIS3	reporter	depends	on	both	the	UASRap1	and	the	UASGcr1	and		Rap1AS	can	drive	expression	of	UASRap1AS-Gcr1-HIS3.		Upper:	Test	of	the	ability	of	WT	and	AS	forms	of	Rap1	to	bind	different	enhancers	to	confer	ATR.		Yeast	strains	carrying	the	indicated	UASRap1-Gcr1-HIS3	reporter	variant	(WT	UASRap1-Gcr1,	WT	UASRap1-Gcr1mut,	3T4A	UASRap1-Gcr1	or	3T4A	UASRap1-Gcr1mut,	as	shown)	and	either	a	second	copy	of	Rap1WT	(blue)	or	Rap1AS	(red)	were	grown	on	non-selective	(+	His)	or	HIS3-reporter	gene	selection	(+	3-AT)	media.		Images	shown	are	representative	of	one	replicate.		Lower:	detailed	structures	of	the	UASRap1-Gcr1-HIS3	reporters	used	in	these	growth	tests.	B.		Schematic	of	the	Rap1	protein,	highlighting	the	well-characterized	Rap1	domains	shown	in	Figure	3.1,	including	the	DBD,	N-terminus,	and	C-terminus	(divided	into	AD?	and	SD	regions).		The	aa	coordinates	of	each	domain	are	indicated	in	the	figure	and	are	the	same	as	those	shown	in	Figure	3.1.		C.		Growth	analysis	of	yeast	strains	carrying	the	3T4A	UASRap1-Gcr1-HIS3	reporter	(left	column;	UASRap1-red;	labeled	3T4A)	and	various	forms	of	Rap1	(labeled	Rap1,	second	column)	either	Rap1AS	(AS,	red),	Rap1WT	(WT,	blue),	or	the	indicated	Rap1AS	deletion	mutant	(∆N,	∆C,	∆N∆C,	∆AD?,	∆SD;	red).		Growth	assay	was	performed	as	in	“A”.		Image	is	of	one	biological	replicate	D.		Immunoblot	analysis	of	Rap1AS	variants	performed	as	described	in	Figure	
2.8		E.		Schematic	indicating	the	location	of	the	Rap1	region	required	for	glycolytic	reporter	expression	(Rap1	N-terminal	activation	domain?	(NTAD;	aa’s	1-339)	mapped	through	the	deletion	mutagenesis	experiments	shown	here.		
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activity	of	the	Rap1	N-terminus	since	Rap1AS∆N	supported	ATR	in	the	3T4A	UASRap1-HIS3	reporter	(cf	Figure	3.1).	Thus,	in	contrast	to	the	3T4A	UASRap1-HIS3	reporter	(cf	Figure	
3.1),	expression	of	UASRap13T4A-Gcr1WT-HIS3	depends	on	aa	in	the	Rap1	N-terminus	(labeled	“Rap1	N-terminal	AD	(NTAD),	Figure	3.2D).	 	Systematic	AD?	Deletion	Mutagenesis	Further	Defines	the	Potential	Activation	Domain		 I	focused	my	continuing	AD	mapping	studies	on	the	Rap1	AD?	because	I	am	interested	in	TFIID	coactivator	function,	and	unlike	the	Rap1	N-terminus,	the	Rap1	C-terminus	(which	contains	AD?)	interacts	with	TFIID	and	is	thus	likely	critical	for	activation	of	the	TFIID-dependent	RP	genes	(Garbett	et	al.,	2007).		Yeast	carrying	the	3T4A	UASRap1-
HIS3	reporter	were	used	to	further	define	which	of	the	aa’s	within	AD?	(aa’s	600-671)	comprise	the	AD	(Figure	3.3A).		Rap1WT,	Rap1AS,	and	Rap1AS∆AD?	were	used	as	controls	in	these	experiments.	The	aa	interval	that	contains	AD	function	was	subjected	to	systematic	internal,	N-terminal,	and	C-terminal	deletion.		Data	for	the	series	of	seven	internal	10	aa	deletions	moving	through	Rap1	aa’s	600-671	is	shown	in	Figures	3.3B-D;	labeled	∆600-
610,	∆611-620,	∆621-630,	∆631-640,	∆641-650,	∆651-660,	∆660-671).		These	Rap1AS	variants	were	tested	for	3T4A	UASRap1-HIS3	expression	by	scoring	growth	on	3-AT-containing	plates	and	mRNAHIS3	levels	by	qRT-PCR.		To	ensure	that	all	constructs	were	stably	expressed,	steady-state	protein	levels	were	monitored	in	parallel	using	the	same	cells	tested	for	ATR	and	mRNAHIS3	levels	(Figure	3.3D).		Deletion	of	the	first	30	amino	acids	of	the	600-671	region	(i.e.	constructs	∆600-610;	∆611-620;	∆621-630;	Figure	3.3B,C)	had	no	significant	effect	upon	either	growth	in	the	presence	of	3-AT,	or	HIS3	reporter	mRNA	transcript	levels.		By	contrast,	removal	of	aa’s	within	the	distal	40	aa’s	of	Rap1	AD?	
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sequences	(∆631-640;	∆641-650;	∆651-660;	∆660-671;	Figure	5B,C)	dramatically	reduced	HIS3	reporter	expression	as	scored	by	ATR	growth	(Figure	3.3B)	and	mRNAHIS3	levels		(Figure	3.3C).			All	Rap1AS	deletion	constructs	were	as	stable	as	Rap1WT,	results	excluding	any	contribution	of	Rap1AS	protein	abundance	to	reporter	gene	expression	
Figure	3.3.		Mapping	the	Activation	Domain	of	Rap1	to	Amino	Acids	630-671.		A.		Schematic	of	the	Rap1	protein	indicating	the	AD?	region	(aa’s	600-671)	located	C-terminal	of	the	DBD	(aa’s	339-600)	to	be	subjected	to	further	deletion	analysis.		B.		Growth	analysis	of	yeast	strains	carrying	the	3T4A	version	of	the	
HIS3	reporter	(left	column;	UASRap1-red;	labeled	3T4A)	and	various	forms	of	Rap1	(labeled	Rap1,	second	column)	either	Rap1AS	(AS,	red),	Rap1WT	(WT,	blue),	or	the	indicated	Rap1AS	deletion	mutant	(∆AD?,	
∆600-610,	∆611-620,	∆621-630,	∆631-640,	∆641-650,	∆651-660,	∆660-671;	red).	Assay	was	performed	as	described	in	Figure	3.1	and	Chapter	II.		Images	are	representative	of	three	independent	replicates.		C.		qRT-PCR	analysis	to	score	reporter	HIS3	mRNA	expression	levels	in	the	various	yeast	strains	tested	in	panel	B.		Results	of	these	analyses	are	plotted	as	in	Figure	2.8	in	Chapter	II,	except	that	data	are	expressed	as	a	percentage	of	the	relative	HIS3	mRNA	levels	in	yeast	carrying	Rap1AS	instead	of	Rap1WT.		Data	represent	three	biological	replicates	(white	circles)	measured	in	duplicate.		Mean	±	SD	is	depicted.							*	=	p	<	0.05,	**	=	p	<	0.01,	***	=	p	<	0.005.		D.		Immunoblot	analysis	of	Rap1AS,	Rap1WT,	and	Rap1AS	deletion	variant	protein	expression	levels.		This	analysis	was	performed	as	detailed	in	Figure	2.8.		Images	are	representative	of	three	independent	replicates.		E.		Schematic	indicating	the	location	of	the	Rap1	activation	domain	(AD;	aa’s	630-671)	mapped	through	the	deletion	mutagenesis	experiments	shown	here.	
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(Figure	3.3D).		These	data,	which	are	consistent	with	the	data	obtained	from	the	N-	and	C-terminal	AD?	deletion	variants	(Figure	3.4A-C),	indicate	that	the	Rap1	AD	resides	within	aa’s	630-671	(domain	labeled	
AD;	Figure	3.3E).		Identification	of	Key	Rap1	AD	Amino	Acids	 The	deletion	mutagenesis-defined	AD	of	Rap1AS	(i.e.	aa’s	630-671)	was	subjected	to	further	site-directed	mutagenesis	in	order	to	identify	the	specific	aa	residues	that	contribute	essential	AD	function.		Based	on	the	idea	that	evolutionary	sequence	conservation	implies	conservation	of	function,	Rap1	AD-like	sequences	from	Saccharomyces	
cerevisiae	and	the	distantly	related	
sensu	lato	yeast	strains	Saccharomyces	
castelli	and	Saccharomyces	kluyveri	
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Figure	3.4.		Rap1	N-	and	C-terminal	Truncation	
Analysis	of	∆AD?	Maps	the	AD	to	Amino	Acids	630-
671..		A.		Growth	analysis	of	yeast	strains	carrying	the	3T4A	version	of	the	HIS3	reporter	(left	column;	UASRap1-
red;	labeled	3T4A)	and	various	forms	of	Rap1	(labeled	
Rap1,	second	column)	either	Rap1AS	(AS,	red)	or	the	indicated	Rap1AS	deletion	mutant	(∆AD?,	∆600-610,	
∆600-620,	∆600-630,	∆600-640,	∆600-650,	∆600-660,	
∆610-671,	∆620-671,	∆630-671,	∆640-671,	∆650-671,	
∆660-671;	red).	Assay	was	performed	as	described	in	
Figure	3.1.		Images	are	representative	of	two	independent	replicates.	B.		Immunoblot	analysis	of	Rap1AS	and	Rap1AS	deletion	variant	protein	expression	levels.		This	analysis	was	performed	as	detailed	in	Figure	2.8.		Images	are	representative	of	two	independent	replicates.		Note:	Rap1∆AD?	is	not	shown	in	this	blot,	but	multiple	blots	have	demonstrated	that	its	expression	levels	are	comparable	to	those	of	Rap1AS		(cf	Figures	3.1,	3.2,	and	
3.3	)C.		Schematic	indicating	the	location	of	the	Rap1	activation	domain	(AD;	aa’s	630-671)	mapped	through	the	deletion	mutagenesis	experiments	shown	here	and	
Figure	3.3.		
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were	subjected	to	a	multiple	sequence	alignment	to	identify	aa’s	conserved	in	all	three	yeast	species	(labeled	S.	cer,	S.	cas,	and	S.	klu,	respectively,	Figure	3.5A).		Alignment	shows	that	24	of	the	41	aa’s	within	the	Rap1	AD	were	identical	among	S.	cerevisiae	and	
sensu	lato	yeast	(Figure	3.5A).		Based	on	this	sequence	conservation,	single	point	mutant	variants	were	generated	within	the	AD	of	Rap1AS	by	changing	each	of	the	24	identical	aa’s	to	Alanine	(A)	(except	for	A670,	which	was	mutated	to	arginine	(R)).		These	Rap1AS	point	mutant	variants	were	transformed	into	the	3T4A	UASRap1-HIS3	reporter	yeast	strain	and	tested	for	the	ability	to	confer	ATR.		Growth	assays	performed	with	very	high	levels	of	3-AT	(300mM)	revealed	that	eight	aa’s,	seven	of	which	were	hydrophobic,	were	required	for	robust	ATR	growth	(Figure	3.5B;	hydrophobic	aa’s	L639,	F646,	L650,	L654,	F663,	Y665,	and	I669,	as	well	as	A670R;	all	boxed).		Steady	state	protein	levels	of	all	variant	proteins	were	essentially	identical	to	WT	(data	not	shown).		Parallel	qRT-PCR	analyses	of	mRNAHIS3	levels	in	these	same	strains	showed	some	correlation	with	ATR	patterns	(Figure	3.5C).		Importantly,	the	L650A	mutant	that	displayed	the	largest	growth	defect	also	showed	a	large	significant	reduction	in	mRNAHIS3	levels	(Figure	3.5C).		These	data	suggest	that	Rap1	AD	activity	depends	on	key	hydrophobic	aa’s.				 Because	prior	AD	mutational	analyses	showed	that	mutation	of	at	least	two	key	hydrophobic	aa’s	was	required	to	significantly	impact	transcription	(Deng	et	al.,	2001;	Drysdale	et	al.,	1995;	Lin	et	al.,	1994;	Mader,	S	et	al.,	1989;	Regier	et	al.,	1993),	Rap1AS	AD	variants	were	created	in	which	key	hydrophobic	aa	mutations	were	combined.		Specifically,	the	best	single	point	mutant	(L650A)	was	combined	with	each	of	the	other	six	key	hydrophobic	aa’s	(i.e.	L650A	+	L639A,	L650A	+	F646A,	L650A	+	L654A,	L650A	+	F663A,	
L650A	+	Y665A,	and	L650A	+	I669A).		Growth	analyses	were	performed	in	the	3T4A	
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UASRap1-HIS3	yeast	reporter	strain	to	test	the	hypothesis	that	combined	mutation	of	key	hydrophobic	aa’s	would	result	in	decreases	in	ATR,	with	combination	of	the	two	strongest	inactivating	single	point	mutations	(L650A	+	F646A)	causing	the	strongest	reduction	in	ATR.		While	all	Rap1AS	AD	combinations	showed	reduced	ATR	compared	to	the	L650A	
Figure	3.5.	The	activation	function	of	the	Rap1	AD	depends	upon	evolutionarily	conserved	
hydrophobic	amino	acids.		A.		Multiple	sequence	alignment	of	S.	cerevesiae	(S.	cer)	Rap1	activation	domain	amino	acids	630-671	with	the	corresponding	region	of	Rap1	proteins	from	the	sensu	lato	yeast	
Saccharomyces	castelli	(S.	cas.)	and	Saccharomyces	kluyveri	(S.	klu).		Amino	acids	that	are	identical	in	all	three	yeast	species	are	boxed	in	yellow.	These	conserved	amino	acids	were	targeted	for	site-directed	mutagenesis.		B.		Growth	analysis	of	yeast	strains	carrying	the	3T4A	UASRap1-HIS3	reporter	and	either	positive	(AS,	Rap1AS)	and	negative	(WT,	Rap1WT)	control	forms	of	Rap1	on	the	three	sets	of	plates	shown	(i.e.	AS,	WT	to	N645A;	AS,	WT	to	Y665A;	or	AS,	WT	to	E671E)	or	the	indicated	Rap1AS	mutant	variant	(shown,	I633A	to	E671A).		Growth	tests	were	performed	as	in	Figures	3.1-3.4,	by	plating	serial	dilutions	of	cells	on	either	non-selective	(+	His)	or	reporter	gene-selective	(+	3-AT)	media.		Rap1AS	AD	point	mutants	that	display	a	large	decrease	in	growth	relative	to	Rap1AS	are	blue-boxed.		Images	are	representative	of	five	independent	replicates.		C.		qRT-PCR	analysis	performed	on	total	RNA	prepared	from	yeast	carrying	the	3T4A	UASRap1-HIS3	reporter	and	either	Rap1AS	(AS),	Rap1WT	(WT),	or	the	indicated	Rap1AS	AD	point	mutant	variant.		Analyses	were	performed	as	detailed	for	Figure	3.3C.		Data	are	representative	of	three	biological	replicates,	each	measured	in	duplicate.		Mean	±	SD	is	depicted.		*	=	p	<	0.005,	**	=	p	=	0.0001.	
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single	mutant,	surprisingly,	L650A	+	L639A,	L650A	+	F663A,	L650A	+	Y665A,	and	L650A	
+	I669A	all	showed	weaker	ATR	than	L650A	+	F646A	(Figure	3.6A).		All	proteins	were	equivalently	expressed	(Figure	3.6B);	thus,	these	interesting	results	suggest	that	the	key	identified	aa	within	the	Rap1	AD	likely	make	different	contributions	to	AD	activity.		 	Finally,	to	test	the	hypothesis	that	the	majority,	if	not	all,	of	the	AD	activity	of	Rap1	is	conferred	by	the	key	hydrophobic	amino	acids	within	the	AD	(aa’s	630-671),	two	more	Rap1AS	AD	variants	were	prepared.		Each	was	predicted	to	ablate,	or	knock	out	(KO)	AD	activity.		The	first	‘AD-KO’	variant	of	Rap1AS	lacked	the	entire	mapped	Rap1	AD	region	(aa’s	630-671	(Figure	3.7A,	top,	labeled	∆630-671.)		The	second	Rap1AS	AD-KO	variant	was	
Figure	3.6.		Rap1	AD	Combination	Mutant	Analysis..		A.		Growth	analysis	of	yeast	strains	carrying	the	3T4A	version	of	the	HIS3	reporter	(left	column;	UASRap1-red;	labeled	3T4A)	and	various	forms	of	Rap1	(labeled	Rap1,	second	column),	either	Rap1AS	(AS,	red)	or	the	indicated	Rap1AS	point	mutant	variants	(∆AD?,	L650A,	etc;	red).	Assay	was	performed	as	described	in	Figure	3.1.		Two	different	3-AT	growth	plates	are	shown;	one	contains	a	“low”	concentration	of	3-AT	(10mM)	while	the	other	contains	a	“high”	concentration	of	3-AT	(100mM).	B.		Immunoblot	analysis	of	Rap1AS	and	Rap1AS	deletion	variant	protein	expression	levels.		This	analysis	was	performed	as	detailed	in	Figure	2.8.			
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created	by	simultaneously	mutating	all	seven	of	the	key	(cf.	Figure	3.5B)	hydrophobic	amino	acids	to	Alanine	(Figure	3.7A,	labeled	7Ala,	bottom).		Plasmid	borne	genes	encoding	Rap1AS,	Rap1WT,	Rap1AS	∆630-671	and	Rap1AS	7Ala	were	transformed	into	the	3T4A-
UASRap1-HIS3	test	strain,	and	protein	and	mRNAHIS3	levels	were	scored	by	immunoblot	and	qRT-PCR	(Figure	3.7B,	C,	respectively).		All	proteins	were	equivalently	expressed.		Notably	
Figure	3.7.	Seven	hydrophobic	Rap1	AD	amino	acids	confer	Rap1	activation	function.	
A.	Schematic	of	Rap1	illustrating	the	structures	of	two	AD	Knock-out	alleles.	Middle,	schematic	of	intact	Rap1	illustrating	the	location	of	known	functional	domains	(DBD,	AD,	SD).			Top,	Rap1	AD	sequences	630	to	671	that	were	deleted	from	Rap1.		Bottom,	the	location	and	sequence	of	the	seven	hydrophobic	amino	acids	identified	by	site-directed	mutagenesis	and	functional	assays	(Figure	6	above)	that	were	all	mutated	to	Alanine	(L639A,	F646A,	L650A,	L654A,	F663A,	Y665A	and	I669A)	to	create	the	Rap1AS	7Ala	variant.		B.		Steady	state	protein	levels	of	Rap1	variants	tested	in	panel	A	(AS,	WT,	D630-671,	7Ala;	specificity	control	=	no	tag,	as	labeled;	blots	performed	as	detailed	in	Figure	2.8).		Images	are	representative	of	two	independent	replicates.		C.		qRT-PCR	analysis	performed	on	total	RNA	prepared	from	yeast	carrying	the	3T4A	UASRap1-HIS3	reporter	and	either	Rap1AS	(AS),	Rap1WT	(WT),	or	Rap1AS	AD	knockout	variants	(∆630-671)	or	(7Ala).		Analyses	were	performed	as	detailed	for	Figures	3.3C,	3.6B.		Data	are	representative	of	three	biological	replicates,	each	measured	in	triplicate.		Mean	±	SD	is	depicted.		*	=	p	=	0.0002,	**	=	p	=	0.0001.		
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though,	the	two	AD-KO	strains	both	displayed	drastically	reduced	HIS3	mRNA	levels	relative	to	the	WT	version	of	Rap1AS.		Thus,	3T4A	UASRap1-HIS3	reporter	gene	expression	depends	predominantly	on	the	mapped	Rap1	AD,	particularly	the	7	key	hydrophobic	amino	acids	implicated	in	AD	function	by	alanine	scanning	mutagenesis.		The	Rap1	AD	is	Specific	for	Activation		 Based	on	previous	analyses	described	above	and	in	Chapter	I,	I	expected	that	the	Rap1	AD	would	be	distinct	from	the	SD	(Chen	et	al.,	2011;	Feeser	and	Wolberger,	2008;	Kyrion	et	al.,	1992;	Moretti	et	al.,	1994b).		Thus,	I	hypothesized	that	Rap1	AD	mutation	would	not	impact	the	silencing	activity	of	Rap1.			To	test	this	hypothesis,	I	used	a	
hmr∆A::TRP1	WT	UASRap1-HIS3	yeast	strain,	which	contained	both	a	reporter	for	Rap1-dependent	transcription	activation	(my	WT	UASRap1-HIS3)	and	a	previously	characterized	Rap1-dependent	silencing	reporter	(Feeser	and	Wolberger,	2008;	Sussel	and	Shore,	1991)(Figure	3.8A).		Because	both	reporters	contain	the	WT	UASRap1	binding	site,	the	7Ala	and	∆SD	(control	for	silencing)	mutations	were	introduced	into	the	context	of	Rap1WT.		Analyses	of	the	activity	of	hmr∆A::TRP1	WT	UASRap1-HIS3	yeast	carrying	only	Rap1WT,	Rap1∆SD,	or	Rap1	7Ala	as	the	sole	copy	of	Rap1	present	in	the	cell	showed	that,	unlike	the	Rap1∆SD,	Rap1	7Ala	failed	to	relieve	transcription	repression	in	an	HMRA	silencing	reporter	strain	(Feeser	and	Wolberger,	2008;	Sussel	and	Shore,	1991)(Figure	3.8C).		Since	all	proteins	were	expressed	equally	in	the	hmr∆A::TRP1	WT	UASRap1-HIS3	yeast	strain	(Figure	3.8B),	this	result	indicates	that,	as	expected,	the	Rap1	AD	plays	no	significant	role	in	transcriptional	repression.		 	
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Figure	3.8.	Mutation	of	the	mapped	Rap1	AD	does	not	affect	transcriptional	silencing.		A.	Structures	of	yeast	in	vivo	reporters.	(Top)	Structure	of	our	yeast	transcriptional	activation	HIS3-reporter	gene.		(Bottom)	The	prototypic	yeast	transcriptional	silencing	TRP1-reporter	(Sussel	and	Shore	(1991))].		Note	that	the	
HMRE	silencer	element	integrated	in	the	Shore	strain	is	deleted	for	the	Orc1	binding	sites	(i.e.	∆ORC).		The	resulting	absence	of	silencer-bound	Orc1	protein	is	indicated	by	the	dashed	box	labeled	Orc1).		Loss	of	Orc1	binding	makes	the	resulting	HMRE	silencer-TRP1	reporter	more	sensitive	to	Rap1	protein	function.		Yeast	strain	YLS34	(	Sussel	and	Shore	(1991)	was	engineered	to	contain	our	WT	UASRap1-TATA-HIS3	reporter	gene,	which	were	integrated	at	the	HIS3	locus	using	HIS3	selection	since	the	TRP1	marker	located	on	the	reporter	integration	construct	had	to	be	removed	for	this	assay.		This	strain	was	then	transformed	with	ADE2-marked	CEN-ARS	plasmids	expressing	Myc5-NLS-WT,	-7Ala	or	-∆C	(aa’s	600-827	deleted)	forms	of	Rap1.			
B.	Equivalent	expression	of	the	various	Rap1	forms.	Rap1	protein	levels	were	scored	by	immunoblotting	as	described	previously		C.	In	vivo	tests	of	silencing	and	activation	function	via	growth	assays.		Cells	expressing	the	indicated	forms	of	Rap1	(Rap1)	were	serially	diluted	and	plated	on	Synthetic	media	containing	histidine	and	tryptophan	(+His,	Trp/Control;	left),	3-Aminotriazole	(+3-AT)	to	score	for	Activation	of	the	UASRAP1-regulated	HIS3-reporter	gene	(center);	or	lacking	Trp	(-Trp)	to	score	for	Silencing	of	the	HMRE-controlled	
TRP1.		Data	shown	in	panels	B,	C	is	representative	of	2	and	4	biological	replicates,	respectively.	
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The	Rap1	AD	is	Required	for	Normal	Cell	Growth	and	Transcription		 We	reasoned	that	if	the	Rap1	AD	(and	key	AD	aa’s	mapped	therein	using	Rap1AS)	truly	represent	the	bona	fide	activation	domain	of	Rap1,	then	introducing	the	7Ala	mutation	in	the	context	of	the	Rap1WT	should	cause	a	decrease	in	the	transcription	of	chromosomal	Rap1-dependent	genes	and	a	concomitant	decrease	in	growth	rate.		Importantly,	testing	these	mutations	into	the	context	of	the	WT	version	of	the	protein	also	controls	for	potential	synthetic	genetic	interactions	between	the	altered	DBD	sequences	of	Rap1AS	and	the	altered	sequences	that	were	introduced	into	the	mapped	AD.		To	probe	the	question	of	the	essentiality	of	the	Rap1	AD	for	growth,	the	ability	of	the	7Ala	mutation	in	the	otherwise	Rap1WT	protein,	carefully	scored	for	complementation	of	a	rap1∆	null	mutant	strain	using	the	plasmid	shuffle	method.		Rap1WT	and	empty	plasmid	vector	respectively,	served	as	positive	and	negative	controls	for	this	test.		While	Rap1WT	efficiently	and	specifically	complements	rap1∆,	the	Rap17Ala	variant	only	weakly	complemented	(compare	growth	of	WT	vs.	7Ala	strains,	row	1	vs.	row	3;	Figure	3.9A)	despite	the	fact	that	the	two	proteins	were	equally	expressed	(Figure	3.9B).		The	dramatic	growth	deficiency	of	the	Rap17Ala-expressing	strain	was	quantified	via	growth	curves.		The	WT	strain	doubling	time	is	94	minutes	while	the	Rap17Ala	expressing	strain	requires	nearly	twice	as	long,	155	minutes,	to	double	(Figure	3.9C).	Thus,	consistent	with	my	expectations,	the	Rap1	AD	is	required	for	normal	rates	of	cell	growth.		 Assuming	that	the	Rap1	activation	domain	mapped	here	actually	functions	specifically	in	the	activation	of	authentic	chromosomal	target	genes,	it	is	reasonable	to	predict	that	Rap1	AD	loss-of-function	mutants	would	exhibit	reduced	expression	of	both	RP-	and	GE-encoding	genes.		Indeed,	extensive	cis-element	mapping,	use	of	conditional	
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Figure	3.9.	The	Rap1	AD	is	required	both	for	normal	growth	and	transcription	of	authentic	
chromosomal	Rap1-target	genes.		A.		The	ability	of	the	Rap17Ala	variant	to	support	cell	viability	was	assessed	by	plasmid	shuffle	analyses.	Yeast	carrying	a	chromosomal	null	RAP1	allele	(rap1∆)	and	a	URA3-marked	RAP1	covering	plasmid	were	transformed	with	a	test	variant	of	RAP1,	labeled	rap1*:	(i)	a	second	plasmid-borne	copy	of	RAP1	(labeled	WT);	(ii)	empty	plasmid	vector	(labeled	-);	or	(iii)	the	same	plasmid	vector	expressing	the	Rap17Ala	variant	(labeled	7Ala).		Yeast	were	serially	diluted	1:4	(left	to	right)	and	growth	was	scored	on	media	either	lacking	5-FOA	(“Unshuffled”;	relevant	genotype:	RAP1,	rap1∆,	
rap1*),	or	containing	5-FOA	(“Shuffled”	relevant	genotype:	-,	rap1∆,	rap1*)	as	detailed	in	“Chapter	II”	
Figure	2.7.		Images	are	representative	of	five	independent	replicates.	B.		Immunoblot	analysis	of	the	in	vivo	steady	state	levels	of	Rap1WT	and	Rap17Ala	proteins.		Analysis	was	performed	as	described	in	above.		Images	are	representative	of	four	independent	replicates.		C.		Growth	curve	analysis	of	three	biological	replicates	of	shuffled	yeast	strains	expressing	either	only	Rap1WT	or	Rap17Ala,	performed	and	plotted	as	described	in	“Chapter	II”	Figure	2.8.		D.		Analysis	of	nascent	RNA	levels	for	several	chromosomal	yeast	genes	(integrated	UASRap1-HIS3	reporter,	ENO1,	PYK1,	RPS3,	RPL26B,	RPL3)	in	cells	solely	expressing	WT	RAP1	or	the	7Ala	variant	of	RAP1.		Cellular	RNAs	were	pulse-labeled	with	4sU	for	2.5	minutes,	extracted,	purified,	RNA	thiol	groups	chemically	biotinylated,	and	affinity	purified	and	analyzed	via	qRT-PCR	to	quantify	the	amount	of	nascent	transcripts	produced	from	each	of	the	six	genes	noted	above.		qRT-PCR	analyses	were	performed	as	described	previously	except	that	data	were	normalized	to	
Schizosaccharomyces	pombe	tubulin	mRNA	present	due	to	the	spike-in	of	4sU	pulse-labeled	S.	pombe	cells	into	each	sample	prior	to	RNA	extraction.		Data	are	representative	of	three	biological	replicates,	each	measured	in	triplicate.		Mean	±	SD	is	depicted.		*	=	p	<	0.0025,	**	=	p	<	0.0001.		See	“Nascent	RNA	Labeling	and	Purification”	section	for	details.		
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alleles,	and	ChIP-based	in	vivo	occupancy	studies	all	support	the	idea	that	Rap1	contributes	importantly	to	the	expression	of	these	two	gene	classes	(Knight	et	al.,	2014;	Kurtz	and	Shore,	1991;	Lickwar	et	al.,	2012b;	Lieb	et	al.,	2001;	Reja	et	al.,	2015;	Yarragudi	et	al.,	2006).		However,	two	considerations	preclude	straightforward	interpretation	of	the	effects	of	mutations	in	Rap1	(or	other	transcription	proteins)	on	cellular	steady	state	mRNA	levels.		First,	unlike	the	synthetic	chimeric	UASRap1-HIS3	reporter	gene	studied	in	the	experiments	in	Chapter	II	and	Figures	3.1-3.7,	expression	of	both	RP-	and	GE-encoding	genes	is	modulated	by	multiple	transactivator	proteins	in	addition	to	Rap1	(Hall	et	al.,	2006;	Kasahara	et	al.,	2007b;	Knight	et	al.,	2014;	Marion	et	al.,	2004;	Mencıá	et	al.,	2002;	Reid	et	al.,	2000;	Rudra	et	al.,	2005;	Schwalder	et	al.,	2004;	Scott	and	Baker,	1993;	Wade	et	al.,	2004b).		As	a	consequence,	mutations	in	the	AD	of	Rap1	will	likely	not	result	in	as	large	a	decrement	in	authentic	chromosomal	target	gene	transcription	as	observed	with	the	HIS3	reporter	gene	(cf.	Figures	3.3,	3.5,	3.7).		Second,	another,	and	perhaps	more	important	factor	complicating	interpretation	of	such	experiments	that	monitor	steady	state	mRNA	levels	is	the	fact	that	transcription	and	mRNA	degradation	are	linked.		Both	prokaryotic	and	eukaryotic	cells	can	maintain	steady	state	transcript	levels	despite	loss	of	key	proteins	involved	in	either	transcription/transcription	activation,	or	mRNA	degradation	by	modulating	these	dynamic	processes	(Bonnet	et	al.,	2014;	Chow	and	Dennis,	1994;	Haimovich	et	al.,	2013;	Schulz	et	al.,	2014;	Sun	et	al.,	2012,	2013).	To	 circumvent	 these	 caveats	 the	 4-thiouracil	 (s4U)	 nascent	 RNA	 pulse	 labeling	method	of	RNA	analysis	(Bonnet	et	al.,	2014;	Duffy	et	al.,	2015;	Schulz	et	al.,	2014;	Sun	et	al.,	 2012,	 2013)	 was	 employed	 to	 monitor	 nascent	 transcript	 levels	 in	 cells	 expressing	either	WT	Rap1	or	 the	7Ala	AD	Rap1	variant	as	 the	sole	source	of	Rap1	(i.e.	 the	shuffled	
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strains	 analyzed	 in	 Figure	 3.9A-C).	 [Note	 that	 both	 strains	 carry	 the	 integrated	 WT	
UASRap1-HIS3	reporter	gene].		Nascent	RNA	levels	for	five	actively-transcribed	chromosomal	genes	and	the	integrated	HIS3	reporter	gene	were	scored	by	qRT-PCR	(see	“Nascent	RNA	Labeling	and	Purification”	for	details).		Four	of	the	actively	transcribed	chromosomal	genes	are	Rap1-dependent	(two	glycolytic,	ENO1,	PYK1;	 two	RP-encoding	genes,	RPS3,	RPL26B),	while	 one	 chromosomal	 Rap1-independent	 RP-encoding	 gene	 was	 scored	 (RPL3).		Alteration	 of	 the	 Rap1	 AD	 by	 the	 7Ala	 mutation	 dramatically,	 and	 specifically,	 reduced	transcription	 of	 the	 known	 Rap1-dependent	 genes	 (UASRap1-HIS3,	ENO1,	PYK1,	RPS3	 and	
RPL26B),	but	not	the	Rap1-independent	RPL3	gene	(Figure	3.9D).		The	specific	reductions	in	transcription	of	the	known	Rap1-dependent	genes	ranged	from	~50%	for	the	synthetic	reporter	 gene	 (UASRap1-HIS3;	 Figure	 3.9D)	 to	 ~80%	 for	 two	 of	 the	 Rap1-dependent	chromosomal	 genes	 (ENO1,	RPL26B;	Figure	 3.9D).	 	 Collectively,	 this	 data	 demonstrates	that	 the	 Rap1	 AD,	 mapped	 and	 characterized	 here	 through	 the	 use	 of	 the	 altered	 DNA-binding	specificity	variant	of	Rap1,	is	a	bona	fide	activation	domain.		Mutation	of	the	Rap1	Activation	Domain	Reduces	Binding	to	the	Rap1	Binding	Domain	(RBD)	of	the	TFIID	Coactivator	Subunit	Taf5	We	have	previously	shown	that	Rap1	binds	specifically,	and	with	high	affinity,	to	distinct	RBDs	within	the	Taf4,	Taf5	and	Taf12	subunits	of	TFIID	(Garbett	et	al.,	2007;	Layer	et	al.,	2010).		Rap1-Taf	RBD	binding	is	sensitive	to	RBD	mutation,	and	we	found	that	yeast	expressing	such	mutations	in	either	Taf4	or	Taf5	display	reduced	RP	mRNA	gene	expression	(Layer	and	Weil,	2013;	Layer	et	al.,	2010).		These	data	argue	that	TFIID	serves	as	a	coactivator	for	Rap1.		However,	we	did	not	know	which	domain(s)	within	Rap1	was	
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responsible	for	Rap1-Taf	RBD	interactions.	I	theorized	that	if	the	Rap1	AD	plays	a	key	role	in	Rap1-TFIID	Taf-RBD	interaction,	then	mutation	of	the	AD	should	reduce	Rap1-Taf	binding.		Because	we	had	previously	documented	synthetic	lethal	interactions	between	Taf5	RBD	mutants	and	Rap1	deletion	variants	(Layer	et	al.,	2010),	we	decided	to	perform	GST-Rap1/Taf5	pull-down	binding	experiments	as	a	first	test	of	our	Rap1	AD-Taf	RBD	direct	interaction	hypothesis.		These	studies	used	an	N-terminal	RBD-containing	fragment	of	Taf5	(aa’s	1-337)	and	either	GST-	alone	(GST-),	GST-fused	to	WT	Rap1	(GST-Rap1	WT),	GST-fused	to	the	7Ala	variant	of	Rap1	(GST-Rap1	7Ala),	and	GST-fused	to	Rap1	∆C	(GST	Rap1	∆C).		I	observed	that	both	the	7Ala-	and	the	∆C-Rap1	variants	reproducibly	displayed	an	~50%	reduction	in	binding	to	the	Taf5	RBD	(Figure	3.10).			These	results	are	consistent	with	the	hypothesis	that	the	Rap1	AD	I	have	mapped	is	central	to	transcriptional	activation.		 Discussion			 Transcription	factor	AD	mapping	represents	a	critical	step	in	the	path	towards	determining	the	mechanism	by	which	a	gene,	or	group	of	co-regulated	genes,	are	activated.		Our	lab	is	particularly	interested	in	the	Rap1	AD	because	Rap1	in	budding	yeast	drives	the	transcription	of	128	of	the	138	genes	encoding	ribosomal	proteins	as	well	as	many	of	the	genes	encoding	the	enzymes	of	glycolysis	(Chambers	et	al.,	1995;	Knight	et	al.,	2014;	Lieb	et	al.,	2001;	Rudra	and	Warner,	2004).		These	two	classes	of	genes	are	among	the	most	vigorously	transcribed	families	of	genes	in	most	organisms.		Understanding	the	mechanisms	controlling	expression	of	such	highly	transcribed	classes	of	genes	will	provide	
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Figure	3.10.	Mutation	of	the	Rap1	AD	Reduces	Binding	of	Rap1	to	the	Rap1	Binding	Domain	(RBD)	
of	the	TFIID	Coactivator	Subunit	Taf5.		A.		Sypro	Stained	NuPAGE	gel	of	Taf5/GST-Rap1	pulldown	protein-protein	binding	reactions.		Pull-down	experiments	were	conducted	using	negative	control	GST-,	positive	control	GST-WT	Rap1,	test	GST-7Ala	Rap1,	and	test	GST-∆C	Rap1-loaded	GST-agarose	beads	and	the	N-terminal	RBD-containing	fragment	of	Taf5	(aa’s	1-337).		Glutathione	sepharose	beads	loaded	with	either	12	pmol	of	GST	or	6	pmol	of	GST-Rap1	variant	(GST-,	GST-WT	Rap1,	GST-7Ala	Rap1,	GST-∆C	
Rap1;	labels,	arrows)	were	incubated	with	either	0	or	100	pmol	of	purified	Taf5	fragment	under	the	conditions	detailed	in	“GST	Pull-down	Assays”.		All	incubations	contained	Bovine	Serum	Albumin	(BSA;	
label,	arrow)	to	minimize	non-specific	protein	binding	to	the	beads.		Bead-bound	proteins	were	eluted	with	SDS-sample	buffer,	heat-denatured	and	fractionated	on	an	SDS-PAGE	gel	in	parallel	with	molecular	weight	standards	(MW)	and	25	pmol	purified	Taf5	(Taf5).	Gels	were	stained	with	Sypro	Ruby	and	images	were	obtained	using	a	Pharos	Fx.		Image	is	representative	of	four	independent	replicates.			
B.	Quantification	of	the	data	shown	in	‘A.’	Quantity	One	software	was	used	to	score	the	intensity	of	GST-,	GST-Rap1	variant,	and	Taf5	bands.		The	intensity	of	each	Taf5	band	was	normalized	to	the	intensity	of	each	GST-	or	GST-Rap1	variant	band	and	then	Taf5	binding	to	GST-beads	alone	was	subtracted	from	the	Taf5	binding	of	all	GST-Rap1	variants.		Taf5	binding	data	obtained	from	four	independent	replicates	are	plotted	using	Graph	Pad	Prism	7	software	as	a	percentage	of	the	Taf5	binding	to	GST-Rap1	WT.		Mean	±	SD	is	depicted.		*	=	p	=0.002.		
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valuable	and	potentially	generalizable	mechanistic	insights	into	how	highly	expressed	eukaryotic	genes	are	regulated.In	budding	yeast,	transcription	of	the	genes	encoding	RPs	is	controlled	through	the	action	of	multiple	DNA	binding	transcription	proteins.		These	include	Rap1,	Ifh1,	Fhl1,	Sfp1	and	Hmo1	(Hall	et	al.,	2006;	Kasahara	et	al.,	2007b;	Marion	et	al.,	2004;	Reid	et	al.,	2000;	Rudra	et	al.,	2005;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004b).		RP	gene	transcription	is	responsive	to	a	variety	of	regulatory	inputs,	several	of	which	respond	to	nutrient	availability	and/or	cell	size	(Lempiäinen	and	Shore,	2009;	Marion	et	al.,	2004;	Rudra	and	Warner,	2004;	Rudra	et	al.,	2005;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004b).		These	two	regulatory	pathways	appear	to	work	through	Ifh1/Fhl1	and	Sfp1	(Marion	et	al.,	2004;	Rudra	et	al.,	2005;	Schwalder	et	al.,	2004;	Wade	et	al.,	2004b),	and	thus	appear	distinct	from	Rap1	function(s).		Meanwhile,	Rap1	is	the	only	activator	that	is	absolutely	required	for	transcription	of	the	RP	encoding	genes,	as	deletion	of	the	genes	encoding	these	other	factors	(or	their	cognate	DNA	binding	elements)	reduces,	but	does	not	eliminate	RP	gene	expression	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002).	Our	lab	has	had	a	long-standing	interest	in	Rap1	and	RP	encoding	genes	because	transcription	of	this	gene	family	requires	TFIID	(Garbett	et	al.,	2007;	Holstege	et	al.,	1998;	Irvin	and	Pugh,	2006;	Kuras	et	al.,	2000;	Layer	and	Weil,	2013;	Layer	et	al.,	2010;	Li	et	al.,	2000,	2002;	Mencıá	et	al.,	2002;	Ohtsuki	et	al.,	2010;	Papai	et	al.,	2010;	Shen	and	Green,	1997;	Shen	et	al.,	2003;	Singh	et	al.,	2004;	Tsukihashi	et	al.,	2001).		The	lab	has	previously	shown	that	Rap1	directly	interacts	with	the	RP	gene	coactivator	TFIID	(Garbett	et	al.,	2007),	that	this	binding	is	specific,	high	affinity,	and	mediated	through	distinct	Rap1	Binding	Domains	(RBDs)	present	in	TFIID	subunits	Taf4,	Taf5	and	Taf12	(Garbett	et	al.,	
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2007;	Layer	et	al.,	2010).		Deletion	of	the	RBDs	from	either	Taf4	or	Taf5	is	lethal,	while	the	aa’s	within	these	ca.	100-300	aa	domains	are	mutable,	and	certain	point	mutations	within	either	RBD	leads	to	temperature-conditional	growth	and	reduced	affinity	of	binding	to	Rap1.		Moreover,	certain	combinations	of	distinct,	non-lethal	rap1	deletion	mutants	with	
taf5ts	mutants	induces	synthetic	lethality,	while	shifting	strains	carrying	either	taf4ts	or	
taf5ts	mutant	alleles	to	non-permissive	temperatures	induces	a	large	and	selective	decrease	in	expression	of	essentially	the	entire	complement	of	RP	encoding	genes	(Layer	et	al.,	2010).	The	lab	also	previously	documented	and	characterized	important	interactions	between	Rap1	and	TFIIA.		Mutations	that	compromise	these	interactions	decrease	TFIIA-TFIID	and	TFIIA-Taf4	interaction/binding,	RP	gene	expression	in	vivo,	and	Rap1-driven	reporter	gene	transcription	in	vitro	(Layer	and	Weil,	2013).		Finally,	the	lab	has	previously	described	unique	Rap1-induced,	TFIIA-	and	TFIID-dependent	DNA	looping	and	Rap1-dependent	protein	structural	transitions	of	TFIIA	within	a	quaternary	Rap1-TFIIA-TFIID-
UASRap1-TATA	DNA	complex	(the	enhancer-promoter	reporter	DNA	used	in	my	work)	(Papai	et	al.,	2010).			Collectively	these	data	lead	us	to	propose	that	Rap1	directly	and	specifically	binds	subunits	of	both	TFIID	and	TFIIA	in	order	to	activate	transcription	of	the	RP	encoding	genes	(Garbett	et	al.,	2007;	Layer	and	Weil,	2013;	Layer	et	al.,	2010;	Papai	et	al.,	2010,	2011).		As	a	prerequisite	to	advance	these	studies,	and	to	more	fully	dissect	the	molecular	mechanisms	utilized	by	Rap1	to	activate	transcription,	it	is	essential	to	have	a	collection	of	AD	variants	of	Rap	that	are	defective	in	RP	gene	transcription	activation.		Unfortunately,	though	much	is	known	regarding	the	TFIID	coactivator	subunit	targets	of	Rap1,	prior	to	the	work	described	in	my	dissertation,	there	was	no	unambiguous	
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data	regarding	whether	Rap1	actually	contains	a	functional	AD.		As	a	consequence,	I	decided	to	use	the	Rap1AS	described	in	Chapter	II	as	a	novel	tool	to	facilitate	the	identification	and	high-resolution	characterization	of	an	AD	within	Rap1.		My	unambiguous	AD	mapping	data	also	show	that	the	best	of	my	altered	DNA-binding	specificity	variants,	Rap1AS,	represents	a	powerful	tool	to	study	Rap1	structure-function	relationships.		Activator	proteins,	such	as	Rap1,	can	contain	one	or	more	ADs,	usually	30-100	aa’s	in	size.		ADs	have	been	classified	based	on	the	kinds	of	aa’s	that	dominate	the	activation	domain:	acidic,	proline-rich,	and	glutamine-rich	(Mitchell	and	Tjian,	1989;	Titz,	2006).			Using	Rap1AS,	I	have	found	that	both	the	Rap1	C-terminus	and	the	Rap1	N-terminus	can	contribute	to	activation,	depending	on	whether	the	assayed	reporter	gene	was	designed	based	on	an	RP	or	a	glycolytic	gene,	respectively.		I	focused	on	the	Rap1-C-terminal	aa’s	involved	in	activation	for	because,	unlike	the	N-terminus,	the	Rap1	C-terminus	interacts	with	TFIID	(Garbett	et	al.,	2007)	and	is	thus,	likely	critical	for	activation	of	the	TFIID-dependent	RP	genes	as	well	as	the	RP	gene	reporter.		There	is	no	evidence,	to	my	knowledge,	that	the	Rap1	N-terminus	interacts	directly	with	a	coactivator	(such	as	SAGA)	at	present,	and	thus	does	not	fit	the	classical	criteria	for	AD	designation.		Indeed,	prior	analyses	have	led	to	the	proposition	that	the	Rap1	N-terminus	contributes	to	GE	gene	transcription	through	facilitating	the	binding	of	the	Gcr1	and	Gcr2	DNA-binding	transcription	activators	to	GE	enhancer	(UAS)	sequences	(López	et	al.,	1998;	Mizuno	et	al.,	2004).		Focusing	on	the	Rap1	C-terminus,	a	single	AD	of	the	protein	was	successfully	mapped	to	Rap1	aa’s	630-671.		This	41-aa	region	exhibits	a	predicted	pI	of	3.84	due	to	the	fact	that	it	contains	nine	glutamate	and	aspartate	amino	acids,	20%	of	the	total	AD	residues.	Thus,	the	Rap1	AD	falls	into	the	acidic	class	of	ADs.	
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	 Although	this	acidic	AD	is	located	within	the	AD	mapped	using	the	Gal4	DBD-Rap1	fusion	approach	(aa’s	630-692)(Hardy	et	al.,	1992a),	my	analyses	provide	important	additional	insights.		Studies	of	acidic	ADs	have	shown	that	typically	they	contain	small	clusters	of	key	hydrophobic	aa’s	that	actually	confer	AD	activity	(Deng	et	al.,	2001;	Drysdale	et	al.,	1995;	Lin	et	al.,	1994;	Regier	et	al.,	1993)	rather	than	their	acidic	aa’s	(Brzovic	et	al.,	2011;	Lin	et	al.,	1994).		Consistent	with	this	principle,	my	mutational	analyses	of	individual	Rap1	AD	aa’s	showed,	for	the	first	time,	that	specific	individual	hydrophobic	aa’s	(i.e.	L639,	F646,	L650,	L654,	F663,	Y665,	and	I669)	contribute	critically	to	Rap1	AD	function.		My	Rap1	AD	analysis,	however,	did	reveal	a	few	interesting	differences	between	the	Rap1	AD	and	other	well-studied	activator	ADs.		First,	in	contrast	to	other	activators	such	as	VP16,	Zta,	Gcn4,	p53,	and	glucocorticoid	receptor	(GR),	where	at	least	two	AD	mutations	must	be	made	to	noticeably	decrease	transcriptional	activity	of	an	intact	AD	in	reporter	assays	(Deng	et	al.,	2001;	Drysdale	et	al.,	1995;	Iñiguez-Lluhí	et	al.,	1997;	Lin	et	al.,	1994;	Regier	et	al.,	1993),	several	single	point	Rap1	AD	mutant	variants	(i.e.	L639A,	F646A,	L650A,	L654A,	F663A,	Y665A,	and	I669A;	Figure	3.5B)	displayed	defects	in	activity	as	scored	by	growth.		It	is	also	surprising	that	it	was	the	non-polar	L650A	mutant	that	showed	a	significant	decrease	in	mRNAHIS3	levels	in	qRT-PCR	(Figure	3.5C),	instead	of	a	bulky	aromatic	hydrophobic	amino	acid	(i.e.	F,	Y,	or	P),	which	have	been	shown	to	be	the	most	critical	contributors	to	AD	function	in	other	well-characterized	ADs	(Deng	et	al.,	2001;	Drysdale	et	al.,	1995;	Iñiguez-Lluhí	et	al.,	1997;	Lin	et	al.,	1994;	Regier	et	al.,	1993).		Finally,	the	Rap1	AD	activity	is	spread	over	a	large	number	of	contiguous	aa’s	(i.e.	seven	aa’s;	see	
Figures	3.5-3.10)	compared	with	other	ADs	whose	activity	is	concentrated	on	only	2-3	aa’s	(Drysdale	et	al.,	1995;	Iñiguez-Lluhí	et	al.,	1997;	Lin	et	al.,	1994;	Regier	et	al.,	1993;	
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Warfield	et	al.,	2014).		It	is	tempting	to	speculate	that	these	seven	key	hydrophobic	aa’s	may	represent	separate/overlapping	binding	domains	for	the	known,	distinct	coactivator	targets	of	Rap1	(Garbett	et	al.,	2007;	Layer	and	Weil,	2013;	Layer	et	al.,	2010;	Tomar	et	al.,	2008).		Alternatively,	collectively,	these	seven	critical	AD	aa’s	may	enable	Rap1	to	bind	with	unusually	high	affinity	to	its	coactivator	targets	and	thus	drive	the	high	levels	of	transcription	observed	at	the	RP-encoding	genes.		Indeed,	it	was	recently	shown	that	the	addition	of	hydrophobic	aa’s	to	a	small	nine	residue	AD	sub-motif	of	yeast	Gcn4	could	increase	coactivator	binding	affinity	and	transcription	activity	(Warfield	et	al.,	2014).		I	believe	that	the	collection	of	Rap1	AD	point	mutants	generated	here	will	prove	to	be	powerful	reagents	for	investigating	these	possibilities.			 Importantly,	my	studies	also	demonstrate,	for	the	first	time,	that	transcription	of	authentic	chromosomal	Rap1-dependent	target	genes	and	Rap1-TFIID	Taf5	coactivator	target	binding	depend	on	a	discrete	AD	within	Rap1.		The	results	of	my	Rap1WT	and	Rap17Ala	variant	pulse-labeling	studies	provide	compelling	evidence	that	the	Rap1	AD	functions	to	specifically	modulate	transcription	activation	of	chromosomal	Rap1	target	genes	(Figure	3.8).		These	results	are	all	the	more	notable	given	the	number	of	recent	studies	that	document	the	robust	ability	of	yeast	to	maintain	normal	steady-state	transcript	levels	in	the	face	of	mutations	in	genes	encoding	key	mRNA	synthesis	and	mRNA	degradation	proteins.		It	is	highly	likely	that	these	findings	would	have	been	difficult	to	observe	without	the	use	of	the	nascent	RNA	labeling	technique.		My	pulse-labeling	analyses	also	revealed	that	the	Rap1	AD	played	a	role	on	both	the	RP	and	GE	genes	tested,	in	contrast	to	my	glycolytic	reporter	gene	expression	analyses	which	suggested	that	the	Rap1	N-terminus	contains	the	Rap1	aa’s	most	important	for	glycolytic	gene	expression.		A	
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possible	explanation	for	this	observation	is	that	the	Rap1	domains	involved	in	activation	may	vary	among	the	GE	genes,	each	of	which	encodes	an	independently	functioning	enzyme.				 Finally,	my	GST-Rap1/Taf5	pull-down	binding	experiments	(Figure	3.10)	show	that	the	Rap1	AD	binds	coactivator	targets	as	expected	and	provides	an	important	starting	point	for	dissecting	the	biochemical	mechanism	of	transcription	activation	by	the	Rap1	AD.	Admittedly,	the	2-fold	reduction	in	Taf5	binding	observed	in	the	Rap17Ala	mutant	may	seem	weak	compared	to	the	magnitude	of	reduction	in	coactivator	target	binding	expected	from	mutation	of	the	key	aa’s	of	the	sole	Rap1	AD.		It	is	very	likely,	however,	that	the	Rap1	AD-Taf5	interaction	is	not	the	only	AD-coactivator	interaction	driving	Rap1-dependent	gene	transcription	given	that	within	the	TFIID	coactivator	Rap1	additionally	targets	Tafs	4	and	12	and	could	possibly	interact	with	TFIIA	(Garbett	et	al.,	2007;	Layer	et	al.,	2010;	Papai	et	al.,	2010).		Indeed,	mutation	of	the	RBDs	within	these	Tafs	4,	5,	and	12	resulted	in	reductions	in	Rap1	binding	of	magnitude	comparable	to	the	reduction	in	Taf5	binding	resulting	from	the	Rap1	7Ala	mutation	(Layer	et	al.,	2010).		Alternatively,	the	affect	of	Rap1	AD	mutation	on	Taf5	binding	in	the	pull-down	assay	could	be	partially	masked	by	Rap1-binding	to	Taf5	surfaces	that	are	not	available	when	Taf5	is	in	the	context	of	the	TFIID	complex.			 The	Rap1	AD	may	also	target	other	coactivators.		Because	Rap1	can	bind	nucleosomal	UASRap1	sites	(Koerber	et	al.,	2009)	and	reposition	nucleosomes	(Yu	and	Morse,	1999),	the	Rap1	AD	may	target	chromatin	remodeling	factors,	in	addition	to	TFIID	and	TFIIA	subunits,	in	order	to	modulate	target	gene	transcription.		In	fact,	several	recent	studies	have	suggested	that	the	high	level	of	RP	and	GE	gene	transcription	requires	altered	
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nucleosome	stabilities	and/or	positioning	(Knight	et	al.,	2014;	Kubik	et	al.,	2015;	Reja	et	al.,	2015).		Consistent	with	these	observations,	the	ATP-dependent	nucleosome	remodeling	complex	Swi/Snf	has	been	shown	to	interact	with	Rap1	(Tomar	et	al.,	2008).		The	Rap1	AD	may	also	directly	contact	the	chromatin	remodeling	RSC	complex	(Kubik	et	al.,	2015)	and/or	the	histone	acetyltransferase	NuA4	complex,	both	of	which	have	been	identified	as	important	regulators	of	Rap1-dependent	gene	transcription	(Reid	et	al.,	2000;	Rohde	and	Cardenas,	2003;	Uprety	et	al.,	2015).		Future	studies	can	address	these	important	questions.		 In	conclusion,	the	Rap1	AD	mapping	and	the	Rap1	AD	mutants	generated	through	my	studies	represent	an	important	advance	in	Rap1	biology.		These	advances	were	made	possible	by	the	generation	of	a	true	altered	DNA-binding	specificity	Rap1AS	and	provide	a	case	study	demonstrating	the	power	of	the	Rap1AS	approach.				This	information	and	the	reagents	generated	will	enable	future	important	work	aimed	at	molecularly	dissecting	the	mechanisms	responsible	for	regulating	the	robustly	transcribed	RP-	and	GE-encoding	genes,	including	testing	our	lab’s	novel	“Lock	to	Load”	model	of	transcription	activation.									
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CHAPTER	IV		FUTURE	DIRECTIONS	
	
	 Summary		 The	work	presented	in	this	dissertation	represents	my	efforts	to	determine	the	domain(s)	and	molecular	mechanism(s)	Rap1	uses	to	activate	protein-coding	gene	transcription.		This	work	achieved	two	important	goals.		The	first	of	these	goals	was	the	generation	of	Rap1AS,	presented	in	Chapter	II	of	this	dissertation.		Rap1AS	represents	both	an	achievement	for	the	field	of	protein	engineering,	where	developing	proteins	with	novel	DNA-binding	specificity	represents	an	important	goal,	and	a	tool	to	provide	more	precise	and	straightforward	dissections	of	the	myriad	functions	of	Rap1.		The	second	goal	was	the	identification	of	the	Rap1	AD	and	the	determination	of	how	it	functions	presented	in	Chapter	III	of	this	dissertation.		In	addition	to	providing	a	thorough	characterization	of	the	Rap1	AD	and	providing	the	critical	demonstration	that	this	AD	functions	on	authentic	chromosomal	Rap1	target	genes,	my	efforts	have	resulted	in	the	identification	of	the	TFIID	Taf5	subunit	as	a	target	of	the	Rap1	AD.		The	identification	of	Taf5	as	a	target	of	the	physiologically	relevant	Rap1	AD	represents	a	critical	step	towards	systematic	testing	of	the	“Lock	to	Load”	model.		Taken	along	with	the	lab’s	multiple	demonstrations	that	Rap1-TFIID	and	TFIID-TFIIA	interactions	are	required	for	RP	gene	transcription	(Layer	and	Weil,	2013;	Layer	et	al.,	2010),	this	result	shows	that	the	protein-protein	interactions	in	the	“Lock	to	Load”	model	proposed	based	on	EM	structural	analyses	(Papai	et	al.,	2010)	are	important	in	vivo.		It	also	links	“Lock	to	Load”	to	an	AD	such	that	it	is	indeed	possible	that	the	TFIIA	conformational	change	identified	in	the	Rap1-TFIID-TFIIA-complex	is	triggered	
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by	direct	Rap1	AD-coactivator	interaction	and	therefore,	represents	a	key	step	in	transcription	regulation.		 These	results	lay	the	groundwork	for	future	studies	aimed	at	thoroughly	testing	the	“Lock	to	Load”	model	of	transcription	activation.		In	my	path	to	generating	these	results,	I	also	made	several	observations	that,	while	not	pertaining	directly	to	“Lock	to	Load,”	could	provide	interesting	and	important	avenues	for	further	experimentation.		I	explore	these	possible	future	directions	in	this	final	chapter	of	my	dissertation.		How	Do	Rap1AS	Screen	Hits	Achieve	Expanded	and	Altered	DNA-binding	Specificities?		 My	successful	generation	of	Rap1AS	in	Chapter	II	presents	a	research	opportunity	to	advance	knowledge	of	protein-DNA	interactions	and	provide	guidance	for	protein	engineering	efforts.		My	Rap1AS	demonstrates	true	altered	DNA-binding	specificity	in	vivo	and	in	vitro.		How	is	this	true	altered	DNA-binding	specificity	achieved?			 To	achieve	true	altered	DNA-binding	specificity,	a	DNA-binding	protein	must	both	gain	the	ability	to	bind	a	mutant	UAS	site	while	reducing/losing	its	ability	to	bind	the	WT	
UAS.		The	MEME-generated	motif	of	Rap1AS	sequences	revealed	that	all	Rap1AS	screen	hit	sequences	possessed	an	N401	mutation	to	either	a	non-polar	aa	(such	as	G,	P,	or	A)	or	(in	the	case	of	Rap1	mutant	#2	a	charged	polar	mutation	(R).		They	also	all	possess	an	H405	mutation	to	either	a	bulky	non-polar	aa	(W	or	F)	or	a	small	non-polar	aa.		The	fact	that	the	same	kinds	of	changes	in	aa’s	N401	and	H405	were	found	in	the	sequences	of	all	Rap1AS	screen	hits	suggests	that	these	changes	enable	functional	interaction	with	the	3T4A	UAS.		Meanwhile,	as	discussed	in	Chapter	II,	comparison	of	the	Rap1AS	hit	sequences	of	those	variants	that	showed	true	altered	compared	to	those	that	showed	expanded	specificity	
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suggests	that	a	bulky	non-polar	hydrophobic	mutation	at	aa	405	and	a	mutation	at	aa	408	reduce	Rap1	variant	binding	to	the	WT	UAS.		Finally,	the	variability	in	the	kinds	of	mutations	present	at	aa	409	shows	that	there	is	little	selection	on	this	aa,	and	it	likely	does	not	contribute	to	either	expanded	or	altered	DNA-binding	specificity.						 These	hypotheses	could	be	tested	using	a	family	of	Rap1	variants	generated	by	systematically	introducing	mutations	found	in	the	Rap1AS	sequence	(N401R,	H405W,	R408L,	V409C)	or	the	H405S	mutation	proposed	to	contribute	to	expanded	rather	than	true	altered	DNA-binding	specificity	individually	and	in	combination	into	RAP1.			This	family	of	Rap1	variants	could	then	be	tested	for	the	ability	to	functionally	interact	with	3T4A	UASRap1	using	the	ATR	growth	assay	and	qRT-PCR.		Variants	that	functionally	interacted	with	3T4A	UASRap1	could	then	be	tested	for	expanded	vs.	true	altered	DNA-binding	specificity	via	the	plasmid	shuffle	and	gel	shift	DNA-binding	competition	assays	utilized	in	this	dissertation.			 Completion	of	the	proposed	analyses	of	the	family	of	Rap1	variants	described	above	would	result	in	the	identification	of	the	aa’s	required	for	both	expanded	and	true	altered	DNA-binding	specificity.		To	gain	insight	into	how	these	aa’s	structurally	achieve	altered	DNA-binding	specificity,	a	structure-prediction	program	such	as	ROSETTA	(Leaver-Fay	et	al.,	2011)	could	be	used	to	model	the	structure	of	Rap1	DBD	variants	in	complex	with	the	WT	and	3T4A	UASRap1	sites.				These	models	could	be	tested	by	crystallizing	the	Rap1	DBD	variants	in	complex	with	the	WT	and/or	3T4A	UASRap1	sites	(depending	on	whether	the	variant	demonstrated	expanded	or	true-altered	DNA-binding	specificity)	using	the	protocol	outlined	by	previous	studies	of	Rap1	DBD-DNA	co-crystal	structures	(König	et	al.,	1996;	Matot	et	al.,	2012;	Taylor	et	al.,	2000).		Finally,	the	data	obtained	from	these	co-
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crystallization	studies	could	be	fed	back	into	protein-DNA	structure	prediction	algorithims	to	improve	their	predictive	capabilities.		These	studies,	especially	when	combined	with	the	data	obtained	from	the	genetic	and	biochemical	experiments	performed	on	the	family	of	Rap1	variants	designed	based	on	the	Rap1AS	sequence,	would	provide	a	thorough	understanding	of	how	expanded	and	true	altered	specificity	are	achieved	by	Rap1AS	screen	hits.		 	What	is	the	Role	of	the	Rap1	N-Terminus	In	Glycolytic	Enzyme	Gene	Expression?		 In	the	Rap1	AD	mapping	studies	described	in	Chapter	II,	I	found	that,	in	contrast	to	the	RP	reporter	gene,	my	glycolytic	reporter	gene	depended	primarily	on	the	Rap1	N-terminus	for	expression.		Although	my	pulse	labeling	studies	show	that	the	Rap1	AD	contributes	to	the	expression	of	the	chromosomal	genes	tested,	this	finding	raises	the	possibility	that	Rap1	domains	may	make	differential	contributions	to	the	activation	of	the	TFIID-dependent	RP	genes	compared	to	the	SAGA-dependent	GE	genes.		The	Rap1	N-terminus	has	been	previously	implicated	in	budding	yeast	GE	gene	expression;	analyses	conducted	prior	to	my	study	showed	that	the	Rap1	N-terminus	interacts	genetically	with	the	glycolytic	transcription	activators	Gcr1	and	Gcr2	(Mizuno	et	al.,	2004)	and	contributes	to	Gcr1	DNA-binding	in	gel	shift	analyses	(López	et	al.,	1998).			However,	these	genetic	and	biochemical	interactions	with	Gcr1	and	Gcr2	have	not	been	further	characterized.				 My	Rap1AS	and	Rap1AS-dependent	glycolytic	reporter	gene	could	be	used	to	precisely	define	which	of	the	Rap1	N-terminal	aa	where	required	for	glycolytic	reporter	gene	expression.		First	though,	the	glycolytic	reporter	gene	would	need	further	characterization.		Prior	to	the	studies	I	conducted	for	my	dissertation,	our	lab	and	others	
	 134	
showed	via	ChIP	that,	like	authentic	RP	genes,	the	RP	reporter	gene	I	used	for	my	AD	mapping	is	occupied	by	both	Rap1	and	TFIID	(Garbett	et	al.,	2007;	Mencıá	et	al.,	2002).		To	determine	whether	or	not	my	glycolytic	reporter	gene	behaves	like	the	chromosomal	PGK1	gene	it	is	based	on,	ChIP	analyses	should	be	performed	to	test	the	occupancy	of	Rap1,	Gcr1,	and	SAGA-specific	subunits	on	the	UAS	and	promoter	on	my	reporter	and	on	PGK1.		Assuming	that	the	chromosomal	PGK1	gene	and	my	reporter	gene	show	similar	transcription	factor	occupancy	patterns,	growth	and	qRT-PCR	analyses	could	be	conducted	on	yeast	containing	this	reporter	and	Rap1AS	N-terminal	deletion/point	mutants	to	define	the	N-terminal	aa’s	required	for	expression.		Mutations	that	reduced	expression	of	the	Rap1AS-dependent	glycolytic	reporter	gene	could	be	introduced	into	the	context	of	Rap1WT;	nascent	RNA	pulse	labeling	coupled	with	qRT-PCR	could	be	used	to	determine	if	the	N-terminal	regions	mutated	were	required	for	expression	of	authentic	chromosomal	glycolytic	genes.			These	analyses	would	determine	whether	the	Rap1	BRCT	domain,	which	shows	weak	transcription	activation	and	chromatin	remodeling	activity	when	fused	to	a	heterologous	DBD	(Miyake	et	al.,	2000),	or	some	other	Rap1	N-terminal	aa	contribute	to	glycolytic	gene	expression.		 To	find	out	whether	or	not	any	Rap1	N-terminal	aa’s	required	for	GE	gene	expression	function	as	hypothesized	via	a	protein-protein	interaction	with	Gcr1	and/or	Gcr2,	GST-Rap1WT	and	GST-Rap1	mutant	variants	could	be	tested	for	interaction	with	purified	Gcr1	and	Gcr2	via	pull-down	assays	similar	to	those	presented	in	Chapter	III.		Alternatively,	protein	samples	prepared	via	coimmunoprecipitation	of	Rap1WT	and	Rap1	N-terminus	mutants	from	yeast	cells	could	be	analyzed	via	mass-spectrometry	as	an	unbiased	approach	to	determining	Rap1-interacting	factors	that	require	the	Rap1	N-terminal	aa’s	
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needed	for	glycolytic	gene	expression.	The	Rap1	7	Ala	mutant	could	be	included	in	these	analyses	to	identify	Rap1	AD	interacting	factors	and	to	test	the	hypothesis	that	the	Rap1	AD	and	N-terminus	interact	with	distinct	sets	of	protein	factors.		Our	lab	has	used	this	approach	previously	to	identify	protein	factors	that	interact	with	each	of	the	TFIID	subunits	(Sanders	et	al.,	2002b).		Completion	of	these	studies	would	provide	a	stronger	characterization	of	the	Rap1	N-terminal	domains	and	protein-protein	interactions	used	to	drive	GE	expression	as	well	as	insight	into	how	Rap1	may	differentially	regulate	the	yeast	GE	and	RP	gene	classes.						 	 How	Does	the	Rap1	AD	Interact	with	TFIID/TFIID	subunits?		 As	part	of	my	efforts	to	determine	how	the	Rap1	AD	biochemically	affects	transcription	activation,	I	have	identified	the	TFIID	subunit	Taf5	as	a	Rap1	AD	target.		This	exciting	and	important	result	suggests	that	Rap1	activates	transcription	through	AD-TFIID	interaction,	as	expected	based	on	our	prior	investigations	of	Rap1-TFIID	interactions	(Garbett	et	al.,	2007;	Layer	et	al.,	2010).			This	result	also	merits	further	investigation,	and	several	experiments	could	be	performed	to	further	define	the	Rap1	AD	interaction	with	TFIID,	let	alone	other	possible	coactivator	targets.		 Previous	analyses	performed	in	the	lab	have	shown	that	Rap1	interacts	with	TFIID	via	RBDs	located	within	Tafs	4,	5,	and	12	(Garbett	et	al.,	2007;	Layer	et	al.,	2010).		Does	the	Rap1	AD	interact	with	Tafs	4	and	12	in	addition	to	interacting	with	Taf5?		Pull-down	experiments	similar	to	those	performed	in	Chapter	III	could	be	used	to	test	this	possibility.		Because	Taf4	is	reportedly	unstable	when	expressed	individually	(Justin	H.	Layer,	unpublished	observations),	I	have	performed	preliminary	pull-down	experiments	to	test	
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Rap1	AD	interaction	with	Tafs	4	and	12	(Figure	4.1A)	using	MBP-Taf4/12	purified	for	a	previous	study	(Layer	and	Weil,	2013).		This	MBP-Taf4/12	material	is	imperfect,	as	the	intensity	of	the	Taf4	and	12	bands	suggests	a	much	greater	than	1:1	stoichiometry	of	Taf4	to	Taf12	(see	Figure	4.1A	“Input”).		Interestingly	though,	as	in	my	Taf5	RBD	pull-downs	(cf	Figure	
3.10)	my	GST-Rap1	∆C	and	GST-Rap1	7Ala	bound	less	MBP-Taf4	than	GST-Rap1	WT	(Figure	4.1A,B).		Additional	pull-down	assays	using	either	Taf4/12	proven	to	be	a	heterodimer	via	gel	filtration	or	Taf4	and	Taf12	individually	could	be	performed	to	validate	this	result,	which	suggests	that	the	Rap1	AD	targets	Taf4/12	as	well	as	Taf5.		The	identification	of	multiple	Rap1	AD	interacting	factors	raises	the	possibility	that	the	seven	key hydrophobic	amino	acids	identified	in	my	Rap1	AD	mapping	actually	make	unique	contacts	with	TFIID	subunits.		This	possibility	should	be	tested	by	performing	GST	pull-down	assays	with	Rap1	
Figure	4.1.	Rap1	∆C	and	7	Ala	mutants	show	reduced	
Taf4/12	interaction.	A.		Sypro	stained	SDS-PAGE	gel	of	GST-	and	GST-Rap1	variant	pull-down	reactions	performed	with	increasing	amounts	of	MBP-Taf4/12.	B.	Quantification	of	the	data	presented	in	“A”	obtained	by	scoring	the	amount	of	MBP-Taf4	in	each	lane,	normalizing	for	the	amount	of	GST-	or	GST-Rap1	variant	present	in	the	reaction,	and	subtracting	out	the	amount	of	MBP-Taf4	in	the	corresponding	GST	only	reaction.		
A. 
M
W
M
BP
 Ta
f4
/1
2 
- - - -4/12 4/12 4/12 4/12
GST-
GST-
Rap1WT
GST-
Rap1∆C
GST-
Rap1 7Ala
B. 
MBP-Taf4/12 Added (pmol)
(M
BP
-T
af
4/
12
 B
ou
nd
)/
GS
T-
Ra
p1
GST-
GST-Rap1WT/ 7Ala
GST-Rap1∆C
MBP-Taf4
Taf12
BSA
0 10 20 30 40
0.0
0.2
0.4
0.6
0.8 = WT
= ∆C 
= 7Ala
	 137	
AD	single	point	(i.e.	L650A)	and	combination	(i.e.	L650A	+	F663A)	mutant	variants,	with	the	goal	of	identifying	separation-of-function	and	graded-loss-of-function	mutants.		 Biophysical	and	cross-linking	studies	could	also	be	used	to	further	understand	Rap1	AD	TFIID-interaction.		For	example,	nuclear	magnetic	resonance	spectroscopy	(NMR),	which	has	been	used	to	biophysically	characterize	the	VP16,	Gcn4,	and	p53	ADs	(Brzovic	et	al.,	2011;	Jonker	et	al.,	2005;	Krois	et	al.,	2016;	Uesugi	et	al.,	1997),	could	be	used	to	define	the	Rap1	AD	structure	alone	and	in	complex	with	the	Taf5	as	well	as	the	Taf4	and	Taf12	RBDs.		These	studies	would	test	the	hypothesis	that	the	Rap1	AD	amino	acids	identified	as	important	for	AD-Taf	RBD	interaction	by	the	NMR	structure	would	be	the	same	as	those	required	for	the	Rap1	transcription	activation	function.		Additionally,	the	Kd	of	Rap1	AD	interaction	with	the	Taf	4,	5,	and	12	RBDs	could	be	determined	and	compared	to	each	other	and	to	the	Kd’s	of	other	so	characterized	AD-coactivator	binding	interactions.		Finally,	site-specific	cross-linking,	which	has	been	used	to	identify	the	in	vivo	targets	of	the	Gal4	and	Gcn4	ADs	(Fishburn	et	al.,	2005;	Reeves	and	Hahn,	2005),	could	be	used	to	determine	whether	or	not	the	Rap1	AD	interacts	with	Tafs	4,	5,	and/or	12	in	vivo	as	expected	based	on	the	complementary	genetic	and	biochemical	analyses	performed	in	our	lab	(Garbett	et	al.,	2007;	Johnson	and	Weil,	2017;	Layer	et	al.,	2010).			Taken	together,	the	results	of	these	studies	would	provide	a	thorough	understanding	of	Rap1	AD-TFIID	interaction.		 What	is	the	Mechanistic	Consequence	of	Rap1	AD-TFIID	Taf	Interaction:	Testing	“Lock	to	“Load”		 In	addition	to	my	identification	of	Taf5	as	a	Rap1	AD	target	and	the	experiments	proposed	above	aimed	at	further	defining	the	Rap1	AD-TFIID	interaction,	biochemical	and	
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structural	analyses	could	be	performed	to	determine	the	mechanistic	consequence	of	Rap1	AD-TFIID	interaction.		Since	pull-down	assays	and	biolayer	interferometry	have	repeatedly	failed	to	detect	a	direct	Rap1-TFIIA	interaction	(Amanda	N.	Meyer,	Justin	H.	Layer,	and	Scott	G.	Miller,	unpublished	observations),	defining	the	biochemical	consequences	of	Rap1	AD-TFIID	interaction	represents	the	most	likely	path	to	uncovering	the	mechanism	of	RP	gene	transcription	activation.		These	experiments	would	ultimately	put	our	“Lock	to	Load”	model	of	transcription	activation	to	the	test.		Immobilized	template	assays	could	be	performed	to	test	the	binding	of	TFIID	and	TFIIA	to	DNA	along	with	Rap1WT,	Rap17Ala,	and,	if	identified	in	the	proposed	Rap1	AD-TFIID	interaction	experiments,	a	series	of	Rap1	AD	mutant	graded	loss-of-function	variants.		The	“Lock	to	Load”	model	predicts	that	these	experiments	will	fail	to	show	that	the	Rap1	AD	is	required	for	TFIID	cooperative	binding	to	DNA.		However,	a	variation	of	these	assays	could	be	performed	to	probe	the	stability	of	the	Rap1-TFIID-TFIIA-DNA	complex,	which	may	be	enhanced	by	a	Rap1	AD-TFIID	interaction	triggered	post-DNA	recruitment	TFIIA	conformational	change.		Alternatively,	Rap1-TFIID-TFIIA-DNA	complex	formation	and	stability	could	be	assessed	via	DNase	I	footprinting	and/or	agarose	gel	shift	analysis.		The	impact	of	the	Rap1	AD	on	enhancer-promoter	DNA	loop	formation,	which	our	“Lock	to	Load”	model	suggests	is	a	consequence	of	TFIIA	conformational	change	could	be	assessed	by	DNA	loop	ligation	assay.		Although	Rap1	itself	has	been	implicated	in	DNA-looping	(Hofmann	et	al.,	1989;	Papai	et	al.,	2010),	it	is	not	yet	clear	whether	or	not	this	DNA-looping	is	influenced	by	the	Rap1	AD	via	its	interaction	with	TFIID.		 Of	course	the	most	critical	tests	of	the	“Lock	to	Load”	model	would	be	performed	via	EM.		Specifically,	EM	analyses	of	the	quaternary	complexes	formed	by	Rap1-TFIID-TFIIA-
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DNA	and	Rap17Ala-TFIID-TFIIA-DNA	could	be	used	to	test	the	requirement	of	the	Rap1	AD	for	TFIIA	conformational	change.		Platinum	shadowing	could	also	be	used	to	visualize	DNA	loops	formed	in	quarternary	complexes	containing	Rap1WT	vs.	Rap1	7Ala.		These	analyses	would	ultimately	determine	if	the	Rap1	AD	is	required	for	TFIIA	conformational	change	and	enhancer-promoter	DNA	loop	formation;	if	so,	these	activities	indeed	likely	represent	key	components	of	our	“Lock	to	Load”	model	of	TFIID-dependent	transcription	activation.			How	Generalizable	Is	the	TFIID	Coactivator	Activity	Observed	In	Budding	Yeast	RP	genes?		 If	indeed	“Lock	to	Load”	accurately	represents	the	mechanism	regulating	transcription	activation	of	the	RP	genes,	how	generalizable	is	the	“Lock	to	Load”	model?		Does	“Lock	to	Load”	only	operate	on	budding	yeast	RP	genes?		Is	the	transcription	activation	of	other	robustly	transcribed	genes,	including	the	RP	genes	of	other	organisms	regulated	via	“Lock	to	Load”?				 Determining	how	RP	genes	are	regulated	in	other	organisms	provides	one	means	of	investigating	the	generalizability	of	the	“Lock	to	Load”	model.		Surprisingly	given	the	intense	selection	pressure	on	RP	genes	based	on	their	requirement	for	cell	growth	and	viability,	the	particular	transcription	activators	that	bind	RP	gene	UAS/enhancer	elements	varies	drastically	over	the	evolutionary	tree.		For	example,	while	most	budding	yeast	RP	genes	depend	on	Rap1	(Knight	et	al.,	2014;	Reja	et	al.,	2015),	basal	metazoan	and	human	RP	gene	enhancers	contain	binding	sites	for	GABP,	Sp1,	and	YY1	transcription	factors	(Perina	et	al.,	2011).		Even	the	RP	genes	of	other	yeast	contain	UAS	elements	for	factors	other	than	Rap1	(Hogues	et	al.,	2008;	Lavoie	et	al.,	2009;	Tanay	et	al.,	2005;	Tuch	et	al.,	2008).			
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	 As	part	of	a	collaborative	project	with	Drs.	Sandy	Johnson	and	Trevor	Sorrells	at	UCSF	investigating	the	rewiring	of	RP	genes,	I	have	performed	a	few	experiments	to	help	define	the	molecular	mechanism	of	RP	gene	regulation	in	the	yeast	Kluyveromyces	lactis	(K.	
lactis).	Compared	to	S.	cerevisiae	RP	genes,	many	K.	lactis	RP	genes	contain	a	binding	site	for	Mcm1	located	in	proximity	to	a	binding	site	for	Rap1	(Tuch	et	al.,	2008).		In	reporter	assays	performed	using	a	K.	lactis	RP	reporter	gene	consisting	of	the	GFP	ORF	driven	by	a	
TATA,	UASRap1,	and	UASMcm1	elements,	Drs.	Sorrells	and	Johnson	have	shown	that	UASRap1	and	UASMcm1	drive	reporter	gene	expression	cooperatively,	suggesting	that	Rap1	and	Mcm1	cooperatively	activate	transcription.		These	investigators	originally	hypothesized	that	this	cooperative	activation	was	achieved	via	a	protein-protein	interaction	between	Rap1	and	Mcm1	gained	in	K.	lactis	compared	to	S.	cerevisiae.		However,	they	found	that	the	UASRap1	and	UASMcm1	sites	cooperatively	activate	expression	of	their	RP	reporter	gene	in	S.	
cerevisiae,	indicating	that	the	ability	of	these	factors	to	cooperatively	activate	transcription	is	likely	ancestral.		Further,	gel	shift	DNA-binding	assays	performed	using	K.	lactis	and	S.	
cerevisiae	cell	extract	and	purified	proteins	showed	that	Rap1	and	Mcm1	bind	DNA	independently	rather	than	cooperatively	(manuscript	in	preparation).		As	a	result,	Drs.	Johnson	and	Sorrells	hypothesized	that	Rap1	and	Mcm1	cooperatively	activate	gene	expression	through	binding	a	shared	transcription	coregulator	target.				 Based	on	our	lab’s	work	on	RP	gene	regulation	in	S.	cerevisiae	(Garbett	et	al.,	2007;	Layer	and	Weil,	2013;	Layer	et	al.,	2010),	Drs.	Johnson	and	Sorrells	hypothesized	that	this	shared	transcription	coregulator	target	was	the	TFIID	coactivator.		They	solicited	our	lab’s	collaboration	in	testing	this	hypothesis.		As	part	of	this	investigation,	I	set	out	to	determine	which	Rap1	domains	were	required	for	expression	of	the	UASRap1-Mcm1	reporter	in	budding	
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yeast	with	the	hypothesis	that,	if	cooperative	reporter	activation	depends	on	TFIID,	then	reporter	expression	should	depend	on	the	Rap1	C-terminus,	which	interacts	directly	with	TFIID.		To	perform	these	experiments,	I	once	again	turned	to	the	HIS3	reporter	and	Rap1AS.		ATR	growth	analyses	of	a	series	of	WT	and	mutant	UASRap1-Mcm1	reporters	designed	based	on	the	GFP	reporters	assayed	by	my	collaborators	(Figure	4.2A)	showed	that,	like	the	GFP	reporters,	expression	of	the	UASRap1-Mcm1-HIS3	reporters	depended	on	both	UASRap1	and	
Figure	4.2.	The	Rap1	∆AD?	is	required	for	expression	of	the	UASRap1-Mcm1	HIS3	reporter	designed	
based	on	a	K.	lactis	RP	gene.		A.	Upper:	ATR	growth	analyses	performed	as	described	in	Chapters	II	and	III	on	yeast	containing	either	a	second	copy	of	Rap1WT	or	Rap1AS	and	the	indicated	UASRap1-Mcm1	reporter	gene.	Lower:	structure	of	the	UASRap1-Mcm1	reporter	gene	used	in	these	assays.		Mutations	introduced	into	the	
UASRap1	and	UASMcm1	sites	by	binding	site	nucleotide	scrambling	are	highlighted	in	black.		The	3T4A	(“AS”)	mutations	introduced	into	UASRap1	to	generate	the	Rap1AS	binding	site	are	shown	in	red.		B.	Rap1	protein	map	indicating	the	location	of	the	major	Rap1	domains.		C.	ATR	growth	analyses	performed	in	yeast	carrying	the	UASRap1AS-Mcm1WT		reporter	and	either	Rap1WT,	Rap1AS,	or	the	indicated	Rap1AS	mutant	variant.			
D.	Immunoblot	analysis	performed	to	assess	steady-state	Myc5-tagged	Rap1AS	and	Rap1AS	variant	protein	expression	levels	using	actin	as	a	protein	loading	control.	
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UASMcm1	(Figure	4.2A).		Additionally	and	importantly,	Rap1AS	conferred	ATR	to	a	UASRap1AS-
Mcm1-HIS3	reporter;	this	ATR	depended	on	UASMcm1	(Figure	4.2A).		These	results	support	the	use	of	my	Rap1AS	and	the	UASRap1AS-Mcm1-HIS3	reporter	gene	for	the	dissection	of	the	Rap1	domains	(Figure	4.2B)	involved	in	UASRap1-Mcm1	reporter	activation.	
	 Analyses	of	ATR	growth	in	UASRap1AS-Mcm1-HIS3	reporter	budding	yeast	containing	Rap1AS	and	Rap1AS	deletion	mutants	revealed	that	expression	of	the	UASRap13T4A-Mcm1-HIS3	reporter	depends	on	the	Rap1	C-terminus,	particularly	the	AD?	domain	(Figure	4.2C).		The	Rap1AS∆C	and	Rap1AS∆AD?	variants	are	stable	and	expressed	at	levels	comparable	to	those	of	Rap1AS	(Figure	4.2D).		Thus,	like	my	budding	yeast	RP	reporter	UASRap1-HIS3,	expression	of	the	UASRap1AS-Mcm1-HIS3	reporter	requires	Rap1	domains	known	to	interact	with	TFIID	as	hypothesized.		To	provide	a	better	test	of	this	hypothesis,	I	am	currently	repeating	these	analyses	using	my	Rap1AS7Ala	variant	to	determine	if	UASRap1AS-Mcm1-HIS3	reporter	expression	depends	on	the	Rap1	AD	that	I	have	mapped	and	shown	interacts	with	the	TFIID	subunit	Taf5.		 I	have	also	performed	Far	Western	protein-protein	binding	assays	using	purified	holo-TFIID	and	TFIID	Tafs	to	determine	if	Mcm1	directly	interacts	with	TFIID	subunits.		Interestingly,	I	have	found	that	Mcm1	interacts	directly	with	Tafs	4,	5,	and	12	in	the	Far	Western	assay	(Figure	4.3A,B),	the	same	TFIID	subunits	that	bind	Rap1.		I	am	currently	working	on	Far	Western	competition	assays	to	test	whether	these	interactions	are	specific.		Assuming	that	the	Mcm1-TFIID	subunit	interactions	I	have	detected	are	specific,	this	result	raises	the	possibility	that	Rap1	and	Mcm1	cooperatively	activate	UASRap1-Mcm1	reporter	and	
K.	lactis	RP	genes	through	the	TFIID	coactivator	as	originally	postulated	by	Drs.	Johnson	and	Sorrells.		Additionally,	this	result	suggests	that	transcription	activator	binding	to	TFIID	
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is	a	conserved	feature	of	RP	gene	transcription,	at	least	across	yeast	species.		Further	testing	will	be	required	to	determine	whether	Mcm1	and	RP	transcription	activators	in	higher	eukaryotes	also	directly	interact	with	TFIID	via	their	ADs	and	if	this	interaction	results	in	the	TFIIA	conformational	change	and	DNA	loop	locking	that	represent	the	key	steps	in	the	“Lock	to	Load”	mechanism	of	transcription	activation.																		
Figure	4.3.		MBP-Mcm1	binds	TFIID	Tafs	4,	5,	and	12	in	the	
Far	Western	Assay.		A.	A	Sypro-Ruby	Stained	SDS-PAGE	gel	containing	MBP-	and	MBP-Mcm1	proteins	tested	for	their	ability	to	interact	with	TFIID	subunits	via	Far	Western.		B.	Far	Western	analysis	of	MBP-	and	MBP-Mcm1	binding	to	TFIID	subunits.		In	this	analysis,	TFIID	and	His6-Tafs	4,	5,	and	12	as	well	as	Taf3	(included	as	a	negative	control)	purified	by	Drs.	Jordan	T.	Feigerle	and	Justin	H.	Layer	were	separated	on	an	SDS-PAGE	gel	and	either	stained	with	Sypro	Ruby	(left	panel)	or	transferred	to	a	membrane	for	the	Far	Western	assay	(middle	and	right	panels).		These	membranes	were	probed	with	either	control	MBP	(middle	panel)	and	MBP-Mcm1	(right	panel).		Binding	of	the	probe	protein	to	any	of	the	proteins	on	the	membrane	was	detected	via	immunoblot	using	an	anti-MBP	antibody.	
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